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—

New Guidelines for
Antithrombotic Therapy
In Surgical Cases
The American College of Chest Physi
cians and the National Heart, Lung and
Blood Institute recently issued new
guidelines for antithrombotic therapy.1
There were four Grade A recom
mendations for the use of warfarin
(Coumadin®) in surgical cases. In each
of these four (and other Grade A and B
recommendations for Coumadin®) a PT
ratio of 1.2-1.5 (rabbit brain) was
emphasized for clinical efficacy and
reduced side-effects risk.
an
INDICATIONS: Elective hip surgery/
surgery for fractured
hips.

CONDITION: Bioprosthetic heart valves.

patients undergoing elective hip surgery
should be pretreated prophylactically with
adjusted-dose heparin or moderate-dose war
farin sodium. .
. patients undergoing surgery for fractured
hips should be treated prophylactically with
moderate-dose warfarin.
"

all patients with bioprosthetic heart valves
in the mitral position be treated for the first
three months after valve insertion with less
intense warfarin ..."
. .
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INDICATION: Prophylaxis of venous
thromboembolism.

1

"It is strongly recommended that the
therapeutic range for prophylaxis ... in highrisk medical or surgical patients should be
equivalent to an INR of 2.0-3.0 (corresponding
rabbit brain thromboplastin ratio 1.2-1.5)."
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(warfarin sodium)

CONDITION: Prophylaxis of venous
thromboembolism.

"It is recommended that anticoagulant therapy
should be continued for three months using
oral anticoagulants to prolong prothrombin
tim e. . ."
1. C h e st 1 9 6 6 ;8 9 (2 );1 S -1 0 6 S
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QUILL ON SCALPEL
This section provides a medium through which Canadian
surgeons can declare themselves, briefly and informally, on
the day-to-day affairs of surgery.

Substitutes for Homologous Blood Transfusion
One cornerstone of surgical treatment,
the use of homologous blood, is being
challenged for very good reasons. The
transmission of infectious diseases, espe
cially acquired immune deficiency syn
drome (AIDS) and hepatitis, and the evi
dence that homologous blood transfu
sions can induce immunosuppression1
have stimulated the search for alternative
therapies. Non-A, non-B hepatitis, for
which vaccination is not available, is the
commonest life-threatening infection
transmitted by blood transfusion.2 A
high prevalence (8% to 17%) of post
transfusion hepatitis has been reported
from Sweden, Spain, Italy, the United
States and Israel. Lower percentages (2%
to 5%) are reported from Australia, Fin
land, West Germany and Canada.2
The transmission of the human
immunodeficiency virus (HIV) is rela
tively low by sexual contact (1% per
exposure),3 even lower by contaminated
needlestick (less than 1% per exposure),
but is highly efficient in single-donor
blood products. Studies4 of recipients of
blood from donors in whom AIDS later
developed have never identified a

recipient who did not acquire the infec
tion after a transfusion from an infected
donor.
At least four strategies to avoid trans
fusion of homologous blood are availa
ble to us — hemodilution, predonation,
normovolemic hemodilution and cell
saving.
Hemodilution with acceptance of a
lower hematocrit (0.25 to 0.30) is one of
the simplest measures, the consequences
of which are reviewed by Landow in this
issue (pages 321 to 325). Patients should
not have any pulmonary defect that might
impair oxygenation of blood and must
have the capacity to increase cardiac out
put to ensure oxygen delivery.
Autologous blood donation is safe and
deserves wider clinical application. Mann
and associates5 found no dangerous
complications in 342 “ high-risk”
patients, including those with severe heart
disease, the elderly, children and pregnant
women. Absolute contraindications to
autologous blood predeposit are bactere
mia, severe coronary artery disease and
anemia. The number of donations, given
at intervals of 2 to 7 days, is calculated.
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assuming that the target preoperative
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Normovolemic hemodilution is a third
option. When a substantial blood loss at
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of blood are withdrawn, before or after
induction of anesthesia, into standard col
lection bags and as CPD blood at room
temperature. The amount of blood with
drawn is replaced simultaneously by
isovolemic infusion of colloids (human
albumin 5%) or Ringer’s lactate solution
in a volume three times that of the blood
withdrawn, to maintain normovolemia.
The autologous blood ideally is reinfused
when hemostasis is established. The units
are reinfused without a filter to ensure
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maximum retransfusion of platelets.
Autotransfusion (cell saving) is the
final technique. Devices are available for
aspirating shed blood into a plastic bag
through a filter with transfusion by
gravity or external pressure. Air embolism
is a risk of systems that aspirate blood
from the operative field into a reservoir
with immediate transfusion. More studies
are required to determine the precise
requirements of cell washing and the
potential risks of infusing clotting factors
and tumour cells, but the equipment used
for blood retrieval in open-heart surgery
is being widely used in clean abdominal

and thoracic noncardiac surgery to save
blood.
All these techniques are extremely
effective and can eliminate completely the
need for homologous blood transfusion
in the majority of patients on whom it is
currently being used.
L loyd D. M a c L ea n ,
Coeditor.

m d , frcsc

Surgeon-in-chief,
Royal Victoria Hospital,
687 Pine Ave. W,
Montreal, PQ
H3A 1A1
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Postresection Empyema
Empyema complicating pulmonary resec
tion is relatively uncommon today. Sur
gical residents and young graduate
surgeons are unlikely to have encounte
red the problem often. Furthermore,
most young surgeons have never perfor
med a thoracoplasty or seen one perfor
med. In this issue of the Journal are two
articles describing the management of
postresection empyema. They will be of
considerable interest to readers. The arti
cle by Bayes and colleagues from Mon
treal (pages 329 to 331) describes their
experience with what can be termed the
“ m odern” treatment of postresection
empyema — the Clagett technique of
open-window thoracostomy followed by
closure of the thoracostomy after sterili
zation of the empyema cavity. The second
article by Gregoire and colleagues from
Quebec City (pages 343 to 345) describes
what can be referred to as the “ oldfashioned” treatment for postpneumo
nectomy empyema — a six-rib singlestage thoracoplasty.
Although these articles appear to pre
sent competing techniques for the mana
gement of postresection empyema, they
are actually complementary and both can
be part of a comprehensive treatment
scheme.
Historically, open-window thoracos
tom y was originally described by
Eloesser1 in 1935 for the management of
tuberculous empyema. The procedure
involves the creation of a U-shaped skin
flap and resection of a 5-cm rib segment,
after which the edge of the cutaneous flap
is sutured to the pleura. Clagett and
Geraci2 modified this procedure by ope
ning the post-thoracotomy incision and
suturing the “ superficial fascia” to the
periosteum of the resected rib, leaving a
good-sized window in the thoracic wall.
This facilitates irrigation of the empyema
space and avoids the use of a tube, resul
314

ting in much greater comfort for the pa
tient. Clagett and Geraci2 also intro
duced the concept that a pleural space
infected after pneumonectomy can be
sterilized by irrigation with an antiseptic
solution (such as half-strength Dakin’s
solution) through an open thoracostomy
window and that in 6 to 8 weeks the pleu
ral cavity can be filled with a saline solu
tion containing 250 mg/dl of neomycin
and the thoracostomy window closed.
It is important to emphasize that
empyema occurring after pneumonec
tomy is an extremely serious complication
with a very high morbidity and mortality.
In the Quebec series of 46 patients with
nontuberculous, postpneumonectomy
empyema, definitive treatment by singlestage thoracoplasty was attempted in only
17 (37%) patients. For a variety of rea
sons, the remaining patients were not con
sidered candidates for definitive treatment
and it can be assumed that many of them
died early after operation as a result of
their empyema. In the Montreal series,
103 patients had empyema but only 41
underwent open-window thoracostomy.
This group included 28 patients with
postpneumonectomy empyema. Although
Bayes and associates were not specific,
it is likely that there were others with
postpneumonectomy empyema who did
not undergo definitive therapy and died
as a consequence of this complication.
Although both articles address primarily
the issue of treatment, perhaps more
emphasis should have been placed on
the prevention of this catastrophic com
plication. As Bayes and colleagues point
out, the published incidence of postre
section empyema varies between 2% and
10%. However, in the current practice
of thoracic surgery, a rate of 10% is
totally unacceptable and 2% should be
the goal. Such a low incidence of post
resection emDyema can be achieved by the

careful selection and preparation of
patients for surgery and by meticulous
surgical technique.
It is also important to emphasize that
postresection empyemas vary in their
associated morbidity and mortality. An
empyema that occurs as a complication
of pneumonectomy is far more serious
than one following lobectomy. Further
more, an empyema that is complicated by
a bronchopleural fistula is more serious
and difficult to manage than one not
complicated by such a fistula. Fistulas
themselves can be subdivided into major
and minor depending on the size of
the bronchial opening. Therefore, a com
parison of different techniques for the
management of postresection empyemas
must take into account the different
types.
The experience of the Montreal group
with the Clagett two-stage procedure sug
gests that this technique may be success
ful in managing patients without a bron
chopleural fistula or in patients with small
fistulas that close spontaneously. Of their
17 patients who had a postpneumonec
tomy empyema and a bronchopleural
fistula, closure of the thoracostomy win
dow was attempted in only 11 and in only
4 (36%) of these was primary closure suc
cessful. Therefore, success was achieved
in less than 25% of the 17 patients. Of
the 11 patients who had postpneumonec
tomy empyema without a bronchopleural
fistula, 7 had attempted closure of the
thoracostomy window with success in 6,
an overall success rate of 55%.
The series reported from Quebec
presents a technique that is well known
to thoracic surgeons who trained during
the era when surgery for pulmonary
tuberculosis was common — a spacereducing thoracoplasty. The authors uti
lized a tailoring six-rib (second to seventh
ribs inclusive) thoracoplasty in 17
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patients, with a successful outcome in 15
(88%). O f the 17 patients, 7 had a
bronchopleural fistula, but in only 2 was
the fistula considered sufficiently major
to require specific treatment. Although
the results appear superior to those
reported by the Montreal group it must
be emphasized that the treated group was
highly selected and only 17 patients from
the entire group of 41 were treated by
thoracoplasty.
The lessons we can learn from these
two articles are fourfold.
• Postpneumonectomy empyema, par
ticularly that associated with a major
bronchopleural fistula, is a very serious
complication and is better prevented than
treated.
• Once the complication occurs, sep
sis must first be controlled and aspiration
avoided. These can be achieved by openwindow thoracostomy; adjuvant treat

ment involves the appropriate use of
antibiotics and careful attention to
nutrition.
• In the absence of a bronchial fistula
or when the fistula closes spontaneously,
the Clagett procedure of irrigation of the
empyema cavity followed by closure of
the thoracostomy window may be success
ful. If the Clagett procedure fails, the
window can be reopened and a spacereducing thoracoplasty, as advocated by
the Quebec group, can be carried out in
“ good risk” patients. The thoracoplasty
must be meticulously performed follow
ing the principles they advocate. If the
bronchial fistula is minor (less than 2 mm
in diameter), closure of the fistula is likely
to result from the thoracoplasty alone. If
the fistula is major, then it will have to
be closed by some type of muscle flap.
• In patients who have evidence of
recurrent neoplasm or who cannot toler

ate a thoracoplasty, the open-window
thoracostomy can be maintained in the
long term.

N.M. Sheiner,

md, frcsc

Member,
Editorial Board.
Chief of Cardiovascular and
Thoracic Surgery,
Sir Mortimer B. Davis-Jewish
General Hospital,
3755 Cote Ste-Catherine,
Montreal, PQ
H3T 1E2
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Lower Extremity Amputation in Elderly Patients
The increasing longevity of the popula
tion combined with improved techniques
of peripheral vascular surgery is produc
ing a growing number of geriatric lower
extremity amputees. Fortunately, better
prostheses and rehabilitation return a
majority to a reasonably independent life
in their own homes. Surprisingly, their
life expectancy is similar to that for their
age.
The surgeon should know what results
to expect from lower extremity amputa
tion at each of the conventional levels.
The article in this issue (pages 374 to 376)
by Lexier and colleagues provides this
information.
In general, the greater the length of
limb preserved, the better the functional
result. By “ length” we do not necessar
ily mean the physical length of the stump,
but the number of joints that are saved
and can function in an appropriate
prosthesis. For example a mid-tarsal
(Chopart) amputation may preserve nor
mal ankle function but the stump is so
short that a conventional shoe or boot
falls off, and a prosthesis that eliminates
ankle movement is required. In other
words, the potential advantage of saving
the ankle joint is lost and, functionally,
not only is there no difference between
this and a below-knee amputation, but
prosthetic fitting is more difficult.
Finally, it is often said that a longer stump
provides a longer lever arm, facilitating
control of the prosthesis. This is not true;
it is a mistake to preserve a long stump
if there is inadequate muscle or skin cover

of the end of the bone. The ideal stump
should be long enough to suspend its
prosthesis, have its bone end covered by
muscle under correct tension (i.e., not so
tight that the muscles pull away from the
bone and not so loose that a floppy mass
of soft tissue impedes prosthetic fitting)
and be surrounded by healthy skin with
the incision line so located that it won’t
adhere to bone.
From time to time surgical fashion has
emphasized “ end-bearing” stumps such
as the Symes at the ankle and the GrittiStokes, Callender and knee disarticula
tion at the knee. Advocates of these
procedures believed that as the patient
could take his full weight at the end of
the stump, prosthetic fitting was more
comfortable and its control improved.
Our experience1 suggests that most
patients cannot tolerate unlimited weight
bearing on the end of the stump, so suc
cessful fitting depends on the use of old
fashioned (and no longer appropriate)
lace-up corsets that distribute weight
throughout the stump. Thus, contrary to
the conclusion of Lexier and colleagues
we see little advantage in saving such a
long stump, particularly in older patients
such as theirs. The long stump makes it
harder to don the prosthesis: it’s difficult
for an elderly patient to stand on one leg
and bend over far enough to get the
socket opening off the end of the stump.
This difficulty is compounded because
most elderly patients have poor vision and
weak hand grasp.
There is another problem with a long

stump: a conventional artificial joint can
not be used because its axis of flexion lies
distal to the anatomical axis. Less satis
factory alternatives, such as outside
hinges or four-bar linkages, must be used.
Many factors influence the outcome of
lower extremity amputation in the elderly
besides surgical technique. They include
number of functional joints that can be
saved and the general vigour of the
patient. Having in mind the great
improvements in current prosthetic tech
nology, we believe that if a transm etatar
sal amputation does not survive, the next
appropriate level is below the knee, and
if this amputation fails the next should
be above the knee at the junction o f its
middle and distal thirds, leaving room to
accomodate an artificial knee so that its
axis of flexion is at the correct anatom i
cal level.
W.R. H arris, md, frcsc
Department of Surgery,
University of Toronto,
Combined Division of Orthopedic Surgery,
Toronto General Hospital and Mount Sinai
Hospital,
1-234 Eaton Wing,
Toronto General Hospital,
Toronto, Ont.
M5G 2C4
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BOOK REVIEWS

BIOLOGIC & BIOPROSTHETIC VALVES.
Proceedings o f the Third International
Symposium. Edited by Endre Bodnar and
Magdi Vacoub. 885 pp. Illust. Yorke Med
ical Books, New York, 1986. $125. (US).
ISBN 09-14316-49-4.

The growing popularity during the last decade
of biologic tissue for heart-valve prostheses has
stimulated interest for the continued assessment
of clinical results, and the need for discussing
problems and sharing experience has resulted
in the organization on a regular basis of inter
national meetings of practitioners involved in
treating heart-valve diseases. After the Munich
and Rome meetings held in 1979 and 1982,
whose presentations have also been published,
this book presents the proceedings of the third
international symposium, held in London in
1985, and includes more than 90 papers on
different aspects of valve replacement with
bioprostheses presented by experienced groups
world-wide.
Clinical results with the use of aortic
homografts, and traditional porcine and
pericardial valve bioprostheses, are reviewed
extensively in the first 27 chapters of the book.
More than one-third of the book is devoted to
valve-related morbidity, which has become a
major concern now that improved surgical
techniques have decreased the operative death
rate substantially. The main and unresolved
problem of tissue heart valves is that of long
term durability. This is particularly true in chil
dren in whom an early degenerative process has
generally been found, as it has also been the
experience of the various groups who reported
their results at the symposium. A consensus has
now developed that, because of the early and
severe calcification of tissue valves in children,
the use of mechanical valve prostheses is gener
ally preferable, although the results reported
with fresh aortic homografts do not appear to
be as dismal as those with bioprostheses.
Since the last symposium in 1982, most
reporting groups have gained experience with
reoperation due to a variety of valve-related
complications, primary tissue failure being the
leading cause among patients with biopros
theses. This problem is discussed in eight
chapters of the book. The pathophysiology,
mechanisms and techniques of prevention of
calcification and degeneration of biologic
valves are addressed by experts in the field. The
major drawback of degeneration, however, is
counterbalanced by a much lower incidence of
other valve complications such as thromboem
bolism, bleeding related to anticoagulation and
infection, which are presented in the next eight
chapters.
The hydrodynamics of bioprostheses and
their postoperative hemodynamic performance
are discussed by various groups. The role of
noninvasive evaluation of valve prostheses is
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apt to become predominant in the postopera
tive assessment of their hemodynamic perfor
mance. As further experience is gained, Dop
pler echo studies will progressively become the
standard technique for postoperative valve
evaluation.
Finally, a long section is devoted to new con
cepts and ideas, including the use of the Kan
garoo aortic valve, the unicusp pericardial
valve, and a number of new designs and
modifications of various bioprostheses. In the
last section, clinical results with bioprostheses
and mechanical valves are compared. From the
general discussion that follows, it is concluded
that one should be eclectic in choosing the right
prosthesis, and that both mechanical and bio
logic valve prostheses have advantages and
drawbacks.
This book presents the state of the art in
regard to the use, limitations, complications,
hemodynamic performance and long-term
results of the various types of biologic valves
available today. It addresses a very specific
group of physicians interested in this highly
specialized area of cardiology. This symposium
represents a world-wide experience that will be
of value to all those involved in the treatment
of patients with heart-valve disease — cardiac
surgeons, cardiologists and internists alike.
This well-edited text is an up-to-date reference
tool and should be readily available to clini
cians so that they can make their own decisions
in regard to choice of valve devices and their
long-term follow-up. Residents in cardiac sur
gery and cardiology will also benefit from this
comprehensive review of the problem of
cardiac valve replacement with tissue valves
and can use this text as a practical reference
guide.

techniques and results surrounding four ana
tomical sites of osteotomy, a major section on
post-traumatic deformity in the growing child
and a short epilogue.
Inevitably, the book has the advantages and
disadvantages of a multiauthor format. A wide
spectrum of opinions is represented, but the
style and quality are uneven. The book does
not read easily, having been translated from
German, but it has many redeeming qualities.
The excellent illustrations, meticulous
descriptions of preoperative planning, surgi
cal technique and results make it a useful refer
ence. While it need not be in the library of every
practising orthopedic surgeon, I would strongly
recommend it to those who are interested in
lower extremity reconstructive surgery and in
the management of the traumatized patient. In
addition, it would be a useful reference text for
orthopedic trainees.

L. Conrad P elletier, md , frcsc, facs

Based on the third postgraduate course in
inflammatory bowel disease held at the Lenox
Hill Hospital in New York, this short text
reflects the views and opinions of the group
at this hospital and those o f a few guest
contributors. In particular, the use of
6-mercaptopurine (6-MP) in the management
of Crohn’s disease is strongly supported.
Because it cannot be regarded as a compre
hensive review of inflammatory bowel disease,
the book is not a reference work. It highlights
certain issues, some controversial, others not.
It is written in a light style and may be read
in two to three evenings.
The book is divided into seven sections, each
with four to seven chapters, some of which are
very short. The first section provides an over
view and points to population groups that have
particular problems in inflammatory bowel dis
ease, such as children. This excellent chapter
highlights nutritional disturbances and growth
retardation, so important in these individuals.

Professor and chairman,
Department of Surgery,
Universite de Montreal and
The Montreal Heart Institute,
CP 6128,
Succursale A,
Montreal, PQ
H3C 3J7

CORRECTIVE OSTEOTOMIES OF THE
LOW ER
EXTR EM ITY
AFTER
TRAUM A. Edited by G. Hierholzer and
K.H. Muller. 407 pp. Illust. SpringerVerlag New York Inc., New York, 1985.
$75. (US). ISBN 0-387-15879-0.

This book is based on proceedings of a sym
posium held to commemorate the 65th birth
day of Dr. Jorg Rehn. It is divided into a num
ber of sections — basic principles, surgical

R .Y . M c M u r t r y , m d , fr c sc , FACS
Director,
Regional Trauma Unit,
Sunnybrook Medical Centre,
2075 Bayview Ave.,
Toronto, Ont.
M4N 3M5

INFLAMMATORY BOWEL DISEASE: EX
PERIENCE AN D CONTROVERSY.
Edited by Burton I. Korelitz and Norman
Sohn. 297 pp. Illust. Grune & Stratton,
Inc., Orlando, Fla.; Academic Press
Canada, Don Mills, Ont., 1985. $46.50.
ISBN 0-8089-1693-9.

continued on page 337
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Contributions to the Correspondence section are welcomed.
They should be typewritten and double spaced.

Equivalence in Treatments
To the editors.—I disagree with Blair and
colleagues who in their article “ Ticarcillin/clavulanic acid (Timentin) compared
to metronidazole/netilmicin in prevent
ing postoperative infection after elective
colorectal surgery” (Can J Surg 1987; 30:
120-122) conclude that these two combi
nations are equally effective in prevent
ing septic complications after elective
colorectal surgery. They reported that
there were no significant differences in
postoperative infections between the two
treatment groups.
There were 46 patients in each group.
Three patients (6.5%) in the ticarcillin/clavulanic acid group and five patients
(10.9%) in the metronidazole/netilmicin
group had wound infections. The differ
ence of 4.4% (which represents a 40%
reduction in infection rate) may be clini
cally important in view of the large abso
lute number of patients who undergo
colorectal surgery. If one calculates the
95% confidence interval on the observed
difference, the true difference could be as
great as 16%.
The power of the study to detect a true
difference of 4.4% was only 11%. To be
reasonably confident (say power 90%) of
detecting this difference, one would need
to study 850 patients in each group. The
Toronto study was therefore much too
small for any conclusions to be drawn.
The authors have confused statistical
nonsignificance with equivalence. To
demonstrate equivalence, I would suggest
the following steps.
• In planning the experiment, decide
on the smallest absolute difference that
is clinically important.
• Calculate the sample size to detect
this difference with appropriate alpha and
beta errors. (When determining equiva
lence a power of 95% would be
appropriate.)
• If the observed difference is not
statistically significant, one may then con
clude equivalence.
Some authors and editors are aware of
type I errors but seem to be less vigilant
in guarding against type II errors. The
quality of most journals would be
enhanced and ethical concerns would be
addressed if investigators were required

to specify in the method section (a) what
difference they considered clinically
important and (b) the power of their
study to detect this difference. As
Altman1 has pointed out, “ The purpose
of power calculations is to maximize the
chances of finding a real and important
effect if it is there, and to enable us to
be reasonably sure that a negative find
ing is strong grounds for believing that
there is no important difference.”
The message is clear but often ignored
or forgotten: the absence of proof is not
proof of absence.
J.F.

GATELY, MB, B CHIR, FRCS(Edin),
FRCS, FRCSC

Department of Surgery,
McMaster University Medical Centre,
1200 Main St. W,
Hamilton, Ont.
L8N 3Z5

had two episodes of severe extravasation
reactions after Adriamycin administra
tion even with the use of the recom
mended needle. One of these patients
required excision of sloughed skin and
skin grafting. In our opinion, the
increased risk using standard needles with
the PAC for the administration of
chemotherapy is not justified either for
patient safety or for medicolegal reasons.
Ia n

G.

Kerr,

m d , frcpc

Medical Oncology,
Toronto-Bayview Regional Cancer Centre,
Sunnybrook Medical Centre,
University of Toronto,
Toronto, Ont.
S h e r if S . H a n n a ,

m d , fr c sc , facs

General Surgery,
Sunnybrook Medical Centre,
University of Toronto,
Toronto, Ont.

Reference
1. A ltman DG: Statistics and ethics in medical research: III
How large a sample? Br M ed J 1980; 281: 1336-1338

Use of the Huber-Point Needle
in the Port-A-Cath System
To the editors.—We would like to com
ment on the letter entitled “ The need to
use the Huber-point needle in the PortA-Cath implantable device” (Can J Surg
1987; 30: 75, 99) and the article “ Implant
able device for venous access” (Can J
Surg 1987; 30: 127-129) by Leclerc and
Loutfi. Although we agree that the PortA-Cath (PAC) system is efficient and safe
and provides easy accessibility in patients
receiving chemotherapy, we do not
believe that the authors should advocate
the use of Yale hypodermic needles in
place of the recommended Huber-point
needle. At our institution we have
implanted over 100 PACs mainly for the
administration of chemotherapy and we
have always used Huber-point needles.
Although the authors report on an
interesting observation of the possible
safety of standard needles, their use in
place of the Huber-point needle puts
patients at risk of significant local toxic
ity should drug leakage occur. We have

McGoey-Evans Total Hip
Prosthesis
To the editors.— As the Evans of the
McGoey-Evans total hip arthroplasty
(Can J Surg 1987; 30: 81-85) I have a
vested interest in the journal article.
It may have been an oversight on our
part, but I thought one of the reviewers
might have realized that Paul McGoey
died June 3, 1984.
Personally, I am very glad the article
was published, because it really is a
memorial to Paul. It was his idea. He did
most of the work, and being as skilled as
he was, did the first procedure, I believe,
in February 1964 with a scrub nurse as
his only assistant. This indicates the facil
ity with which the procedure could be
done in the hands of a skilled surgeon.
The original criteria for the operation
were very simple and threefold; to relieve
pain and to allow the patient to sit and
walk. These objectives were fulfilled in
patients who had the operation. The arti
cle indicates the problems we had.
I remember once during a presentation
Paul was asked by a member of the
audience if there were any complications.
He said “ sure” and described the com
plications of all hip surgery. The fact that
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he admitted that he had experienced every
one of them confirms his forthright ap
proach to surgery, to his patients, to
teaching and to writing during all his
years in practice.
One of the reviewers was apparently
critical of our paper. Possibly he is one
of the junior surgeons now reaping the
benefits of the older researchers who
really did the bulk of the work on total
joint arthroplasty. It does not come over
night and some of the pioneers really
deserve some credit.
In teaching the present-day residents
and fellows, I constantly remind them
that bones did heal before the “ AO” peo
ple arrived on the scene and that there
have been many skilled surgeons through
out the world who were not born in Swit
zerland.
I asked Doctor Brian McGoey, Paul’s
son, if he had seen the March 1987 issue
of Canadian Journal o f Surgery. He said
yes, he had read Bob Harris’s note about
the cost of arthroscopic surgery but did
not turn through and see the article
about his father. I suppose this is a bit
ironic.
In any case, I am glad the article was
published; it really is a tribute to Paul.
J ohn G. E vans, md , frcsc
Ste. 800,
55 Queen St. E,
Toronto, Ont.
M5C 1R6

Management of Urinary Stress
Incontinence
To the editors.—The editorial in the May
1987 issue of the Journal by Taguchi
(pages 150-151) and the article by Boyd
(pages 157-159) on stress urinary incon
tinence in women are both timely and per
tinent. With the ever-increasing life expec
tancy of women in this country, the
management of urinary incontinence is of
paramount importance to many health
care workers.
The advent of modern urodynamic
techniques of investigation has provided
clinicians with safe, reliable and reprodu
cible methods of differentiating inconti
nence problems in women. Incontinence
is not necessarily a simple anatomical
weakness of the sphincter. The patient’s
history may be suggestive but is not diag
nostic and no longer the sole basis for sur
gical treatment. Urodynamics is not con
fined to one test — cystometrography, a
urethral pressure profile (static or
dynamic), a uroflow study, video
cystourethrography or pelvic electro
myography. It is a series of tests that
provide the clinician with a picture of nor
mal versus abnormal voiding mechan
isms. Certainly, both Taguchi and Boyd
would agree that the woman with a dis
organized uroflow pattern preoperatively,
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showing decreased peak flow rate,
prolonged voiding time, increased
residual urine and delayed time to peak
flow will do poorly after any incontinence
procedure.
When surgery for stress urinary incon
tinence is indicated, it should no longer
be a b attle w hether a M arshallMarchetti-Krantz operation is a better
choice than a Burch procedure. [The
reader should be aware that the former
operation was devised by a urologist
(Marshall) and two gynecologists (Marchetti and Krantz).] There is no single
operation, whether vaginal or retropubic,
or the two combined, that will cure all
cases of genuine stress urinary inconti
nence. Each case must be treated
individually, and surgery should not only
be based on the position of the urethrovesical junction but also take into con
sideration degrees of genital prolapse,
cystocele, rectocele and enterocele as well
as the patient’s age, parity, weight,
general habitus, sexual function, smok
ing habits, occupation and degree of
physical activity. The adage “ do a vagi
nal procedure first and when that fails go
from above” is antiquated and plays no
role in modern medicine.
Today, many disciplines (nursing,
family practice, urology, gynecology,
neurology, geriatrics, rehabilitation medi
cine, pediatrics, psychology) are involved
in the care of the incontinent woman.
Although surgery plays a role in some
cases, the majority of women can be
helped with conservative treatment. This
may involve neuropharmacologic mani
pulation of the lower urinary tract, exer
cises, mechanical aids, biofeedback and
relaxation therapy. It is only through
ongoing dialogue, not monologue, be
tween the various health-care workers
that improved care for incontinent
women will be provided.
H arold P. Drutz , md , frcsc, facog ,
facs

Director of Gynecological Urology
and Urodynamic Investigative Units,
Mount Sinai Hospital and Baycrest
Geriatric Centre,
Toronto, Ont.
M5G 1X5

To the editors.—The article on stress
incontinence of urine by Boyd (Can J
Surg 1987; 30: 157-159), which purports
to review the state of the art of stress uri
nary incontinence contains many inac
curacies. Some of these are noted by
Taguchi in his editorial (Can J Surg 1987;
30: 150-151) and his criticisms are ap
propriate. There has been an explosion of
information and ideas regarding alterna
tive surgical procedures for urinary stress
incontinence. Various techniques of
endoscopic needle suspension have
become widely used in the United States
and Canada. These offer similar results

and substantially less morbidity. For a
“ state-of-the-art” article not to mention
these procedures is unacceptable.
Individuals operating on patients with
stress incontinence must be competent in
performing cystoscopy and both en
doscopic and conventional procedures.
L. Klotz, md , frcsc
Division of Urology,
Sunnybrook Medicai Centre,
University o f Toronto,
2075 Bayview Ave.,
Toronto, Ont.
M4N 3M5

To the editors.—Although I enjoyed the
article “ Stress incontinence of urine” by
Boyd (Can J Surg 1987; 30: 157-159), I
do take issue with some statements at the
end of his paper.
I have been using the MarshallMarchetti-Krantz procedure for over 30
years and the results have been excellent
with no serious complications.
Parnell and colleagues, in their 1982
review1 of 151 patients, reported 14
patients with clinical osteitis pubis, only
5 of whom had radiologic changes. Years
ago, when retropubic prostatectomy first
came into vogue, the incidence of ostei
tis pubis was quite high. But I have not
seen a case in the past 25 years, probably
due to routine prophylactic use of anti
biotics. It has not occurred in the
Marshall-Marchetti procedures I have
done.
I never found it necessary to open the
bladder suprapubically except to free it
in those patients who had undergone
retropubic surgery previously. I have
always used 0 chromic catgut for sutures,
finding them to be more than sufficient
in maintaining suspension of the bladder
and urethra. If one uses Prolene or other
nonabsorbable sutures, then entering the
bladder is a serious complication. 1 have
removed many nonabsorbable sutures
from the urinary bladders of women
operated on previously by gynecologists.
Chromic catgut is absorbed and causes no
problems.
As far as endangering the ureteral
orifices, one would have to work very
hard to obstruct them, if the MarshallMarchetti-Krantz procedure is correctly
carried out.
P hilip G. Klotz, md , frcsc, facs
Associate professor of surgery,
Ste. 455,
Mount Sinai Hospital,
University o f Toronto,
600 University Ave.,
Toronto, Ont.
M5G 1X5
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SURGEONS’ UPDATE
What's new in surgery is the subject of this column. The short items are designed to let readers know
who's doing what and why. Surgeons are interested in what other surgeons are doing in
research, education, practice and administration. Surgery is a vibrant specialty, and, as
its practitioners, you must be the source as well as the readers of this column.

Surgical Research:
Who’s Doing It and Who’s Paying?
The feeling is that the numbers of surgi
cal researchers have reached an all-time
low, says Jean Couture, FRCSC, former
president of the Royal College of Physi
cians and Surgeons of Canada. He is a
member of the committee appointed by
the Association of the Departments of
Surgery Chairmen who will shortly
launch a survey to find out who is doing
research in the surgical specialties, what
facilities are available within the medical
schools and who is providing the funds.
Couture, David Mulder, FRCSC, sur
geon in chief at the Montreal General
Hospital, and John Duff, FRCSC, pro
fessor and chairman of the Department
of Surgery at the University of Western
Ontario, who make up the committee,
have drawn up a questionnaire and hope
to get the go ahead from other members
of their association this month.
Mulder, who spoke briefly to CJS, out
lined the rationale and the time frame for
the survey: “ We as surgical chairmen feel
that research has fallen off dramatically,
but we don’t have the empirical data.”
He said that the 14-item questionnaire
had been translated and had been re
viewed by experts in epidemiology.
The questions were designed to elicit
information on “ level of grants provided
externally and internally, the level of
faculty funding, physical plant and labo
ratory facilities available to surgical
researchers, ways that surgical trainees are
involved in research, and the productivity
of different departments,” he said.
“ When we have the responses, we will
decide whether we need to find someone
to conduct personal visits to the depart
ments, which was the approach in the last
Contributions to this column are welcome.
Please send your material to: Mrs. Amy
Chouinard, Canadian Journal o f Surgery,
PO Box 8650, Ottawa, Ont. K1G 0G8.

study — undertaken in the late 1960s by
Dr. Robert Macbeth.
“ The Royal College has identified
research as an important part of training
and we are trying to find ways and means
for surgical departments to mount suc
cessful research programs.”
Couture noted that the concern is for
all the surgical disciplines not only gene
ral or orthopedic surgery, although these
two disciplines may be the most affected
by the low level of funding. He said, “ We
have contacted all surgical specialties and
there seems to be interest in joining us to
exert pressure that would bring about
more funding and better organization and
facilities for surgical research.
“ Our plan is to hold a 1-day conference
in spring 1988 with representatives from
all the surgical disciplines to discuss the
results of the questionnaire and to draft
plans to improve the level of research in
surgery. The second objective of the mee
ting will be to consider the establishment
of a conjoint council on surgical research.
“ This would be similar to an organi
zation in the United States. About 3 years
ago, the Americans undertook a survey
similar to the one we are doing and, as
a result, they formed a conjoint council
that has been very effective in getting trai
ning grants from the NIH [National Ins
titutes of Health].
“ The Americans found that research in
surgery was lower than in other health
disciplines and that research teams incor
porating PhDs had better chances of
obtaining funds than did teams with only
MDs. They also found that some topics
were more attractive than others: trauma,
gastrointestinal surgery and transplanta
tion were singled out in their report as
being able to attract funds easily. Fol
lowing the publication of their findings,
they obtained training grants for sur
geons, and we are hoping we can get the

same from MRC [Medical Research
Council].”
Robert Maudsley, FRCSC, coordina
tor of the Royal College’s research com
mittee, spoke briefly with CJS about resi
dents’ exposure to research: “ A few years
ago the credentials committee looked at
the training requirements for all the
specialties and found that most allowed
residents to do research for 6 or 12
months and receive credit for the work.
“ In practice, not a great number of
residents do so, and many who ask for
credit for a year’s research actually have
done the work before or during medical
school — some time distinct from the
specialty training.
“ In the surgical disciplines in particu
lar, the residents are concerned that they
have to develop and maintain their clini
cal skills and they feel hard pressed to
undertake research in time set aside for
their training.”
Henry Dinsdale, FRCPC, professor
and head, Department of Medicine,
Queen’s University, is chairman of the
Royal College research committee; he
accompanied the accreditation team sur
veying residency training programs at the
University of Alberta in April, and this
was the first time someone on the team
had gone specifically to look at research
facilities. One of his aims was to deter
mine whether adequate information could
be gathered by questionnaire and normal
survey procedures.
He told CJS, “ The programs were
evaluated in the usual fashion by the sur
vey team, but as a result of my report
there may be some modifications or addi
tions to the way in which future surveys
are carried out by the College....I had the
opportunity of meeting with heads of
basic science and clinical departments and
with a number of residents who were
either engaged in research training or
planning to do so next year. One item for
discussion was the pros and cons of man
datory years of research. Some programs
at Alberta such as urology and general
surgery require a year of research,
whereas for others such as neurosurgery
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a year of research is optional. There was
also a review of salary funding for
individuals wishing to do research train
ing and considerable and increasing
interest at the university in the relation
ship between basic science and clinical
departments in providing research years
and supervision.”
The research committee and, later, the
Council for the Royal College were elated
to review his findings and consider recom
mendations.
One step taken by the Royal College to
increase interest in research was to revive
a program in which it provides $1500 to
university departments to defray some of
the costs for a visiting professorship in
research. For 1987, the money will go to
the universities of British Columbia (Dr.
D. Bichet, FRCPC, Montreal), Saskatch
ewan (Dr. M.L. Flalperin, FRCPC, To
ronto), Toronto (Dr. R. Cotton, Boston)
and Western Ontario (Dr. R. Kelch, Ann
Arbor). The visiting professors were
chosen on the basis of stature, back
ground and ability to excite students
about a career in research.
However, the problem is not a lack of
interest on the part of surgeons. Just a
year ago, a group of orthopedic surgeons
and basic scientists conducted a survey of
research and submitted their findings to
the MRC. Although the focus was ortho
pedic research, the information was
applicable to surgeons and clinicians in
general, according to Derek Cooke,
FRCSC, who chaired the task force.
Cooke summarized the report for CJS:
“ We reviewed information from each
university centre about what was being
done in orthopedic research and where
the researchers were getting their funding.
We emphasized in our examination
m oney coming from the M edical
Research Council, but we found that
much of the money was coming from out
side MRC through the efforts of sur
geons, local groups and industry.
“ We looked at the problems of getting
money from MRC and found that we as
surgeons weren’t very professional at
preparing grant applications. It wasn’t
that we didn’t have good questions to ask;
we just didn’t have know-how in making
a scientific case for the work to be done.
“ However, more important, we lacked
peer review in the MRC. When applica
tions for funding in the musculoskeletal
system were submitted, they went to a
variety of committees and the people who
were doing the reviews often didn’t have
expertise in orthopedics or this system.
Being reviewed by experts in a relevant
field is crucial.”
One surprise, said Cooke, was “ that
research was going on in every centre
across Canada. We had expected sur
geons to be less active than they turned
out to be; they are generating their own
funds — sometimes from their own
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pockets. Some centres are stronger than
others. Where we found strength — Mon
treal, London, Toronto, Winnipeg and
here in Kingston — we also found links
between surgeons and basic scientists,
particularly PhDs, for example, in
engineering.
“ Clinicians don’t have the epidemio
logic skills needed to design appropriate
methods but they do have an interest in
doing research. They need training — at
least 2 years — to get the expertise to do
research, and they need input from other
disciplines. Also, the incentives — in sim
ple terms money — are not adequate for
surgeons to do basic research. They can
generate their income much more easily
by seeing patients.”
According to Cooke, the attitude
among other researchers that surgeons are
doers not thinkers can be a deterrent to
cooperative research. Yet, he said, sur
geons have a unique contribution to make
because they directly examine damaged
and diseased tissue, bone and organs.

Do You Want Routine Testing
for HIV Antibodies?

“ How many physicians in this room
have had an accident in the operating
room and hit themselves with a needle?”
asked John Lamont, FACOG, FRCSC,
and most members of the audience raised
their hand.
Lamont, speaking in a session on AIDS
at the annual meeting of the Society of
Obstetricians and Gynaecologists of
Canada in June, said that there had been
102 occasions “ just from one major
teaching hospital reported over the last
year, and 16 were experts who should
have known better.” Yet had any one of
them been treating a patient with human
immunodeficiency virus, the contact
could have been deadly.
Such accidents have prompted a new
anxiety, he said — “ the worried well who
develop psychosomatic symptoms” . He
noted that the New England Journal o f
Medicine had recently carried an article
in “ Sounding Board” that recommended
all sexually active adults have voluntary
testing. According to Lamont, the facili
ties are not in place to handle such mass
screening and many of the groups for
whom testing has been recommended —
the soon-to-be-married, immigrants and
patients admitted to hospital — are not
high-risk groups. In an interview with
CJS later, he commented that the ethical
questions are just beginning to be posed:

What rights do physicians have to
demand testing? What dangers do sur
geons and their teams have to accept in
their moral obligation to provide care for
a patient? Without refusing treatment,
how can one ensure against lifethreatening accidents in the operating
room and elsewhere in and out of
hospital?
The anxiety about AIDS stems at least
partly from the lengthy incubation of the
disease: the maximum is as yet unknown,
according to the next speaker at the con
ference, and the average asymptomatic
period is 5 years. Kate Hankins, FRCPC,
assistant professor at McGill and epidemi
ologic consultant on sexually transmitted
diseases, went on to say that the long
incubation means that most of the new
cases are among men 30 to 39 years old
and “ what we are reporting is the tip of
the iceberg” .
What was clear from this exchange was
the uncertainty. It surfaced again last
month at the annual meeting of the Cana
dian Medical Association in a debate on
whether physicians should be required to
report patients who test positive for the
HIV antibody and to trace their sexual
contacts.
In June the surgeon general of the
United States, C. Everett Koop, called for
routine antibody testing for all patients
who were to undergo major surgery.
Others have encouraged routine testing on
admission to hospital, and still others, cit
ing the emotional and social trauma
associated with a false-positive result and
recent evidence of false-positive rates as
high as 8%, have recommended treating
body fluids from all patients as if they
were infected.
The debate is on; what do readers of
this column think?

Two Alma Maters in US
Honour C. Barber Mueller

CJS coeditor C. Barber Mueller,
FRCSC, recently received an honorary
doctorate of humane letters from Black
burn University, Carlinville, Illinois,
where he earned his first degree. More
recently he added the 1987 alumni
achievement award from Washington
University School of Medicine, St. Louis,
where he graduated in 1942. Mueller is
professor emeritus at McMaster Univer
sity and is vice-president elect of the
American College of Surgeons.
AMY C houinard
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Perioperative Hemodilution
Perioperative hemodilution is one way of
minimizing the morbidity and mortality
associated with blood transfusion. A
review of the literature indicates that, for
many patients, substitution of crystalloid
solutions for surgical blood loss is safe
and physiologically advantageous as long
as euvolemia is maintained. Increased
stroke volume is the principal mechanism
responsible for augmented tissue oxygen
delivery. Based on this review the surgi
cal population can be divided into three
groups: most patients under 60 years of
age (group 1); those with important
cardiac disease (group 2); and the elderly
(group 3). Patients in group 1 can safely
undergo hemodilution to a hematocrit of
0.25; patients in the other groups should
probably not be subjected to hemodilu
tion. Implementation of this proposal
could diminish the risk and expense of
many surgical procedures.
L'hemodilution peroperatoire represente
une facon de minimiser la morbidite et la
mortalite associees aux transfusions san
guines. Une revue de la litterature suggere que, pour plusieurs patients, les
pertes sanguines durant les interventions
chirurgicales peuvent etre compensees
par des solutions de cristalloides; le procede est securitaire et physiologiquement
avantageux aussi longtemps que I'euvolemie est maintenue, L'augmentation du
volume systolique est le principal mecanisme responsable de I'amelioration de
I'apport d'oxygene aux tissus. A partir
de cette revue on a pu diviser la popula
tion en trois groupes: la plupart des
patients de moins de 60 ans (le groupe
1); ceux qui ont une maladie cardiaque
importante (le groupe 2); et les personnes agees (le groupe 3). Les patients du
groupe 1 peuvent, en toute innocuite,
etre soumis a l'hemodilution jusqu'a ce
que I'hematocrite atteigne 0.25; les
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patients faisant partie des autres groupes
ne doivent probablement pas subir
d'hemodilution. L'application de ces
recommandations peut diminuer le risque
et le cout de plusieurs interventions chi
rurgicales.

Intimidated by the link between blood
products and potentially lethal infections
(e.g., AIDS and hepatitis), some patients
are refusing transfusions of any blood but
their own, if needed during major surgi
cal procedures. This problem will likely
be of increasing importance to physicians.
The purpose of this paper is to examine
the literature on hemodilution and pro
pose recommendations for future clinical
trials based on this research.
Background
The decline of paid donor blood clinics
in the United States in the 1970s stimu
lated intense research into alternatives to
blood transfusion. These studies were
based upon two well-known physiologi
cal principles — the amount of blood deli
vered to the tissues (cardiac output) is a
product of heart rate and the volume of
blood pumped each beat (stroke volume),
and the amount of oxygen delivered to the
tissues is a product of cardiac output,
hemoglobin saturation and hematocrit.
Despite decreasing hematocrit, euvolemic
hemodilution attempts to improve oxygen
delivery to the tissues by augmenting
cardiac output.
Hemodilution and Tissue Oxygenation
The amount of oxygen available to the
body is governed by the equation: oxy
gen available = cardiac output X oxy
gen saturation x hemoglobin X 1.34.1
Although oxygen utilization as a whole
is low, there is great variation between tis
sues — from 5% by the skin to 55% by
the coronary circulation.1 Thus, the
myocardium, being a tissue with a high
oxygen extraction, is particularly vulner
able to a reduction of its available oxygen.
Euvolemic hemodilution causes major
physiological changes. By far the most
important compensatory mechanism for

decreased hematocrit during hemodilu
tion is increased stroke volume.2-5 Heart
rate usually remains constant. Transport
of oxygen to tissues actually increases as
hematocrit decreases to 0.20 to 0.25 when
oxygen delivery starts to decrease.6 On
the other hand, cardiac output increases
steadily as the blood is diluted. The rise
in cardiac output depends more upon
decreased blood viscosity than upon any
reduction in either oxygen-carrying capac
ity or mixed venous oxygen tension.7
Augmented oxygen delivery can be
analysed in terms of pressure-volume
loops. Laboratory studies in dogs have
shown that decreasing the hematocrit
from 0.40 to 0.20 slightly increases enddiastolic volume, does not significantly
alter end-diastolic pressure nor diastolic
compliance, but decreases end-systolic
volume, thus explaining the increased
stroke volume.8 The decrease in endsystolic volume that accompanies a
decreased hematocrit occurs because the
systolic function curve shifts to the left,
secondary to a decreased afterload.9"11
In other words, without changing the
cross-sectional area of the blood vessels,
decreased viscosity lowers systemic vas
cular resistance.11 (Studies have shown
that these effects are seen even when the
animals are prevented from changing the
contractile state of their heart by /3adrenergic blockade.8)
Blood Rheology
The Poiseuille-Hagen law describes
laminar flow in noncollapsible tubes as
follows:
Q =

P, - P 2(3.14)R4
8 VL

where P, = inlet pressure, P2 = outlet
pressure, R = radius of tube, L = tube
length and V = viscosity. Viscosity can
be defined as a measure of internal fric
tion in a laminar flow system.12 If the
pressure and radius from one end o f a
tube to the other remain constant,
hemodilution, by lowering blood vis
cosity, will increase flow. For anatomic
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reasons, this effect is most noticeable in
the postcapillary venules and capil
laries,13 and is clinically manifested as
improved homogeneity of capillary blood
flow.
However, capillaries and post-capillary
venules rather than being straight tubes
are composed of right angles and T pieces
that generate turbulence. This causes loss
of inertial energy and calculated overes
timation of true flow.14 Moreover, blood
rheology (the science of physics applied
to blood flow) must be considered. Nor
mal saline and Ringer’s lactate solution,
two solutions commonly used in hospi
tals for replacement of blood loss, show
no change in viscosity as flow decreases.
Such solutions are known as Newtonian
fluids. On the other hand, blood with a
hematocrit of 0.45 is characterized by a
marked increase in viscosity with decreas
ing flow velocity;13 although the effect is
attenuated if this same blood is diluted
to a hematocrit of 0.30, at a hematocrit
of 0.15, blood essentially behaves as a
Newtonian fluid.15 Why does blood
change its behaviour at different erythro
cyte concentrations?
As blood makes its way through the
subdivisions of the circulatory system, its
velocity diminishes; this change is
associated with erythrocyte clumping
(Rouleux formation), which in turn is

thought to be due to the formation of
electrostatic bridges between the surface
of the erythrocyte membrane and fibrino
gen m olecules.16 As more of these
bridges are created, flow is impeded,
necessitating more energy to maintain
movement (increasing internal friction
expressed as viscosity). Stated otherwise,
erythrocytes suspended in saline
(hematocrit = 0.40) show virtually no
change in viscosity as flow rates dimin
ish. Addition of fibrinogen causes a
marked increase in viscosity most notice
able in the microcirculation. Other fac
tors that play a role include flow veloc
ity, platelet concentration and function,
leukocyte aggregation, osmolality and
pH .17 In conclusion, areas most sensitive
to oxygen deprivation are supplied by
capillaries whose flow velocity clinically
depends principally upon hematocrit.

needs. In the animal laboratory, investi
gators,13 using multiwire, platinum,
oxygen-tissue electrodes, measured actual
tissue-oxygen tension in liver, pancreas,
small intestine and kidney during hemodi
lution in the rat and found no significant
change as the hematocrit was decreased
from 0.42 to 0.20. Other studies,18 using
radioactive microsphere techniques in the
dog, have shown that total oxygen deliv
ery increases as hematocrit is reduced
toward 0.25 to 0.30; more importantly,
organ oxygen transport (i.e., the absolute
amount of oxygen transported to the
heart, liver, spleen, muscle and skin)
progressively increased in a similar
fashion, suggesting that hemodilution
does not effect a redistribution of cardiac
output (at least in animal studies).
Sophisticated animal studies have con
firmed that microcirculatory nutrient
flow and oxygenation are enhanced, not
retarded, by diluting the blood to “ abnor
mally low” hematocrits of 0.20 to 0.25.

Microcirculation

The microcirculation is where the
advantages of hemodilution are most evi
dent. Since the tendency for aggregation
is diminished by hemodilution, erythro
cytes are able to negotiate the narrowest
of capillaries. This promotes homogenous
perfusion of surrounding tissues and les
sens the chance that cells will utilize
anaerobic metabolism for their energy

Brain

Numerous laboratory and clinical
studies19-25 have confirmed that hemo
dilution, presumably by homogenizing
microcirculatory flow, is beneficial in
severe cerebral stenosis and ischemia. In
one study,21 the size of hemispheric
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infarction resulting from clipping the dis
tal internal carotid and proximal middle
cerebral arteries was reduced by 60% in
animals receiving two serial infusions of
low molecular weight dextran, a sub
stance known to cause disaggregation of
erythrocytes. In contrast, a study using
an experimental model of focal cerebral
ischemia demonstrated that whole blood
infusions, despite substantial elevations
in cardiac output via the Frank-Starling
effect, failed to improve cortical blood
flow in the area of focal ischemia.26
Once again, the clinical evidence supports
the practice of lowering the hematocrit
(while maintaining euvolemia) to augment
homogenous distribution of flow to the
microcirculation, rather than simply aug
menting cardiac output (at constant
hematocrit) and continuing maldistribu
tion in the capillary bed.
H eart

Pressure loss across a stenosis is an
important determinant of ischemia. To
estimate this loss, the appropriate prin
ciples of fluid mechanics have been
adapted to the geometry of the nonuni
form stenotic lumen encountered in prac
tice and validated experimentally. The
following expression provides a good
approximation of the hemodynamic

behaviour of a typical high-grade human
coronary stenosis:27 pressure drop across
stenosis = loss due to viscosity + 3(loss
due to inertial energy).2
Therefore, despite decreased viscosity,
any increase in turbulence from hemodilution worsens the pressure drop and
evokes distal arteriolar dilatation in the
face of increasingly severe stenosis. This
pressure loss in the stenosis is an im por
tant determinant of ischemia. Imagine a
vessel in skeletal muscle with a high-grade
stenosis. Proximal to the stenosis, the
blood pressure is 120/80 mm Hg with
good flow. Once the stenosis is encoun
tered, turbulence increases markedly,
pressure falls to 80/40 mm Hg and flow
rates decrease. The net effect is decreased
velocity and increased viscosity. This may
create a vicious circle wherein elevated
blood viscosity further compromises
blood flow and ischemia worsens. In spite
of this, one study employing hemodilution in patients with peripheral vascular
disease showed a beneficial effect on the
healing of trophic ulcers and rest pain,28
suggesting that in some p a tie n ts,
improved homogeneity of flow in the
microcirculation more than compensates
for the decline in overall flow rate.
Stenosis in coronary vessels is differ
ent from that in skeletal muscle for two
important reasons:

• Since mechanical effects o f ventric
ular contraction impede systolic perfusion
to a greater extent in the inner layers of
the heart than the outer, the inner layers
must receive a proportionately greater
portion of their perfusion during diastole.
Diastolic flow to the inner layers o f the
heart therefore exceeds that to the outer,
and it appears that coronary vascular
resistance is lower in the subendocardium
than in the subepicardium.29 Conse
quently, the subendocardial vessels are
closer to maximum vasodilatation at rest.
It therefore seems reasonable to assume
that the capacity of subendocardial ves
sels to dilate is much more limited
than that of vessels in other parts of the
heart, resulting in maximal suben
docardial vasodilatation at all times and
strict dependence on diastolic filling
time.30
• Being collapsible tubes, the driving
pressure for subendocardial coronary
flow is determined not by the outlet pres
sure minus the inlet pressure, but by the
surrounding pressure at the point of col
lapse minus the inlet pressure (aortic
diastolic pressure). The surrounding pres
sure is in turn determined by the com
bined effects of extravascular compres
sion of coronary vessels and intrinsic
vasomotor tone. Not only may the sur
rounding pressure be substantially higher
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than the measured right or left atrial pres
sure, but in the presence of critical
stenotic lesions, the inlet pressure may be
considerably less than the aortic diastolic
pressure!31 The uncertainties inherent in
such a situation and our rudimentary
knowledge of the factors affecting the
coronary circulation obligate the clinician
to question maneuvers that may exhaust
the reserves of the myocardium at risk.
This, then, is a critical issue with
respect to hemodilution in patients with
coronary artery disease — can the suben
docardium extract any more oxygen and
can subendocardial vessels dilate any fur
ther to provide the needed flow? Recall
that increased stroke volume is the main
compensation for a decreased hematocrit.
Thus, inability to increase oxygen output
will lead to ischemia and infarction
should oxygen delivery be inadequate
d u rin g hem odilution. B uckberg’s
studies32'33 performed in the early 1970s
with dogs illustrate this nicely ./E ndo
cardial flows are slightly more than
epicardial flows initially. With hemodilu
tion, flows in both layers increase but the
ratio o f endocardial to epicardial flow
remains similar to the control. With artifi
cially created coronary stenosis or valvu
lar aortic stenosis in the presence of
moderate hemodilution (hematocrit 0.30),
the epicardium receives substantially
more flow than the endocardium, and
subendocardial ischemic changes appear
within a few minutes on the electrocardi
ogram. These ischemic changes also occur
with extreme hemodilution (hematocrit
0.15) in dogs with normal arteries and
normal aortic valves. Subsequent studies
have confirmed Buckberg’s work and
shown that hearts with normal coronary
arteries may be unable to compensate for
severe hemodilution with sufficient coro
nary dilation.32,34 In spite of these data,
patients with severe coronary artery dis
ease routinely undergo hemodilution to
hematocrits of 0.20 at the start of cardi
opulmonary bypass. Since the morbidity
and m ortality of coronary artery bypass
surgery is low, it appears that by the very
nature o f the operation (to bypass
obstructed coronary arteries and improve
flow) and by the various methods used to
minimize oxygen consumption (cardiople
gia, hypothermia), the diseased heart is
usually able to withstand a transient
period o f hemodilution. It must be
emphasized, however, that in the absence
of these events, hemodilution of the
patient with important coronary artery
disease is hazardous and cannot be
recommended, despite the use of sophisti
cated monitoring capable of detecting
regional ischemia in real time (2 D Echo).
Hemodilution and the Elderly

A nother question is whether patients
over 60 years of age, even those without
324

substantial coronary artery disease, can
compensate for moderate hemodilution
by increased stroke volume. Studies in
aged rats35 have shown a diminished
intrinsic inotropic response to catechola
mines when compared with that of young
control rats.
In humans, the influence of age on
cardiovascular performance, especially
during exercise, has long been recognized
and it has been suggested that cardiac
function deteriorates with age. Decreases
in cardiac output in patients over 60 years
old have been noted at rest and during
maximal exercise, whereas systolic blood
pressure and total peripheral resistance
are increased.36-38 A study of 39 healthy
men and women, 70 to 83 years old,
showed that 26% had a decreased ejec
tion fraction with exercise and 35%
exhibited minor regional abnormalities of
wall m otion.39 A recent report from
Sweden showed that many elderly
patients were not able to increase stroke
volume in the presence of hemodilu
tion.40 In other words, the vital organs
of elderly patients might possibly become
ischemic when subjected to this tech
nique, in contrast to younger patients in
whom hemodilution was clearly benefi
cial to tissue oxygenation. To summarize,
whether they have overt coronary artery
disease or not, the elderly patient must be
considered at risk in the presence of
hemodilution.
Summary

Although intraoperative normovolemic
hemodilution has been used in cardiac
surgery for over 20 years, only recently
has this technique been applied to other
areas of surgery.
Based on data from the literature, the
surgical population can be divided into
three subsets. The first consists of healthy
patients from under 2 to the age of
around 50 to 60 years41 who most likely
can tolerate euvolemic hemodilution
down to hematocrits of around 0.25 with
no untoward effects. Group 2 consists of
patients with symptomatic heart disease
or those suspected of having heart disease
but who are asymptomatic, e.g. diabetics,
sedentary patients, patients with claudi
cation, left ventricular hypertrophy on the
electrocardiogram and documented idi
opathic hypertrophic subaortic stenosis.
These patients probably should not
undergo hemodilution unless shown to be
free of important coronary artery atheros
clerosis. Group 3 consists of the elderly,
symptomatic or not, who probably
should not undergo hemodilution at all.
For any patient who is to undergo
hemodilution, the following guidelines
seem prudent: since the heart is the prin
cipal organ at risk, it should be monitored
with sophisticated electrocardiography,

preferably with a print-out so that trac
ings can be compared. Although some
investigators believe that the epicardiogram is sensitive for transmural ischemia
but insensitive for mild subendocardial
ischemia,42'43 the differential diagnosis
of any marked ST-segment change must
include inadequate oxygen delivery secon
dary to hemodilution and be treated
appropriately. If a pulmonary artery
catheter is in place, filling pressures
should be kept constant throughout the
hemodilution process and the “ wedge”
tracing examined frequently to detect the
appearance of new “ V” waves suggestive
of an ischemic left ventricle.
Numerous studies have shown that
euvolemic hemodilution in appropriately
selected patients is physiologically advan
tageous. What we need to do now is to
document that the use of blood products
can be substantially reduced if guidelines
set forth in this article are followed. Once
the results of these studies become avail
able, transfusion-related morbidity may
become rare.
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NO TICES
AIDS and Surgery
An international symposium on protec
tive policy is planned for Dec. 1 and 2,
1987 at the Royal Lancaster Hotel in Lon
don, England, for surgeons, anesthetists,
senior theatre staff and administrators.
For information contact Ms Pauline
Sleight, BDI Conferences Ltd., 9/11 Ken
sington High Street, London W8 5NP;
telephone 01-938 2151.

Canadian AIDS Research
Conference
This conference will be held Jan. 26-29,
1988 in Toronto, providing a forum in
which delegates can learn about research
aspects of AIDS. International experts
will address such topics as: detection of
AIDS, working with the virus, prepara
tion of vaccines and the functioning of
viral proteins. Further information can be
obtained from the Conference Office,
Suite 4, 1172 Pembina Highway, Winni
peg, Manitoba R3T 2A4; telephone (204)
474-1565 or 474-1617.
continued on page 362
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best of them.

A winning nationwide distribution
network.

Price is important! We know that! When
you’re shopping around, you’ll find we’re as
competitive as anyone.
But price isn’t everything. What
really counts is value; knowing that when
you place an order, you’ll be getting
superior quality products backed by a com
pany that’s in business for the long term.
That describes Becton Dickinson.
We’ve been in business in Canada since
1951 and we plan to do business here for
many years to come. If we didn’t intend
staying around, we wouldn't be undergoing
a major expansion of our office, ware
house and production facilities.
So while it’s nice for you to know
that we’re just as price conscious
as you are, it’s also good to
know that we refuse to
compromise on
quality and
Product
"
service,

When you deal with Becton Dickinson, you’re
dealing with a sophisticated, integrated,
manufacturing/distribution delivery system.
Our large and expanding warehouses
in Mississauga and in Calgary provide fast,
easy access to inventory.
Our network of established distribu
tors work with us to ensure that you get
the supplies you need promptly and efficiently.
For you it means no waiting for
deliveries. For us it means satisfied customers
who keep coming back.

quality puts us
out ahead.
At Becton Dickinson, we base our
success on a reputation for product
quality, innovative design and unequalled
quality control.
It’s these high standards that
have made B-D* the world’s leading
producer of disposable hypodermic
syringes and needles. We’re also
a world leader in evacuated blood col
lection systems. Our BARD-PARKER*
surgical blades have been the choice of
leading surgeons around the world for
over 75 years. In hospitals, clinics and
physicians’ offices, TRU-TOUCH* brand vinyl
medical gloves are providing the protection
that health care professionals require.
That’s the Becton Dickinson differ
ence. We stand behind our products after
they’ve left our plant.

We lead the field in technical
support services.
You get more than
quality health care
products when
you buy from
Becton Dickinson.
Every product we sell
is backed by highly experi
enced support professionals.
Technical support specialists will help
you with advice and assistance on the use
of our products. Our own sales force, located
in major centres across the country, backs
the efforts of our distributors. Our personnel
are always available to provide in-service
training in the use of our products.
You’re assured of on-the-spot back
up service. There are no overseas phone
calls to track down a manufacturer. No frus
trating, time-consuming wait to get an
answer. At Becton Dickinson we're just a
phone call away.
So if you’re buying from one of our
competitors now, give us a call.
We thrive on competition.
‘ BARD-PARKER, B-D and TRU-TOUCH are registered
trade marks of Becton Dickinson and Company
reg. user Becton Dickinson Canada Inc.
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is virtually lint free and non-fraying to m inim ize the risk
o f potential infections and foreign reactions
that could enhance scar formation1;
adheres less to wounds and causes less disruption
of exposed and friable dermal capillary beds';
provides a drier wound site because it is 56%
and 26% more absorbent than 8 & 12 ply cotton gauze
sponges respectively1;
is more economical in use than cotton gauze sponges
and has shown overall sponge savings of 10 to 25% and more
in Canadian hospitals, not including savings
on non-adhering dressings, combine pads, post-op sponges
and nursing time.
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NU GAUZE* sponges are totally
Canadian made, are used
in the majority of Canadian
hospitals and exported
to many countries.
Z 'F I ')

Reference: 1. Birdselt DC, Davidson JSD: A Report on Clinical Trials of NU GAUZE*
Rayon Sponges, Including In Vitro and In Vivo Comparisons with Conventional Cotton Gauze
Sponges. July 1986.
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Patients with empyema not responding
to simple chest-tube drainage and antibi
otic therapy have been managed by a
"Clagett"-type procedure that consists
of open-window thoracostomy, antibiotic
irrigation and closure of the window. The
results of such treatment were reviewed.
Of the 103 patients with empyema
treated between 1967 and 1983, 41
underwent open-window thoracostomy.
Twenty-eight (group 1) had empyema
after pneumonectomy, 13 (group 2)
did not; however, 9 of the 13 in
group 2 had undergone lobectomy. The
mean follow-up was 46 months for
group 1 and 42 months for group 2.
When surgical closure of the open-window
thoracostomy was attempted, the suc
cess rate in group 1 was 8 5 % for those
without concomitant bronchopleural
fistula, but only 3 6 % in patients with a
fistula. In group 2 the respective success
rates were 5 0 % and 5 7 % . Unsuccessful
closure resulted in chronic fistulas in four
patients in each of the two groups. Six
deaths in group 1 and two in group 2
were related to the original disease, but
one was an operative death. These
results demonstrate both the effective
ness and limitations of open-window
thoracostomy in the management of
these difficult cases.

From the Department o f Surgery, Montreal
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sity, Montreal, PQ
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Les patients souffrant d'empyeme qui ne
repondaient pas a un simple drainage
thoracique et a une antibiotherapie ont
ete soumis a une operation de type "C ia gett” qui consiste a pratiquer une fenetre de thoracostomie, a irriguer avec des
antibiotiques. puis a refermer I'ouverture.
On passe en revue les resultats de cette
therapie. Sur 103 patients souffrant
d'empyeme tra ils entre 1967 et 1983,
41 ont eu une fenetre de thoracostomie.
Vingt-huit (le groupe 1) avaient un
empyfeme consicutif a une pneumonectomie, 13 (le groupe 2) ne I'avaient
pas; alors que 9 des 13 avaient subi
une lobectomie. En moyenne, les examens de surveillance s'etalaient sur 46
mois pour le groupe 1 et sur 42 mois
pour le groupe 2. Le taux de fermeture
avec succ&s de la fenetre de thoracosto
mie a ete de 8 5 % chez les patients du
groupe 1 qui n'avaient pas de fistule
bronchopleurale concomitante, mais seulement de 3 6 % chez les porteurs d’une
fistule. Dans le groupe 2, les taux de
succes respectifs ont et6 de 5 0 % et
5 7 % . Les echecs de fermeture ont
resulte en des fistules chroniques pour
quatre patients dans chacun des deux
groupes. Six deces du groupe 1 et deux
du groupe 2 sont attribuables a la maladie sous-jacente, mais on a enregistre un
deces operatoire. Ces resultats demontrent, a la fois, I'efficacite et les limites
de la fenetre de thoracostomie dans le
traitement des cas difficiles.

Modern techniques of anesthesia allow
major pulmonary resections, but post
resection empyema has emerged as an
important cause of morbidity, with pub
lished incidences ranging from 2% to
10%, most series reporting less than
5%.' This complication often committed
the patient to a series of major procedures
each with its associated complications and
high death rate.

In 1963, Clagett and Geraci2 from the
Mayo Clinic proposed a definitive twostage procedure, emerging from a previ
ous single-stage palliative procedure
described by Eloesser.3 Although the
overall course of therapy is longer, the
main advantage of the Clagett procedure
is the lesser magnitude of each procedure
compared with that of staged thoraco
plasties. It is better tolerated by patients
who are recovering from recent major
surgery, are malnourished or are
immunologically depleted from extensive
inflammatory or neoplastic diseases.
There have been numerous reports of
the management of empyema, with suc
cess rates ranging from 4°7o to 66%.4-7
This study is a retrospective analysis of
all patients with surgically managed
empyema seen at the Montreal Chest
Hospital Center.
Patienls and Methods

Between 1967 and 1983, 103 patients
were treated surgically for empyema, 41
of whom were managed by the Clagett
open-window thoracostomy. Clagett and
Geraci2 originally described their proce
dure for the treatment of post pneumo
nectomy empyema and 28 (group 1) of the
41 patients in our study had previously
undergone pneumonectomy. However,
the principles of the procedure could also
be applied to selected cases of loculated
empyema as in the remaining 13 patients
(group 2) in the study. Carcinoma was the
most common indication for pneumonec
tomy with inflammatory and miscella
neous diseases such as tuberculosis,
bronchiectasis and emphysema being less
frequent.
The preponderance of postpneumo
nectomy empyemas in men over women
(22 versus 6) reflects the increased inci
dence of pulmonary resections, mainly
for carcinoma, in men. The mean age was
63 years (ranging from 45 to 77 years).
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The mean follow-up for group 1 patients
was 46 months and was 42 months for
group 2 patients.
The organisms implicated in the infec
tions changed during the study. In the
earlier years, cultures tended to be
monobacterial, mainly staphylococcal or
streptococcal. The infections in later years
tended to be poly bacterial, often with
mixed gram-negative aerobic organisms
together with anaerobic organisms. There
was one positive fungal culture.
Results

operating room during the procedure
under local anesthesia, presumably of a
myocardial infarction, two were left with
a chronic chest-wall fistula and one died
of his disease. The mean follow-up was
60 months.
The interval from the previous surgery
to the appearance of the empyema ranged
from 3 days to 6 years. The length of time
for closure of the thoracostomy ranged
from 6 weeks to 2 years, depending on the
physical and nutritional status of the
patient, the extent and status of the origi
nal disease process and the time required
to sterilize the empyema cavity.

fistula was defined as air leak persisting
for more than 14 days. Of the seven
patients with empyema associated with a
bronchopleural fistula (Table IV), three
had a successful first-time closure of the
fistula, three were left with a chronic
fistula and one had spontaneous closure.
Of those with no fistula, two had success
ful closure of the thoracostomy, one a
spontaneous closure, one was left with a
chronic fistula and two died of their
disease.
Discussion

The problem of intrathoracic infection
Group 1
has been recognized for many centuries.
Group 2
Hippocrates described a method of locat
Of the 28 patients in this group, 17 had
of the 13 patients in this group ing and draining an empyema and
a concomitant bronchopleural fistula — hadNineundergone
lobectomy previously drainage remained a mainstay of manage
14 on the right side and 3 on the left (Table III); the other
had not had any ment. The fact that drainage of empyema
(Table I). There was a similar preponder thoracic surgery. In 4patients
who had was effective was further demonstrated by
ance of right-sided empyemas that were undergone lobectomy, a bronchopleural
Everts Graham and the World War I
not associated with bronchopleural fistula
(8 of 11). The main reason for pneu
monectomy was neoplastic disease, a
Table 1—Location of Empyema and Reason for Resection
trend that became more evident later in
in 28 Group 1 Patients Who Had Empyema After Pneumonectomy
the study. Of the 17 patients with bron Location/reason
Bronchopleural
No bronchopleural
chopleural fistula, 4 of 11 (36%) in whom for resection
fistula
fistula
closure of the window was attempted had Right side
14
8
an apparently successful primary closure Left side
3
3
of the fistula, sterilization of the cavity
Carcinoma
14
and final closure of the open-window Inflammatory
5
condition
3
6
thoracostomy (Table II).
The method of management of the
*" _*ichopleural fistula varied during the
Table II—Results of Open-Window Thoracostomy in Group 1 Patients
study period in the 11 patients who had
Bronchopleural
No bronchopleural
attempted closure of the open-window Result
fistula (n ~17)
fistula (n-11)
thoracostomy. The fistula closed spon
closure
taneously in five patients, three had a sim Attempted
Successful
4
6
ple operative closure consisting of dissec
Successful reoperation
1
0
tion, reamputation and closure of the
Failure
bronchial stump and three had reclosure
Breakdown
3
0
of the bronchial stump with a muscle bun
Reinfection
2
0
dle translocation. Of these 11 patients, 4
Esophageal fistula
1
1
remained well with no further evidence of No attempted closure
leakage or infection. One patient had a
Chronic fistula
2
2
recurrence of empyema 5 years later and
Death from disease
4
1
underwent reopening, resterilization and
Operative death
0
1
successful reclosure of open-window
thoracostomy (follow-up 11 years). Three
patients had a breakdown of the bron
Table Ill-Previous Surgery in Group 2 Patients
chial stump. Two others had a recurrence
Bronchopleural
No bronchopleural
of infection alone and in one patient an
Procedure
fistula
fistula
esophagopleural fistula developed; all
Right upper lobectomy
3
3
three underwent reopening of the openLeft lower lobectomy
1
0
window thoracostomy. In six patients
Right middle lobectomy
1
1
whose initial open-window thoracostomy
No previous surgery
2
2
was left open intentionally, two were left
with a chronic open fistula and four died
of their disease early after the procedure.
Table IV—Results in Group 2 Patients
The mean follow-up was 48 months.
Bronchopleural
No bronchopleural
Of the 11 patients in this group of 28
fistula
fistula
who had no bronchopleural fistula, 7 had Result
closure
3
2
an attempted closure of the open-window Successful
Recurrence
0
0
thoracostomy after stabilization; in 6 it Chronic
fistula (OWT)
3
1
was successful. The remaining patient had Spontaneous
closure
1
1
an esophageal fistula that required Early death
0
2
reopening of the thoracostomy. Of the
OWT - open-window thoracostomy.
remaining four patients, one died in the
330
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Empyema Commission who, it was esti
mated, reduced the death rate of parap
neumonic empyemas from 75% to 15%
with the use of tube thoracostomy. The
advent of safe resectional lung surgery
brought with it the new complications of
postresection empyema. In 1963, Clagett
and G eraci2 described a two-stage
drainage and reconstruction procedure
that replaced the former deforming
thoracoplasties.
Bronchopleural fistula may occur at
any time postoperatively.8 In our series,
it ranged from 3 days to 6 years with two
peaks in incidence: less than 1 month and
more than 1 year. The early fistulas are
usually a result of technical errors at the
time of operation, such as inadequate
suturing or, less commonly, misfired sta
ple lines.9 Ischemia from over-zealous
dissection may be manifest from 10 days
to 3 weeks postoperatively. The late
fistulas are usually a result of recurrent
tumour or, less likely, from an indolent
infection.
The treatment of the fistula depends on
the time of presentation. If it presents
within several days of the initial opera
tion, early reoperation is advisable to gain
control of the bronchial stump and effect
a secure closure. If the onset is delayed
beyond 10 to 14 days, it is probably bet
ter to pursue a more conservative course,
although in selected cases one may be able
to secure the bronchial stump at this late
date. The method of dealing with the
fistula varies. In our series, 5 of 11 (45%)
closed spontaneously. This has also been
noted by others who reported spontane
ous closure in 20% to 33%. This, of
course, assumes that the margins of the
fistula are free of tumour or active infec
tion. The spontaneous closure may take
from weeks to months, but in the
moderate- to high-risk group it is well
worth the wait in an effort to avoid major
thoracostomy. It is unlikely, however,
that the pleural cavity will be completely
sterilized so long as the fistula is open.
At the tim e o f closure o f the
thoracostomy, an antibiotic saline solu
tion is instilled. This has traditionally
been a 1% neomycin solution with the
volumes ranging from 250 ml to more
than 1000 ml, thus giving a dose ranging
from 2.5 to 10 g of neomycin. Despite a
thick empyema peel, this has been shown
by Meakins and Allard10 to be absorbed
in significant and toxic quantities with
subsequent neuromuscular blockade
requiring ventilatory support. Deafness,
nephrotoxicity and lesions of the central
nervous system have also been reported.
As a result, it is both acceptable and
advisable to use a 0.25% neomycin solu
tion or to add a second antibiotic solu
tion such as bacitracin.
The success rates with the Clagett
procedure in treating intrathoracic infec
tion have varied widely. When Clagett

first reported his results, he had a success
ful outcome in all three patients, none of
whom had a bronchopleural fistula. Since
then, there have been reports with success
rates ranging from 4% (with fistula) to
14% (with no fistula)6 and as high as
66% .5 These authors all noted a
decreased rate of successful permanent
closure in the presence of bronchopleural
fistula. Our results confirm this observa
tion in that the presence of a fistula
reduced the chance of permanent closure
from 85% (6 of 7 patients without a bron
chopleural fistula) to 36% (4 of 11
patients with such a fistula).
It appears now that the aggressive use
of muscle flaps may improve results. Our
early experience with muscle flaps (in two
using intercostal muscle bundles and in
one using latissimus dorsi) was less than
encouraging in that two of these three
patients had a recurrence of the fistula
infection. Recently, Pairolero and
colleagues11 from the Mayo Clinic
reported on the use of transposed mus
cle flaps in controlling the bronchopleural
fistula in 11 patients. Good results were
obtained in seven.
As mentioned, the original openwindow thoracostomy was described for
use in postpneumonectomy empyema.
The same principles should be applicable,
however, to a loculated empyema. Open
drainage of an abscess cavity is a standard
surgical procedure. Once the empyema is
established and loculated in patients who
have not undergone pneumonectomy, the
remaining lung is firmly adherent to the
chest wall and risk of collapse in the
presence of an open-window thoraco
stomy is no longer a concern. In our ser
ies, 13 such patients were treated in this
manner, including 7 who also had a
proven bronchopleural fistula. The results
in this group appear to be better in that
there were no cases of recurrent infection
or breakdown of the fistula after
thoracostomy closure. Although the num
ber is small, satisfactory results suggest
that this is an acceptable option for
patients in whom decortication is
undesirable or unsuccessful.
Summary and Conclusions
Open-window thoracostomy, intro
duced by Clagett and Geraci, was a major
improvement in the management of post
pneumonectomy empyema, particularly
that associated with a bronchopleural
fistula. Tolerated by acutely ill patients,
the two major complicating factors, sep
sis and aspiration of infected material into
the contralateral lung, were rapidly con
trolled. Although our results indicated a
61% success rate in those in whom closure
of the window was attempted, this is
often associated with a prolonged period
of disability and several subsequent oper

ations. In addition, there remains a dis
turbingly high failure rate.
What are the possibilities for improve
ment? Prevention by more careful selec
tion of patients for resection. Patients
with cancer who have had major weight
loss or show evident muscle weakness are
unlikely to benefit from resection o f their
tumour, particularly if pneumonectomy
is required. Resection should not be done
unless the resection margin is visibly free
of tumour. In the presence of gross medi
astinal node involvement, node sampling
for staging is preferred to radical medi
astinal dissection which is unlikely to alter
ultimate survival and may predispose to
the form ation of bronchial fistulae.
In managing the acute phase o f an
empyema, particularly that associated
with a bronchopleural fistula, openwindow thoracostomy remains the treat
ment of choice. One should then pay par
ticular attention to nutritional support. If
the bronchial fistula is small and likely to
close spontaneously, the Clagett proce
dure should be followed through. If the
fistula is large, it would be wise, when the
patient is stable, to close the fistula by
reamputation of the bronchus through an
extrapleural transpericardial approach. If
the empyema is likely to recur because of
its size or difficulty in controlling infec
tion, it would be wise to fill the space with
a large pedicled muscle flap bearing an
intact blood supply.
For certain postlobectomy and other
localized empyemas where decortication
is not feasible, open-window thoraco
stomy appears to be an effective form of
treatment and preferable to thoracoplasty
particularly in the lower thorax.
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o r pre d isp o se patients to the above indications are: T hrom bophleb itis; C ongestive heart failure; Surgical
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e m b o lis m . It m ay also be useful as an a d ju n ct in th e tre a tm e n t of tra n s ie n t cereb ral ischem ic attacks due
to in tra v a scu la r clotting.
C O N T R A IN D IC A T IO N S : Any lo ca lize d o r g ene ral physical c o n d itio n o r pe rso n a l circum stance in w hich
th e ha za rd of hem orrhage m ight be grea ter th a n the pote ntial c lin ic a l b e n e fits of anticoagulation, such
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s h o u ld be d is c u s s e d in light of th o s e risks. H em o rrh ag ic te n d e n c ie s o r blood dyscrasias. R ece n t or
c o n te m p la te d surgery of: 1. ce n tra l n ervo us system ; 2. eye; 3. tra u m a tic surge ry re su ltin g in large
o p e n surfa ces. Bleeding ten d e n c ie s asso ciated w ith active u lce ratio n or overt b lee d in g of:
gastro in te stin a l, genitourinary or respiratory tracts; cerebrovascular hem o rrhage; aneurysm s - cerebral,
d is s e c tin g aorta ; pericarditis a n d peric a rd ia l effu s io n s; bacterial e n d o ca rd itis. Threatened ab o rtio n ,
e c la m p s ia a n d preeclam psia. In ad e q u ate lab o rato ry fa c ilitie s o r unsu p e rvise d senility, alcoh olism ,
psychosis, o r lack of patient cooperation. Spinal puncture and other diagnostic or therapeutic procedures
w ith pote ntial fo r uncontrollable blee ding. M iscellaneou s: m ajor regio nal, lum b ar block anesthesia and
m a lig n a n t hypertension.
W A R N IN G S : The m ost serious risks are hem o rrhage in any tissu e or o rga n and, less frequently, necrosis
and/or gang rene of skin and othe r tissues. R isk of hem orrhage is related to th e level of intensity and duration
of therapy. H e m o rrh a g e and n ecro sis have in som e case s been repo rted to result in death or perm a nent
d isab ility. N ecro sis appears to be associated w ith local thro m b o sis and usu a lly appears w ithin a few days
o f th e s ta rt o f therapy. In severe ca se s of n ecro sis, tre a tm e n t th ro u g h d e b rid e m e n t or a m pu tation of th e
affected tissue, lim b, breast or penis has been reported. Careful diag nosis is required to determ ine whether
n e c ro s is is ca u s e d by an u n d e rly in g disease. Thera py s h o u ld be d isco n tin u e d when w arfa rin is the
s u s p e c te d ca u s e of developing n ecro sis a n d h epa rin m ay be con s id e re d . A ltho ugh various on e s have
b e e n atte m p te d , no treatment fo r necro sis h as been co n s id e re d u n ifo rm ly effective. See belo w for infor
m a tio n on pred isp o sin g conditions. T hese a n d othe r risks m u st be w e ig h e d against the risk of th ro m 
b o s is o r e m bo lization in untreated cases. C O U M A D IN is a pote nt d rug w ith a half-life of 2.5 days; therefore
e ffe c ts m ay b e co m e more pron o u n ce d as d a ily m a in tenance do se s overlap. It cannot be em ph asized
to o stro n g ly th a t treatm ent o f each p atie n t is a highly in d iv id u a lize d m atter. Dosage s h o u ld be co n 
tro lle d by p e rio d ic determ inations of p ro th ro m b in tim e o r o th e r s u ita b le coagulation tests. D ete rm ina
tio n s of w h o le bloo d clotting and blee ding tim e s are not effective m easures fo r control of therapy. Heparin
prolo ngs th e one-stage prothrombin time. W hen heparin and C O U M A D IN are administered concom itantly,
refer to C O N V E R S IO N FROM H EPA RIN TH E R A P Y fo r reco m m e n d a tio n s. C aution shou ld be observed
w h e n C O U M A D IN is administered in any situa tion or in th e prese nce of any predisposing cond ition where
a d d e d ris k o f hem orrhage or n e cro sis is prese nt. A dm in istration of antico a g u la n ts in th e follo w in g co n 
d itio n s w ill b e base d upon clin ic a l ju d g e m e n t in w h ich risks of thera py are w eighed against the risk of
th ro m b o s is o r em bolization in untre ated case s. The fo llo w in g m ay be asso ciated with th e s e increased
risks: L acta tio n . Severe to m o d e rate h ep a tic o r renal in su fficien cy. Infectious diseases o r distur
b a n c e s of in tes tin al flora - sprue , a n tib io tic therapy. Traum a w h ich m ay result in intern al bleeding.
S u rg e ry or trau m a resulting in large expo sed raw surfaces. Indw elling catheters. Severe to m oderate
h y p e rte n s io n . Known or su sp ected d efic ien cy in p ro tein C: T h is h e re d ita ry or acqu ired cond ition,
w h ic h s h o u ld be suspected if th e re is a h is to ry o f recurrent ep iso d e s of throm boem bo lic disorders in the
p a tie n t o r in th e fam ily, has been asso ciated w ith an incre ased risk of deve lo p in g necrosis follo w in g war
fa rin adm inistration. Tissue necrosis may occu r in the absence of protein C deficiency. It has been reported
th a t co n c u rre n t anticoagulation thera py w ith hepa rin fo r 5 to 7 days d u rin g initiation of th e ra p y w ith
C O U M A D IN m ay minimize th e in cid ence of th is reaction. W arfa rin thera py should be d isco ntinued when
it is su sp e cte d to be the cause of deve loping necrosis, and hepa rin m ay be considered. M iscellaneou s:
p o ly c y th e m ia vera, vasculitis, severe diabetes, severe a lle rg ic and a n a p h yla ctic disorders. Patients w ith
c o n g e s tiv e h e a rt failure may b e co m e m ore sen s itive to C O U M A D IN , th e re b y requiring m ore frequent
la b o ra to ry m onitoring, and re d u ce d doses. C o n c u rre n t use of antic o a g u la n ts with strep tokinase or
u ro k in a s e is not recom m ended and m ay be hazardous. (P lea se note recom m endations acco m panyin g
th e s e prep a ra tio n s.)
P R E C A U T IO N S : Periodic dete rm in a tio n o f prothro m bin tim e o r o th e r suitable coag ulation test is
e s s e n tia l. N um erous factors, alone o r in co m b in a tio n , in clu ding trave l, changes in d ie t, en viron
m e n t, physical state and m edication m ay influence resp onse to anticoagulants. It is good practice
to m onitor th e response w ith additional prothrom bin tim e determ inations in the period im m ediately
a fte r d is c h a rg e from the ho sp ital, and w h en ever o th e r m ed ic a tio n s are initiated, d isc o n tin u ed or
ta k e n hap h a zard ly. The fo llo w in g factors are listed fo r yo u r referen ce; however, o th e r factors may
also a ffe c t th e anticoagulant response.
T h e fo llo w in g factors, alone o r in co m b in a tio n , m ay be resp o n sib le for IN C R E A SED pro
throm bin tim e response: EN D O G E N O U S FACTORS: cancer, collagen disease, congestive heart failure,
d ia rrh e a , eleva ted temperature, h epa tic d isorders: (in fe c tio u s hepa titis, jaundice), poor nu tritio n a l state,
ste a to rrh e a , vitam in K deficiency. E X O G E N O U S FACTORS: a lc o h o l,! allop urinol, am in osa licylic acid,
am io darone HCI, anabolic steroids, anesthetics, inhalation, antibiotics, bromelains, chloral hydrate,! chlor
propam ide, chym otrypsin, cim etidine, clofibrate, CO U M AD IN overdosage, dextran, dextrothyroxine. diazoxide, d iflu n isa l, diure tics,! disulfiram , eth a cryn ica cid , fenoprofen, glu ca g o n , hepatotoxic drugs, ibuprofen,
in flu e n za v iru s vaccine, m e fe nam ic acid, m eth yldopa, m eth ylphenid ate, m etronidazole, m iconazole,
m o n o a m in e oxida se inhib ito rs, n a lid ix ic acid , nap ro xe n , n a rco tics, prolonged, pen to xifyllin e ,
p h e n ylb u ta z o n e , phenytoin, pyrazolones, quin id in e , quin in e , ra n itid in e ,! salicylates, sulfinpyrazone,
s u lfo n a m id e s , long-acting, su lin dac, th yro id drugs, tolb u ta m id e , trim ethoprim /su lfam etho xazole, othe r
m edications affecting blood elem ents w hich m ay m odify hem ostasis. Also: dietary deficiencies, prolonged
ho t w eather, unreliable proth rom bin tim e dete rm ination s.
T h e follow ing factors, alone or in com bination, m ay be responsible for DECREASED prothrom 
bin tim e resp onse: EN D O G ENO US FACTORS: edem a, here ditary coum arin resistance, hyperlipem ia,
h y p o th yro id is m . EXO GENOUS FACTORS: a d re n o co rtica l stero ids, a lc o h o l,! antacids, antih istam ine s,
b a rb itu ra te s, carbam azepine, chloral h y d ra te ,! ch lordiazepoxide, cholestyram ine, C O U M A D IN u nde r
dosage, d iu re tic s ,! ethchlorvynol, glute thim ide, grise ofulvin, halo peridol, meprobamate, oral contracep
tives, para ldehyde , primidone, ra n itid in e ,! rifa m p in , vita m in C. A lso: d ie t high in vitam in K, u n re lia b le PT
d e te rm in a tio n s. Because a pa tie n t m ay be expo sed to a co m b in a tio n of the above factors, th e net effect
o n PT re sp o n se may be unpredictable . M o re frequ ent lab o ra to ry m o n ito rin g is, therefore, advisable.
C ou m a rin s m ay also affect th e actions of othe r drugs. H ypoglycem ic agents (chlorpropamide, tolbutam ide
and glyb u rid e ) and anticonvulsants (phenytoin and phen obarbita l) m ay accum ulate in the body as a result
o f in te rfe re n ce w ith either th e ir m eta bolism or excretion.
A D VE R SE REACTIONS: Potential adverse reactions may include: • H em orrhage from any tissu e or o rga n.
T h is is a consequence of th e a n tic o a g u la n t effect. S ig n s a n d sym p tom s w ill vary acco rding to th e loca
tio n and d e g re e or extent of ble e d in g . Therefore, th e p o s s ib ility of h em o rrhage should be considered
in eva lu a tin g th e condition of any a n ticoagulated p a tie n t w ith c o m p la in ts which do not ind ic a te an o b 
vious diagnosis. Bleeding durin g anticoagulant therapy does not always correlate with prothrom bin activity.
(S ee S Y M P TO M S AND TR E A T M E N T O F O V E R D O SAG E .) B le e d in g w h ich occurs w hen th e proth rom 
b in tim e is w ith in the th e ra p e u tic rang e w arrants d ia g n o stic investigation, since it m ay unm a sk a

p reviously unsu spected lesio n, e.g. tum or, ulcer, etc. • N ecrosis of skin and oth e r tissu es. (SEE W A R N 
INGS). • O the r adverse reactions are infrequent and consist of alopecia, urticaria, derm atitis, fever, nausea,
diarrh ea, abdo m inal cram ping, a syndrom e called "p u rp le toes,” chole static h epa tic injury, and hypersen
s itiv ity reactions. • P ria p ism has been associated w ith a n ticoagulan t adm in istra tio n , however, a causal
re la tio n sh ip has not been established.
DO SA G E A N D LABO RATO RY CO N TR O L: A dm in istration: A d m in istration and dosage m ust be
in d iv id u a lize d . A dju st th e dosage a cco rding to results of th e one-stage pro th ro m b in tim e (PT) w ith
com m only used rabbit brain throm boplastin. There is am ple evidence that prolongation of the prothrom bin
tim e 1.2 to 1.5 tim e s control is su ffic ie n t for prop hylaxis and treatm ent o f veno us throm boem bo lism ,
m in im iz in g th e risk of hem o rrhage associated w ith m ore prolo nged PT values. W here th e risk of th ro m 
b o e m b o lism is grea t, su ch as w ith recurrent system ic em bo lism , a PT of 1.5 to 2.0 tim e s control should
be m aintained. A ratio greater than 2.0 appears to provide no additional thera peutic benefit in most patients
and is asso ciated w ith a h ig h e r risk of bleeding.
Table of R eco m m ended T h era p eu tic PT R anges*
R ab b it Brain PT Ratio**

C lin ic al State
P rop hylaxis - venous throm boem bo lism
H igh-risk s u rg e ry
H ip s u rg e ry
Treatm ent-deep vein throm bosis or pulm o n a ry em bolism
P revention of system ic e m bo lism in patients w ith:
• atrial fib rilla tio n ,
• tis s u e he a rt valves, or
• acute m yocardial infarction
R e cu rre n t system ic e m bo lism

1. 2 - 1.4

1.3-1.5
1.2-1.5

1.2-1.5
1.5-2.0

'M o d ifie d from C hest, ACC P -N H LBI National C onference on A n tith ro m b o tic Therapy, volum e 89,
n u m b e r 2, page 14S, 1986.
" F o r the three thro m b o p la stin s curren tly used in N orth A m erica, a PT w ith rab b it brain th ro m b o 
pla stin of 1.3 to 2.0 is equivalent to an International N orm a lized Ratio (IN R ) of 2.0 to 4.0. For other
th ro m b o p la stin s the INR can be calcu lated as: INR = (observed PT).ISI T h e ISI (International
S e n s itivity Index) is available from th e m anu facturers of th rom boplastin.
IN ITIA L DOSAGE: Is com m only started above anticipated m ain tenance dosage levels. A comm only-used
regim en is 10m g/day fo r 2 to 4 days, w ith d aily adju stm ents base d on the results of PT determ inations.
A large load ing do se (i.e., 30m g) m ay increase th e incid ence of h e m o rrh a g ic and o th e r com plications,
does not o ffe r m ore rapid protection against throm bi form a tion, and is not recom m ended . Lower doses
are re com m ended for e ld e rly and/or debilitated patients and patie nts w ith incre ased sensitivity (see
PR EC AU TIO N S). M ain tenance: Most patients are satisfactorily m a in tained at a dose of 2 to 10mg daily.
F lexibility of dosage is provided by breaking scored tablets in half. The in dividual dose and interval should
be g a u g e d by th e p a tie n t’s p roth rom bin response. Duration of therapy: T he du ra tio n of therapy in each
p a tie n t s h o u ld be indiv id u a lize d . In general, thera py shou ld be co n tin u e d u ntil th e d ang er of throm bosis
and e m b o lism has passed. Treatm ent During D entistry and S urgery: M an a g e m e n t of patients w ho
und e rg o dental and surg ica l proce dures requires close liaison betw een atte n d in g physicians, surgeons
and dentists. In patie nts w ho m ust be anticoagulated prior to, durin g , o r im m e d ia te ly follow ing dental or
surg ica l proce dures, a dju sting th e dosage to m ain tain th e PT at the low e n d o f th e thera peutic range,
m ay safe ly a llow for co ntinued anticoagulation. T he operative site s h o u ld be suffic ie n tly lim ited and
a cce ssible to perm it th e effective use of local procedures for hem ostasis. U nde r these conditions, dental
and surgical procedures may be perform ed w itho ut undue risk of hem orrhage. Conversion from Heparin
T h era p y: S ince the onse t of C O U M A D IN ’S effect is delayed, hepa rin is pre fe rre d in itia lly for rapid anti
coagulation. C onversion to CO U M AD IN may begin concom itantly w ith hepa rin thera py or may be delayed
3 to 6 days. As h epa rin may affect the PT, patients receiving both hepa rin a n d C O U M A D IN shou ld have
bloo d draw n for PT dete rm ination , at least: • 5 hours after the last IV bolu s do se of heparin, or • 4 hours
after cess a tio n of a co n tin u o u s IV infusion of hepa rin, or • 24 hours after the last subcutaneou s heparin
injection. W hen C O U M A D IN has produced the desired thera peutic range or prothrom bin activity, heparin
may be disco ntinued .
SYM PTOM S AND TREATM ENT OF OVERDOSAGE: Sym ptoms: Suspected o r overt abnorm al bleeding
(i.e., appe arance of blood in stools or urine, hem aturia, excessive m enstrual blee ding, m elena, petechiae,
excessive bruising o r persistent oozing from superficial injuries) are early m anifestations of anticoagulation
beyond a safe and satisfactory level. Treatm ent: E xcessive anticoa g u la tio n , w ith or w itho ut bleeding,
m ay be controlled by discontinuing therapy and if necessary, by adm inistration of oral or parenteral vitam in
K, 2 .5 m g to 10mg. (P lea se see recom m endations acco m panyin g vitam in K, prep arations prior to use.)
Use of vitam in K, reduces responses to subsequent CO U M AD IN therapy. Patients m ay return to a pretreat
m ent th ro m b o tic statu s follow ing the rapid reversal of a p rolo nged PT. R esu m ption of CO U M A D IN ad
m inistration reverses the effect of vitam in K ,, and a therapeutic PT can again be obtained by careful dosage
adju stm ent. If rapid a nticoagulation is indicated, hepa rin m ay be prefe rable for initia l therapy. If m inor
b le e d in g p rog resses to m ajor blee ding, give 5 to 25m g (rarely up to 50m g ) parenteral vitam in K ,. In
e m erg ency s itu a tio n s of severe hem orrhage, clotting factors can be return ed to norm al by adm inistering
200 to 50 0 m L of w h o le blood o r fresh frozen plasm a, or by g ivin g com m ercial Factor IX com p lex. Packed
red bloo d cells m ay a lso be given if s ig n ifica n t blood loss has occu rred. Infu s io n s of blood or plasm a
shou ld be m onitored carefully to avoid precipitating pulm onary edem a in elde rly patients or patients with
he a rt disease.
D O S A G E FO R M S: C O U M A D IN TABLETS are single-scored, and are im p rin te d as follows:
10mg
2m g
2.5m g
5m g
SIZE:
0401
0101
0301
C O DE :
0201
lavender
peach
w hite
CO LO R :
orange
IMPRINT:
C O U M A D IN
C O U M A D IN
C O U M A D IN
C O U M AD IN
S ide 1:
b isec ted 2
bisected 2 1/2
bisected 5
bisected 10
Du Pont
Du Pont
Du Pont
Du Pont
S ide 2:
S u p p lie d in bottles of 100.
in c r e a s e d and decre ased proth rom bin tim e respo nses have been repo rted.
R eference:
1. O ’R e illy RA, A g g e le r PM: Studies on co um arin antic o a g u la n t drug s: in itia tio n of w arfarin therapy
w ith o u t a lo a d in g dose. C ircula tion 38:169-177, 1968.
P rod uct m ono graph available on request.
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Peritracheal Membranous Adipose Tissue for Early
Revascularization of the Bronchial Anastomosis
The effect of a peritracheal wrap of
membranous adipose tissue on revas
cularization of the bronchial anastomosis
after left lung autotransplantation was
evaluated in four groups of dogs. The
bronchial anastomosis was performed
just distal to the carina in groups 1 (6
dogs) and 2 (7 dogs) and as close to the
lobar division as possible in groups 3 (14
dogs) and 4 (7 dogs). Peritracheal mem
branous adipose tissue was used in
groups 1 and 3 only. The other two
groups served as controls. Three dogs
from group 2 had elastic Dacron fabric
wrapped around the anastomotic site.
Revascularization of the distal bron
chus through the wrap was demon
strated in all dogs in groups 1 and 3. 7
days after surgery by postmortem injec
tion studies but not in control groups 2
and 4, and serious bronchostenosis was
also observed in the latter two groups.
Histologic examination of the bronchial
anastomosis revealed better structural
preservation of the bronchus distal to the
suture line with the adipose tissue wrap.
The dogs with elastic Dacron fabric
wraps showed poor structural integrity
below the suture line (necrosis and cal
cification).
Our results suggest that the level of
bronchial anastomosis does not alter the
healing process of the distal bronchus
when a peritracheal membranous adipose
tissue wrap is applied to the anastomotic
site. They also indicate that the wrap is
effective in restoring vascular flow
across the suture line within 1 week of
lung autotransplantation.

Le role d'un pedicule de membrane adipeux a localization peritracheal pour la
revascularization prgcoce de I'anastomose bronchique apres une reimplanta
tion pulmonaire gauche, a ete evalue
dans quatre groupes de chiens. (.'anasto
mose bronchique a ete effectuee a proximite de la carene dans les groupes 1 (6
chiens) et 2 (7 chiens) et le plus proche
possible de la division lobaire dans les
groupes 3 (14 chiens) et 4 (7 chiens). Le
pedicule de membrane adipeux a localiza
tion peritracheal a ete utilise dans les
groupes 1 et 3 seulement. Les deux
autres groupes ont servi de groupes
temoins. Chez trois chiens du groupe 2
une bande de Dacron elastique a 6te
employee pour envelopper I'anastomose
bronchique.
Sept jours apr6s la chirurgie, la revas
cularization de la bronche avec I'aide du
pedicule de membrane adipose a ete
dgmontree dans les groupes 1 et 3 par
des etudes radiographiques avec des
injections de Microfil faites a post
mortem. Le retablissement de la circula
tion bronchique semblait considerablement plus abondant chez les chiens du
groupe 3 dans lesquels I'anastomose
avait §te performee pres de la division
lobaire. Par contre, I'absence de vaisseaux bronchiques, a travers et au dela
de I'anastomose, 7 jours apres I'autoplastie pulmonaire a ete constatee chez
les chiens temoins des groupes 2 et 4.
L'examen histologique a demontre que
les structures essentielles de la bronche
distale de la zone anastomotique, etaient
bien plus prgservees dans les groupes
d'animaux avec le pedicule de membrane
adipeux a localization peritracheale, que
dans les groupes d'animaux temoins. La
conservation de la vitalite et de I'int6grite structurale de la bronche, au niveau
et au deld de la ligne de sutures, s'est
montree extremement pauvre (necrose et
calcification) chez les chiens avec une
bande de Dacron entourant la zone anas
tomotique.
La nettete des resultats obtenus dans
ce travail experimental permet de conclure que ('application d'un pedicule de
membrane adipeux a localization peritra
cheal sur I'anastomose bronchique, favorise effectivement le retablissement de la
circulation bronchique dans les 7 jours
qui suivent la reimplantation du poumon.

Poor healing of the bronchial anastomo
sis, which has been a serious obstacle to
the success of human lung transplanta
tion,1 may occur as a result of ischemia
secondary to division of the bronchial
blood supply.
In an attempt to correct this problem,
we have assessed a technique to enhance
early revascularization of the distal bron
chus by using a peritracheal membranous
adipose tissue graft fastened around the
anastomosis.
Peritracheal membranous adipose tis
sue is that part of the mediastinal pleura
overlying the aortic arch and the thora
cic aorta. It is microscopically composed
of membranous adipose tissue, numerous
capillaries and small blood vessels,
lymphatics and peripheral nerve fibres.
The blood supply is from the thoracic
aorta.

Material and Methods
Thirty-four adult mongrel dogs, each
weighing 18 to 22 kg, were premedicated
with atropine sulfate (0.04 mg/kg) and
anesthetized with intravenous droperidolfentanyl citrate (Innovar Vet, 0.1 ml/kg).
General anesthesia was maintained with
1% halothane in oxygen and nitrous
oxide-oxygen in a ratio of 3 to 2. Mus
cular relaxation was provided by pancu
ronium bromide (0.05 mg/kg). The sur
gical technique was similar to that
previously described,2 but the following
brief account emphasizes several points
pertinent to the adipose tissue wrap (Fig.
1).
The thorax was opened through the
fifth interspace and the lung mobilized,
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from the aortic arch to the inferior pul
monary ligament. During the procedure,
an area o f bronchus from the lobar
orifices to a point a few millimetres dis
tal to the carina was cleared by blunt dis
section. The bronchial arteries accom
panying the left main bronchus were
ligated and transected, severing the vagus
branches to the bronchus. The left main
bronchus and atrium were clamped and
divided; then the lung was flushed with
a 2% solution o f Rheomacrodex in
R in g e r’s lactate and reim planted.
Ischemic time averaged 104 minutes.
The animals were divided at random
into four groups as follows: bronchial
transections and reanastomoses were per
formed at a level 5 to 6 mm distal to the
carina in groups 1 (6 dogs) and 2 (7 dogs)
and at a point 1 to 2 mm proximal to the
bifurcation of the upper and lower lobes
in groups 3(14 dogs) and 4 (7 dogs). With

Fig. la

several 5-0 Prolene sutures, peritracheal
membranous adipose tissue was grafted
to the peribronchial tissue over the left
posterolateral and inferolateral aspects of
the bronchial anastomosis in groups 1 and
3 only. The other two groups served as
controls. From control group 2, three
animals had elastic Dacron fabric
wrapped around the bronchial anasto
mosis.
Antibiotics were administered for 6
days and Demerol intramuscularly as
needed for relief of pain. Blood-gas ana
lyses were carried out before and during
surgery and for 48 hours postoperatively
in order to maintain the measurements
within normal limits. Chest x-ray films
were made routinely in the postoperative
period.
All dogs were put to death 7 days after
lung reimplantation and bronchial heal
ing was evaluated.

To demonstrate that bronchial revas
cularization had occurred from the adi
pose tissue circulation, 20 ml of radio
paque dye (Microfil, Canton Bio-Medical
Products, Inc., Boulder, Colo.) was
injected at a pressure of 120 mm Hg into
the descending aorta which was clamped
immediately above and below the origin
o f the bronchial vessels. After the
Microfil injection was cured, the thoracic
contents were removed en bloc with the
wrap, the tracheobronchial tree was par
tially dissected and roentgenograms of the
specimen were obtained.
The cross-sectional area of the anasto
mosis was estimated as previously
described2 and expressed as a percentage
o f the cross-sectional area of the left
bronchus 4 to 5 mm proximal to the
anastomotic site. The left and right bron
chial tree was then slit and photographed
before fixing in formalin. Histologic sec-

Fig. lb

FIG. 1—(a) Operative view and (b) diagrammatic representation of peritracheal membranous adipose tissue (P.M.A.T.) wrap. Dog
is in left lateral position; surgeon is standing at dog’s abdomen and lung and wrap are reflected anteriorly.

Fig. 2a

Fig. 2b

FIG. 2—Group 1 dog 1 week after left lung autotransplantation just distal to carina with application of wrap, (a) Magnification roent
genogram of distal trachea, main-stem bronchi and lobar bronchi. Bronchial arterial blood supply has been re-established at level of anastomo
sis and is extending well beyond (arrow), (b) Microfil-injected autopsy specimen dissected from posterior aspect. Dye-filled bronchial capillaries
are seen distal to anastomosis as demonstrated in roentgenogram. Mucosal pattern appears normal.
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tions of all anastomoses were stained with
hematoxylin and eosin. The slides were
randomized and the histologic features
evaluated in a blind fashion by the pathol
ogist (S.M.C.).
Statistical analysis of the cross-sectional
areas was done by one-way analysis of
variance. The data are presented as means
± standard error of the means and p
values.
All animals used in this study received
care in compliance with the Guide to the
Care and Use o f Experimental Animals
formulated by the Canadian Council on
Animal Care.
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Results

All dogs survived the operation. On

Fig. 3a

postoperative day 2, an intermittent
cough, productive of blood-tinged spu
tum, developed in two animals from
group 1 and one from group 2; they all
recovered without complication after 5
days of anticoagulant therapy.
Chest X-Ray Films
In all groups of animals, serial chest xray films were generally clear within 48
to 72 hours of surgery. In some cases,
opacification of the autotransplanted
lung was noted for 2 or 3 days after oper
ation, thereafter the lung’s appearance
returned to normal.
When the animals were put to death at
7 days the gross appearance of all reim
planted lungs was normal with the excep

tion of a few adhesions and focal atelec
tasis secondary to open thoracotomy.
Bronchial Anastom osis
Group 1— anastomosis just distal to the
carina, with wrap.—At autopsy, gross
examination of the wraps showed them
to be adherent to the underlying bron
chus. Microfil injection of the aortic seg
ment containing the bronchial arteries
demonstrated filling of the submucosal
capillaries distal to the anastomotic site
(Fig. 2).
Histologic examination revealed the
presence of bundle fibres, numerous
Microfil-injected capillaries and lym
phatic channels, and a few patchy areas
of fibrosis in well-preserved adipose-tissue

Fig. 3b

FIG. 3—Group 2 control dog 1 week after left lung autotransplantation just distal to carina. (a) Magnification roentgenogram of
distal trachea, main-stem bronchi and lobar bronchi. Bronchial circulation appears to stop at level of anastomosis (arrows), (b) Microfil-injected
autopsy specimen dissected from posterior aspect. No dye is present beyond anastomosis; bronchoanastomotic line shows loss of epithelium
and patchy areas of ischemic necrosis.
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Fig. 4a

Fig. 4b

FIG. 4—Group 3 dog 1 week after left lung autotransplantation proximal to lobar orifice with application of wrap, (a) Magnification
roentgenogram of distal trachea, main-stem bronchi and lobar bronchi shows rich network of small vessels extending toward periphery of bron
chial tree (arrows), (b) Microfil-injected specimen dissected from posterior aspect confirming roentgenogram study. Mucosa is abundantly vas
cularized and well preserved.
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wraps. The bronchial mucosa was com
pletely epithelialized with small areas of
squamous metaplasia present at the suture
line. The cartilage appeared viable except
in focal areas of atrophy. Organized
thrombus of a pulmonary vein with
recanalization was noted in two dogs
(nos. 31 and 34).
Group 2—anastomosis ju st distal to the
carina, without wrap.— No filling of the
bronchial circulation distal to the anasto
mosis could be seen in these dogs (Fig. 3),
except in no. 33 in which radiopaque dyefilled vessels were observed in the mucosa
and near the cartilage.
Evidence of bronchial strictures was
noted at autopsy in this group. Micro
scopic examination of all anastomoses
showed loss of epithelium at the suture
line, patchy dystrophic calcification of the
mucosa below the anastomosis with par
tial calcification of the cartilage. Isolation
of the bronchial anastomosis from the
adjacent peritracheal membranous adi
pose tissue with Dacron fabric resulted in
sloughing of the mucosa, necrosis of the
submucosa and acute inflammatory
reaction.
Group 3—anastomosis proximal to the
lobar orifices, with wrap.—Seven days
after autotransplantation, multiple,
small, Microfil-injected vessels were
visualized crossing the anastomotic site
and spreading out toward the periphery
of the bronchial tree (Fig. 4). In all cases,
the integrity of the wrap was similar to
that noted in group 1 animals. Histologic
sections of the left main bronchus rev
ealed excellent restoration of bronchial
epithelium, preservation of the smoothmuscle fibres above and below the suture
line and abundant Microfil-injected ves
sels distal to the anastomosis.

Fig. 5a

Group 4— anastomosis proximal to the
lobar orifices, without wrap.—No bron
chial circulation distal to the anastomo
sis was apparent at 7 days. The distal
bronchus displayed epithelialization but
the subepithelial tissue was attenuated
and distorted with some inflammation
and ulceration at the suture line (Fig. 5).
Degree o f Bronchial Patency
The mean cross-sectional areas of the
bronchial anastomosis of control group
2 dogs with (three) and without (four)
elastic Dacron wrapped around the
anastomotic site were 58.7% ± 1.9% and
65.5% ± 2.3% of normal respectively.
Since there was no significant difference
between these two means, all cross
sectional-area values for group 2 were
pooled to give a mean value of 62.3% ±
2.3% of normal. The mean value of the
bronchial anastom osis o f group 1
exceeded that of group 2 by 20.1% and
group 3 surpassed that of group 4 by
21.2%; these differences were significant
(p < 0.001; Table I). No significant
difference in the degree of bronchial
patency could be found between dogs of
group 1 and group 3 at 7 days.

appears promising, it is time-consuming
and certainly not free of postoperative
complications such as incisional dia
phragm atic h ern ia10-12 and gastric
obstruction.13
In a recent study2 we demonstrated
that a pedicled intercostal muscle graft
wrapped around the bronchial anastomo
sis improved bronchial healing by restor
ing vascular flow across the sutured bron
chus as early as 7 days after canine lung
autotransplantation. The efficacy of this
technique has also been reported by
others.14 They have shown that the
application of an intercostal pedicle flap
to the pneumonectomy bronchial auto
graft, with and without concomitant
administration of corticosteroids in dogs,
provides early revascularization and ade
quate bronchial healing.
Ideally, a graft should be developed
within the chest and most importantly
with minimal intervention. It should pos
sess an adequate vascular, lymphatic and
nervous supply to promote the develop
ment of a rich capillary network at the
critical line of repair and to reduce the
degree of stenosis. The present study
strongly suggests that the peritracheal
membranous adipose tissue wrap could
fulfil these requirements.

Discussion
Several techniques have been developed
to promote bronchial healing following
lung transplantation, but they add to the
difficulty of the transplant operation and
increase the operating time.3 9 An omen
tal pedicle flap has been used successfully
to revascularize the bronchial autograft
after pneum onectom y in dogs.9
Although the bronchial omentopexy

Table 1—Bronchial Patency (Percentage of
Cross-Sectional Area of Proximal Bronchus
7 Days After Operation*)
Group
No.
Patency, %
1
82.4 ± 2.0
6
2
7
62.3 ± 2.3
3
14
83.8 ± 2.5
4
7
62.6 ± 2.9
'Mean ± standard error.

Fig. 5b

FIG. 5—Group 4 control dog 1 week after left lung autotransplantation proximal to lobar orifices, (a) Roentgenogram demonstrates
bronchial circulation down to but not beyond anastomotic site (arrows), (b) Microfil-injected specimen dissected from posterior aspect parallels
findings in (a). Distal bronchus displays epithelialization with some ischemic areas; parts of suture line are ulcerated.
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Light microscopic examination o f this
membranous tissue showed vessels and
capillaries, peripheral nerve bundles and
lymphatics. At the light microscopic level,
there is no difference in the composition
o f this tissue in dogs and in that obtained
from a similar location in human
cadavers.
Our results demonstrated that the level
o f bronchial anastomosis does not alter
the healing process of the distal bronchus
when peritracheal membranous adipose
tissue is wrapped around the anastomo
sis. They also showed that the peritracheal
membranous adipose tissue wrap is
indeed effective in the anatomic reconsti
tution o f the bronchus as early as 7 days
after lung transplantation.
A study is under way to assess the effi
ciency o f the wrap (a) in canine lung
autografts with immunosuppressive ther
apy and (b) in lung allograft rejection
with and without immunosuppression.
We are indebted to Ken Austin and Luke
Grenning for technical assistance in surgery,
Gladys Jackson for expert technical assistance
in radiology, Charles Chano for preparing
histologic slides, Dr. Dave Bryan for his advice
in the analysis of the data and Janet Dupree
for providing excellent animal care. We thank
the staff of the Department of Laboratory
Medicine and Department of Medical Audi
ovisual of the Health Sciences Complex and
Linda Morrissey for her assistance. We also
thank Gail Cornick for typing the manuscript.

BOOKS REVIEWS
continued from page 316
Other groups discussed include the elderly and
homosexuals.
The section on etiology reflects the lack of
knowledge in this area and gives specific com
ments on the importance of immunology and
infection. The chapters on epidemiology are
rather fragmented and describe the experience
of three individuals, rather than giving a global
assessment. More could be made of data avail
able outside the United States. Pitfalls in the
construction of epidemiologic studies and
problems of data interpretation are discussed
and are helpful.
Section three comprises short chapters on
gynecologic complications and inflammatory
bowel disease in pregnancy together with
problems of cancer surveillance. The negative
approach to the finding of dysplasia as a m ar
ker for malignant disease in ulcerative colitis
is perhaps controversial.
The fourth section details the modalities
available in the treatment of inflammatory
bowel disease giving heavy emphasis to Crohn’s
disease. The chapter on salazopyrin does not
discuss the newer 5-ASA preparations and that
on corticosteroids scarcely alludes to topical
steroid preparations. As expected, the chap
ter on the use of 6-MP reflects the enthusiasm
of the Lenox Hill group. A later chapter on
the use of 6-MP from the hematologic aspect
further reinforces the local crusade. The impor
tance of nutritional support and particularly

dietary management is superficially treated. A
chapter on metronidazole completes this
section.
From this point on the book rather loses its
way. A chapter on flexible endoscopy is fol
lowed by very short chapters on sig
moidoscopy, pathology and radiology, all of
which are of poor quality.
Section six deals with m iscellaneous
problems — 6-MP, substance abuse in inflam
matory bowel disease, C rohn’s disease of the
upper gastrointestinal tract, management of
strictures in Crohn’s disease and toxic megaco
lon, infectious agents and differential diagno
sis of inflammatory bowel disease. There is lit
tle new here.
The final section on surgery is of rather bet
ter quality and describes indications, outcome,
recurrence and quality o f life. The effect of
diversion procedures on defunctioned bowel
figures prominently. The chapter on manage
ment o f strictures in C rohn’s disease is partic
ularly useful. Sphincter-saving procedures
receive scant attention and deserve more
thorough review.
Clearly from its content this book was not
designed to be presented in book form. Rather
it represents topics gathered together in a
haphazard way. The order o f the chapters is
not entirely logical, some are repetitive, some
could be combined and some are so short that
their impact is negligible. Other chapters are
anecdotal and the enthusiasm for particular
approaches is infrequently balanced by a review
continued on page 347
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There’s method to our madness here. We’re dramatizing a point about Marcaine:*
The point is, Marcaine lasts a lot longer than other local anaesthetics. Up to
twice as long, in fact. (See Covino, B.G. and Scott, D.B. Handbook of Epidural
Anaesthesia and Analgesia. Grune & Stratton. In Orlando, 1985; 70.)
Since Marcaine lasts twice as long, our ad is twice as long. We understand
that you may not have the time at one sitting to read and digest the amount of
information shown here. But if you’ve read this far, you have the main point
about Marcaine, the reason why it is so well respected and so well used, and later
we’d like to table some discussion points about additional uses for Marcaine,
and perhaps reacquaint you with its other advantages, such as the degree of
participation it allows the mother in labour, and the fact it is 95% plasma protein
bound which limits the amount of drug transfer across the placental barrier to
the foetus.
Longer duration is the key benefit of Marcaine to the anaesthetist. It lasts
up to twice as long as lidocaine which means that you can achieve optimum
pain control during surgical procedures. It also saves the obstetric anaesthetist
time because fewer top-ups are necessary with Marcaine (see Ostheimer, G.W,
Regional Anaesthesia Techniques in Obstetrics, Breon Laboratories Inc., 1980,
p.23). But another key point about Marcaine is that it separates sensory from
motor block. Excellent sensory anaesthesia can be obtained with less motor
block than any other local anaesthetic. This separation allows for complete pain
relief during and after surgery, yet lessens immobility in the post-operative
phase. In obstetrics, Marcaine can maintain the mother’s ability to bear down
in labour while providing relief of pain. Greater involvement and cooperation of
the mother are considered desirable in obstetrics for the 80’s. (The reference
material in the above paragraph outlines data on this phenomenon as well as
evidence for the duration of Marcaine.)
Indeed, the long duration of Marcaine (and in actual fact, Marcaine can
last twice as long as other.injectable local anaesthetics) not only reduces the
time you spend because of fewer top ups during a procedure, it produces an
extended pain free period in the mother after the birth when perineal repair has
been required. Unlike general anaesthesia, the mother is also conscious during
and immediately after the delivery so bonding and breast feeding can occur
earlier.
What are the advantages of Marcaine and epidural anaesthesia relative to
general anaesthesia? First and foremost is the avoidance of one of the principal
hazards of general anaesthesia, i.e. vomiting and aspiration of stomach contents.
Secondly, consider the area of endocrine stress response to anaesthesia and
surgery (Lindall, S., et al: Endocrine Stress Response during General and Epidural
Anaesthesia for Elective Caesarean Sections, Acta Anaesthesiol Scand. 1983;
27:50-55). With inhalation anaesthesia maternal plasma levels of cortisol and
ACTH - endocrine stress markers - are consistently higher. The foetus may have a
higher endocrine stress response.
And the argument can be effectively summarized by this statement:
“Bupivacaine (Marcaine) is currently established as the safest and most
effective amide-linked local anaesthetic for obstetric anesthesia!’ (Bromage RR:
Choice of Local Anesthetics in Obstetrics. In Shnider, S.M. and Levinson, G.
(eds.): Anesthesia for Obstetrics. The Williams & Wilkins Company, Baltimore,
1979,113.) And this statement: “The clear advantages to the post-partum
mother are sufficient grounds for encouraging the teaching and eventually the
routine use of epidural anaesthesia for caesarean section on all suitable patients?
(Morgan B.M., et al: Anaesthetic Morbidity Following Caesarean Section Under
Epidural or General Anaesthesia. The Lancet. 1984: 328-330). We have already
mentioned the longer duration of Marcaine and the additional benefit that
Marcaine is 95% plasma protein bound which limits the amount of drug transfer
across the placenta to the foetus. Marcaine also causes minimal foetal and neo
natal depression of neuro behaviour and muscle tone.
At this point, please allow for a pertinent digression from the discussion
on the longer duration of Marcaine and other benefits.
INDICATIONS: Peripheral nerve block, infiltration, sympathetic blockade,
caudal, epidural, and pudendal blocks.
CONTRAINDICATIONS: Bupivacaine is contraindicated in persons with
known sensitivity to local anesthetics of the amide type. The use of bupivacaine
is contraindicated in the presence of sepsis near the site of proposed injection, in
severe shock and in heart block.
WARNINGS: USAGE IN PREGNANCY: Decreased pup survival in rats and
an embryocidal effect in rabbits have been observed when bupivacaine
hydrochloride was administered to these species in doses comparable to nine
and five times respectively the maximal recommended daily human dose
(400 mg). There are no adequate and well-controlled studies in pregnant women
of the effect of bupivacaine on the developing fetus. Bupivacaine hydrochloride
should be used during pregnancy only if the potential benefit justifies the

potential risk to the fetus. This does not exclude the use of Marcaine 0.25% or
0.50% at term for obstetrical anesthesia or analgesia.
OBSTETRICS: The highest (0.75%) concentration is not recommended for
obstetrical anesthesia. There have been reports of cardiac arrest with difficult
resuscitation or death following its use for epidural anesthesia in obstetrical
patients. Due to the high risk to the fetus, paracervical block is no longer
recommended. The obstetrician is warned that severe persistent hypertension
may occur after administration of certain oxytocic drugs, if vasopressors have
already been used during labor (e.g. in the local anesthetic solution or to correct
hypotension). Until further experience is gained in children younger than 12
years, administration of bupivacaine in this age group is not recommended.
PRECAUTIONS: RESUSCITATIVE EQUIPMENT AND DRUGS SHOULD
BE READILY AVAILABLE WHEN ANY LOCAL ANESTHETIC IS USED.
The safety and effectiveness of local anesthetics depend upon proper dosage,
correct technique, adequate precautions, and readiness for emergencies.
Marcaine (bupivacaine) should be used cautiously in persons with known drug
allergies or sensitivities, particularly to the amide-type local anesthetics. Caution
is advised in administration of repeat doses of bupivacaine to patients with
severe liver disease. The following precautions apply to all local anesthetics:
Select needles of proper length and bevel for the technique employed. Inject
slowly with frequent aspirations and if blood is aspirated, relocate the needle.
Inadvertent intravascular injection may cause serious complications. Absorption
is more rapid when injections are made into highly vascular tissues. In caudal or
epidural anesthesia, abandon the method if the subarachnoid space has been
entered, as shown by aspiration of spinal fluid. The lowest dosage that gives
effective anesthesia should be used, to avoid high plasma levels and serious
systemic side effects. Injection of repeated doses of bupivacaine may cause a
significant increase in blood levels due to accumulation of the drug or its
metabolites or slow metabolic degradation. Tolerance varies with the status of
the patient. Debilitated, elderly and acutely ill patients may require reduced
doses commensurate with age and physical condition. It should be remembered
that solutions containing a vasopressor agent, e.g. epinephrine, should be used
with caution, if at all, in patients who are receiving monoamine oxidase
inhibitors or anti-depressants of the triptyline or imipramine type, because
severe, prolonged hypertension may result. Dose-related cardiac arrhythmias
may occur if preparations containing epinephrine are employed in patients during
or immediately following the administration of chloroform, halothane,
cyclopropane, trichloroethylene or other related agents. In deciding whether to
use these products concurrently in the same patient, the combined action of
both agents upon the myocardium, the concentration and volume of vasocon
strictor used, and the time since injection, when applicable, should be taken into
account. The decision to use a local anesthetic containing a vasoconstrictor in
areas with a limited blood supply or in patients with peripheral vascular disease,
will depend on the physician’s appraisal of the relative advantages and risks.
Local anesthetics which contain preservatives, i.e. those supplied in multiple
dose vials, should not be used for caudal or epidural anesthesia.
EPIDURAL USE: It is advised that a test dose, generally 2-3 mL of 0.5%
bupivacaine (or other amide anesthetic) containing 1:200,000 epinephrine (10-15
micrograms) be administered to check that the spinal canal or a blood vessel has
not been entered while locating the epidural needle or catheter. In the event of
spinal injection clinical signs of spinal block would become evident in a few
minutes. In the event of intravascular injection a transient increase in pulse
rate and possibly momentary increase in systolic blood pressure are usually
detectable with a monitor The other symptoms and signs of “epinephrine
response” are less dependable. The effects of other medication the patient has
received may modify this response. When reinforcing doses are required the test
dose should be used again to check the catheter location.
ADVERSE REACTIONS: Reactions to bupivacaine are characteristic of those
associated with amide-type local anesthetics. A major cause of adverse
reactions to this group of drugs is excessive plasma levels, which may be due to
over-dosage, inadvertent intravascular injection, or slow metabolic degradation.
Other causes of reactions to these local anesthetics may be hypersensitivity,
idiosyncrasy, or diminished tolerance. Excessive plasma levels cause systemic
reactions involving the central nervous system and the cardiovascular system.
The CENTRAL NERVOUS SYSTEM EFFECTS are characterized by
excitation or depression. The first manifestation may be nervousness, dizziness,
blurred vision, or tremors, followed by drowsiness, convulsions, uncons
ciousness, and possibly respiratory arrest. Since excitement may be transient or
absent, the first manifestation may be drowsiness, sometimes merging into
unconsciousness and respiratory arrest. Other central nervous system effects
may be nausea, vomiting, chills, constriction of the pupils, or tinnitus. The
CARDIOVASCULAR MANIFESTATIONS of excessive plasma levels may
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include depression of the myocardium, blood pressure changes (usually
hypotension), and cardiac arrest. Recent clinical reports and animal studies
suggest this may be more likely to occur with the long acting amide local
anesthetics such as bupivacaine. .
ALLERGIC REACTIONS are characterized by cutaneous lesions (e.g.
urticaria, edema) and other manifestations of allergy. Reactions following
epidural or caudal anesthesia may include: high or total spinal block, urinary
retention; fecal incontinence, loss of perineal sensation and sexual function;
persistent analgesia, paresthesia, and paralysis of the lower extremities;
headache and backache; and slowing of labor and increased incidence of forceps
delivery. It should be noted that reactions due to systemic absorption may be
slow or rapid in onset. Those of rapid onset include respiratory depression,
cardiovascular collapse and cardiac arrest. This type of reaction necessitates a
high degree of preparedness since it can occur with little warning.
In co-ordinated studies of 3200 procedures carried out by 15 investigators,
there were 2 severe systemic reactions. Both patients experienced convulsions
as a result of inadvertent vascular injection. Fetal bradycardia has been
observed with the use of bupivacaine. Most cases, including a few fatalities,
occurred when the paracervical route was used (see “Warnings”).
In some subjects bupivacaine may produce marked peripheral vasoconstric
tion in unanesthetized areas which may last for several hours.
TREATMENT OF OVERDOSE AND SEVERE REACTIONS: Toxic effects of
local anesthetics require symptomatic treatment; there is no specific cure. The
physician should be prepared to maintain an airway and to support ventilation
with oxygen and assisted or controlled respiration as required. Supportive
treatment of the cardiovascular system includes intravenous fluids and, when
appropriate, vasopressors (preferably those that stimulate the myocardium).
Convulsions may be controlled with oxygen and intravenous administration, in
small increments, of a barbiturate or muscle relaxant, as follows: preferably, an
ultra short-acting barbiturate such as thiopental or thiamylal, if this is not
available, a short-acting barbiturate (e.g. secobarbital or pentobarbital) or a
short-acting muscle relaxant (succinylcholine). Intravenous muscle relaxants
and barbiturates should only be administered by those familiar with their use.
DOSAGE AND ADMINISTRATION: As with all local anesthetics, the dosage
varies and depends upon the area to be anesthetized, the vascularity of the
tissues, the number of neuronal segments to be blocked, individual tolerance,
and the technique of anesthesia. The lowest dosage needed to provide effective
anesthesia should be administered.
In recommended doses, bupivacaine produces complete sensory block,
but the effect on motor function differs between the three concentrations.
0.25% when used for caudal, epidural, or peripheral nerve block, produces
incomplete motor block. Should be used for operations in which muscle re
laxation is not important, or when another means of providing muscle relaxation
is used concurrently.
0.5% provides motor blockade for caudal, epidural, or nerve block, but
muscle relaxation may be inadequate for operations in which complete muscle
relaxation is essential.
0.75% produces complete motor block. This concentration is recommended
only for epidural block (single dose) in abdominal operations requiring complete
muscle relaxation without the aid of other medication. It is not recommended for
epidural block in obstetrical patients.
The duration of anesthesia with bupivacaine is such that, for most pro
cedures, a single dose is sufficient. Maximum dosage limit must be
individualized in each case after evaluating the size and physical
status of the patient, as well as the usual rate of systemic absorp
tion from a particular injection site. Most experience to date is
with single doses of bupivacaine up to 225 mg with epinephrine
1:200,000 and 175 mg without epinephrine; more or less drug
may be used depending on individualization of each case. At
present there is insufficient clinical evidence with multiple
dosage or intermittent dose techniques to permit precise re
commendations for such procedures to be given. However
limited clinical experience in this area of use indicates that
bupivacaine may be repeated in 3 to 6 hours up to a maxi
mum dose of400 mg in 24 hours. In most cases the duration
of anesthetic effecr is prolonged by the addition of epine
phrine. The following table is presented as a guide to the use
of bupivacaine. The doses shown have generally proved
satisfactory for the average adult. They may require adjust
ment in relation to age and the physical condition of the
patient.

RECOMMENDED CONCENTRATIONS AND DOSAGE FOR ADULTS
Type of Block
Local Infiltration
Epidural^

Epidural^
Test Dose
Caudal
Peripheral Nerves
Sympathetic

Concentration

mL

0.25%
0.75%1
0 .50%
0.25%
0.50%
w/epi

up to max
10-20
10-20
10-20
2-3

0.50%
0.25%
0.50%
0.25%
0.25%

Each Dose

15-30
15-30
5-30
5-60
20-50

mg
up to max
75-150
50-100
25- 50
10- 15
(10- 15/ig
epinephrine)
75-150
37.5- 75
25-150
12.5-150
50-125

Motor Block1

Complete
Moderate to Complete

Moderate to Complete
Moderate
Moderate to Complete
Moderate to Complete

1. With continuous (intermittent) techniques in caudal and epidural block using 0.25 and 0.5% solutions,
repeat doses increase the degree of motor block. The first dose of 0.5% may produce complete m otor block
in most intercostal nerve blocks for intra-abdominal surgery, the 0.25% concentration has produced
satisfactory motor blockade.
2. For single dose use not for intermittent technique.
3. Use of an appropriate test dose is recommended prior to injecting the full epidural dose (see “Precautions”)

AVAILABILITY: ISOTONIC SOLUTIONS:
0.25%-10 mL single dose vials (without preservative), (boxes of 5).
-20 mL single dose vials (without preservative) with and without
epinephrine (boxes of 5).
- 50 mL multiple dose vials (containing methylparaben as preservative)
without epinephrine (boxes of 1).
0.50% - 3 mL single dose ampuls (without preservative) with epinephrine (boxes of
-10 mL single dose vials (without preservative), (boxes of 5).
-20 mL single dose vials (without preservative) with and without
epinephrine (boxes of 5).
-50 mL multiple dose vials (containing methylparaben as preservative)
without epinephrine (boxes of 1).
0.75%>-3mL single dose vials (without preservative) without epinephrine (boxes
of 5).
The solutions are made isotonic with NaCl and the pH is adjusted with
NaOH or HC1. The pH range for solutions without epinephrine is 4.0-6.5 and
for solutions with epinephrine is 3.4-4.5. Plain solutions may be autoclaved but
those containing epinephrine may not. Each mL of solution with epinephrine
contains 0.0091 mg epinephrine bitartrate with 0.5 mg sodium metabisulfite.
0.001 mL monothioglycerol, and 2 mg ascorbic acid as antioxidants, 0.002 mL
60% sodium lactate buffer and 0.1 mg edetate calcium disodium as stabilizer
Product Monograph is available on request.
Marcaine allows better participation of the mother in labour. Marcaine is
95% plasma protein bound which limits the amount of drug transfer across the
placenta to the foetus.
But first and foremost, Marcaine offers longer duration of pain control
needed for surgical and obstetrical procedures.

Marcaine.
The local anaesthetic

that lasts twice as long.
(fyiritlviop
Winthrop Laboratories
Division o f Sterling Drug Ltd.*
Aurora, O ntario LAG 3H6
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A non-adhering dressing
should be truly non-adhering.
It shouldn’t have heavy petrolatum
or paraffin coatings that smear
and clog. It shouldn’t have
loose gauze fibres that adhere to
closing wounds. It shouldn’t have wide
open mesh that allows granulation
to form through and around it.
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The incidence of mediastinal node
involvement of T1 non-small-cell bron
chogenic carcinomas was determined in
262 patients for the period June 1981
to January 1986. All patients underwent
mediastinoscopy as part of their evalua
tion. Thirty-five patients (1 3 % ) had clini
cal primary T1 lesions. There were 17
adenocarcinomas. 10 squamous cell car
cinomas, 6 large-cell anaplastic carci
nomas and 2 bronchoalveolar carci
nomas. Five patients had node
involvement at mediastinoscopy: two
had large-cell anaplastic carcinomas and
one was a squamous cell carcinoma.
Thoracotomy in the remaining 30
patients revealed 2 with pleural
metastases. 1 with left upper lobe
adenocarcinoma with metastases to the
subaortic nodal area (not assessed by
cervical mediastinoscopy). The other
patients underwent resection, for a
resectability rate of 9 0 % . Therefore the
overall incidence of mediastinal node
involvement in this series was 1 7 % (6 of
35) and was found to be highest among
patients with large-cell anaplastic carci
nomas (2 of 6), followed by adenocarci
nomas (3 of 19) and squamous cell car
cinomas (1 of 10). The larger number of
large-cell anaplastic carcinomas in this
series probably accounts for the higher
incidence of N2 disease found compared
with that of previous studies in the liter
ature. Accordingly, preoperative medi
astinal staging is recommended for all T1
large-cell anaplastic carcinomas and
adenocarcinomas and for suspicious
lesions of undetermined histology.
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L'incidence des atteintes ganglionnaires
mediastinales dans les carcinomes bronchopulmonaires au stade T 1 , a I'exclusion des cancers a petites cellules, a ete
determinee chez 262 patients qui ont ete
vus au cours de la periode de juin 1981
a janvier 1986. Parmi les examens d'evaluation, tous patients avaient subi une
mediastinoscopie. Trente-cinq patients
(1 3 % ) presentaient des tumeurs primiti
ves au stade T1. On comptait 17 adenocarcinomes, 10 epitheliomas epidermofdes bronchiques, 6 carcinomes
anaplasiques a grosses cellules et 2 can
cers broncho-alveolaires. Cinq patients
presentaient des atteintes ganglionnaires
a la mediastinoscopie: il s'agissait de
carcinomes anaplasiques a grosses cellu
les dans deux cas et d’un epithelioma
epidermoide bronchique. Chez les 30
autres patients, la thoracotomie a revele
deux metastases pleurales, un adenocarcinome metastasie a la region ganglionnaire sous-aortique (qui n'avait pas ete
vu a la mediastinoscopie cervicale). Les
autres patients ont subi une resection ,
ce qui donne un taux de cas operables
de 9 0 % . Done, dans cette serie,
l'incidence des atteintes ganglion
naires mediastinales a ete de 17%
(6 sur 35); elle etait plus elevee dans les
patients avec les carcinomes anaplasi
ques a grosses cellules (2 sur 6), suivi
des adenocarcinomes (3 sur 19) et des
epitheliomas epidermoVdes bronchiques
(1 sur 10). Le plus grand nombre de car
cinomes anaplasiques a grosses cellules
dans cette serie est probablement responsable de l'incidence plus elevee de
cancers au stade N2 qui a ete trouvee,
par rapport aux etudes deja publiees. II
est done recommande d'etablir en preoperatoire le stade d'atteinte mediastinale
dans tous les cas de carcinomes anapla
siques a grosses cellules et d'adenocarcinomes au stade T1 de meme que
lorsqu'on est en presence de lesions suspectes d'histologie indeterminee.

The incidence of mediastinal node
metastases with small peripheral nonsmall-cell bronchogenic carcinomas is
reported to be 10% or less.1-3 Conse
quently, prethoracotomy mediastino

scopy for staging is frequently thought to
be unnecessary for such lesions.3 The
impression that the incidence was higher
than 10% led to this review which reports
the incidence of mediastinal node
metastases (N2) with T1 bronchogenic
carcinoma in our patient population over
a 4!/2-year period.
Patients and Method

Between June 1981 and January 1986,
262 patients with lung cancer were consi
dered candidates for surgical resection
after initial clinical assessment. We first
performed bronchoscopy and mediastino
scopy before thoracotomy for all malig
nant lesions and for any suspicious lesion
of unknown histology, whatever its size
and location on the chest x-ray film.
Transcervical mediastinoscopy with
sampling of the paratracheal, tracheo
bronchial angle and anterior subcarinal
nodal areas was carried out as previously
described.4 All sampling was done under
general anesthesia with coincident bronchoscopic evaluation. For this study, a
clinical T1N0 lesion is defined by radiologic and clinical criteria as follows:
• A lesion 3 cm or smaller in diameter
on plain posteroanterior chest x-ray film.
• Radiologic evidence of lung paren
chyma or visceral pleura surrounding the
lesion.
• A normal mediastinal shadow as
seen radiologically.
• A lesion not visualized at bron
choscopy.
• No clinical suggestion of more
advanced disease as evidenced by hoarse
ness, dysphagia, cervical adenopathy or
symptoms associated with bone or brain
metastases.
Hospital and office charts of the 262
patients were available for review as were
pathology reports and chest films.
Findings

Complications
There were no deaths and only two
complications. One patient suffered a dis-
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located arytenoid, presumably due to
endotracheal intubation. Another had
transient, recurrent, nerve palsy but reco
vered completely.
Clinical T1N0 Lesions
Thirty-five patients (13%) (21 men, 14
women) were found to have clinical T1N0
lesions. In 17 of these, the lesion was 2
cm in diameter or smaller.
The 35 patients ranged in age from 44
to 81 years (mean 64 years). Twenty-three
had no symptoms and the lesion was iden
tified by routine chest roentgenography.
The following symptoms prompted inves
tigation in the other 12 patients: cough
(4), hemoptysis (3), chest pain (2) and
postpneumonia follow-up (3).
A diagnosis of cancer was obtained
preoperatively in 23 patients (66%) either
by sputum or bronchial-washings cytol
ogy or by percutaneous needle aspiration
biopsy of the lesion. In the remainder,
surgical intervention by mediastinoscopy
or thoracotomy was necessary.
Twenty-one lesions were located in the
left lung and 14 in the right. Upper lobe
lesions were predominant (left upper lobe
11, right upper lobe 8). Seventeen lesions
(48.6% ) were adenocarcinomas, 10
(28.6%) squamous cell carcinomas, 6
(17.1 %) large-cell anaplastic carcinomas
and 2 (5.7%) bronchoalveolar carci
nomas. Two peripheral T1 small-cell
anaplastic carcinomas were encountered,
but the chest x-ray film suggested medi
astinal spread so the patients were
excluded from this report.
T1N2 by Mediastinoscopy
By transcervical mediastinoscopy,
nodal involvement was diagnosed in five
patients. In four of these, both primary
and secondary lesions were asympto
matic. Three of the five patients had
primary lesions 2 cm in diameter or
smaller on the chest x-ray film. Histologic
examination of the lesions revealed two
adenocarcinomas, two large-cell anaplas
tic carcinomas and one squamous cell car
cinoma.
None of the patients with mediastinoscopically proven N2 disease underwent
further surgery. Thoracotomy in the other
30 patients revealed multiple pleural

metastases in 2 and subaortic N2 nodal
spread in 1 patient with a left upper lobe
adenocarcinoma. The aorticopulmonary
window had not been assessed surgically
before thoracotomy. The other 27
patients underwent curative resection for
a resectability rate at thoracotomy of
90%.
The overall incidence of N2 disease was
17% in our population, being highest
among patients with large-cell anaplastic
carcinoma (33%) (2 of 6), followed by
adenocarcinoma (18%) (3 of 17) and
squamous cell carcinoma (10%) (1 of 10)
(Table I).
Age, sex, histologic distribution of the
lesions and the presence or absence of
symptoms were not predictive of the final
outcome in this small group of patients.

lesions in 23 patients who appeared radiologically to have T1N0 cancers.
It is likely that the relatively larger
proportion of adenocarcinomas and
large-cell anaplastic type (65% of our ser
ies) accounts for the increased incidence
of T1N2 disease we found. In a study of
32 patients, Hutchinson6 reported a 65%
incidence of N2 disease with peripheral
large-cell tumours 4 cm or smaller in
diameter, compared with 15% with
adenocarcinoma and 0% with squamous
cell carcinoma. Even though we describe
lesions of smaller size, a similar trend of
incidence according to cell type is
observed: large-cell anaplastic 33%,
adenocarcinoma 18% and squamous cell
10% .

Conclusions
Discussion
Mediastinal exploration has not rou
tinely been carried out in patients with
small peripheral bronchogenic carci
nomas.1-3 The overall 17% incidence of
peripheral T1N2 lesions in this retrospec
tive series is somewhat higher than that
previously reported.
In 1975, Stanford and colleagues'
noted a 6.2% incidence of N2 disease
among peripheral lesions of various sizes
with normal mediastinum on plain chest
film. Subsequently, Baggs and Braun2
reported a 4.2% incidence in 42 lesions
3 cm or smaller in diameter. These reports
cover the period 1967 to 1975. Adenocar
cinoma and large-cell anaplastic carci
noma represented only 25% and 12%,
respectively, of the lesions in the 1975
report. The histologic distribution of the
lesions was not specified in the latter. In
1979, Baker and associates3 described a
10% incidence in a group of 40 patients
with peripheral T1 lesions who underwent
mediastinoscopy. Again, the overall celltype distribution of the lesions was not
stated, but three of the four N2 lesions
were of the squamous cell type. In view
of these reports, routine mediastinoscopy
in patients with such small peripheral
lesions was not considered indicated,
since the incidence of N2 lesions found
was low.
More recently, M cKenna and
colleagues5 noted a slightly higher inci
dence — 13% histologically proven N2

Our data suggest that the incidence of
T1N2 bronchogenic carcinomas in
patients who appear radiologically to
have T1N0 lesions is probably higher than
that previously reported.
In view of our results and of the poor
outcome of patients with stage III (N2)
lung cancer who undergo resection, we
recommend routine preoperative medi
astinoscopy for all peripheral T1 bron
chogenic carcinomas. This approach is
also suggested for suspicious T1 lesions
of undetermined histologic type.
The finding of positive mediastinal
nodes may prevent an unnecessary thora
cotomy or radically alter the approach.
One may also request further investiga
tion for metastases in this setting. To
avoid mediastinoscopy is to accept a
definite incidence of N2 disease at thora
cotomy. We feel this is not in the patient’s
best interest. The influence of cell type is
less clear cut. Although our series shows
fewer N2 metastases with squamous cell
tumours, the difference is not significant.
Further study on larger numbers of
patients is indicated to elucidate this
aspect.
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Dalacin C Phosphate Sterile Solution
(clindamycin phosphate)

Antibiotic
Recommended Applications
Action: Clindamycin exerts its antibacterial effect by causing cessation of protein synthesis and also by
causing a reduction in the rate of synthesis of nucleic acids.
Indications: Dalacin C Phosphate (clindamycin phosphate) is indicated for the treatment of infections
where the oral route is not indicated or feasible.
Dalacin C Phosphate is indicated in the treatment of serious infections due to sensitive anaerobic
bacteria, such as Bacteroides species, peptostreptococcus, anaerobic streptococci, Clostridium
species and micro-aerophilic streptococci.
Dalacin C Phosphate is also indicated in serious infections due to sensitive Gram-positive organisms
(staphylococci, including penicillinase-producing staphylococci, streptococci and pneumococci)
when the patient is intolerant of, or the organism resistant to other appropriate antibiotics.
Contraindications: The use of Dalacin C Phosphate (clindamycin phosphate) is contraindicated in
patients previously found to be hypersensitive to this compound, the parent compound, clindamycin, or
clindamycin palmitate. Although cross-sensitization with Lincocin® (lincomycin hydrochloride) has not
been demonstrated, it is recommended that Dalacin C Phosphate not be used in patients who have
demonstrated lincomycin sensitivity.
Until further clinical experience is obtained, Dalacin C Phosphate is not indicated in the newborn (in
fants below 30 days of age), or in pregnant women.
Warnings: Some cases of severe and persistent diarrhea have been reported during or after therapy
with Dalacin C Phosphate (clindamycin phosphate). This diarrhea has been occasionally associated with
blood and mucus in the stools and has at times resulted in acute colitis. When endoscopy has been
performed, some of these cases have shown pseudomembrane formation.
If significant diarrhea occurs during therapy, this drug should be discontinued or, it necessary, con
tinued only with close observation. Significant diarrhea occuring up to several weeks post-therapy
should be managed as if antibiotic-associated.
It colitis is suspected, endoscopy is recommended. Mild cases showing minimal mucosal changes
may respondtosimpledrugdiscontinuance.Moderatetoseverecases.includingthoseshowingulceration or pseudomembrane formation, should be managed with fluid, electrolyte, and protein
supplementation as indicated. Corticoid retention enemas and systemic corticoids may be of help in
persistent cases. Anticholinergics and antiperistaltic agents may worsen the condition. Other causes
of colitis should be considered.
Studies indicate a toxin(s) produced by Clostridia (especially Clostridium difficile) may be a principal
cause of clindamycin and other antibiotic-associated colitis. These studies also indicate that this
toxigenic Clostridium is usually sensitive in-vitro to vancomycin. When 125 mg to 500 mg of vanco
mycin were administered orally four times a day tor 5 -1 0 or more days, there was a rapid ob
served disappearance of the toxin from faecal samples and a coincidental recovery from the diarrhea.
It should be noted that serious relapses have occurred up to one month after apparently successful
treatment. A relatively prolonged period of continuing observation is therefore recommended.
Precautions: Dalacin C Phosphate (clindamycin phosphate), like any drug, should be prescribed with
caution in atopic individuals. Dalacin C Phosphate must be diluted for intravenous administration.
(See Dosage and Administration)
The use of antibiotics occasionally results in overgrowth of nonsusceptible organisms - particularly
yeasts. Should superinfections occur, appropriate measures should be taken as dictated by the
clinical situation.
As with all antibiotics, perform culture and sensitivity studies in conjunction with drug therapy.
Since abnormalities of liver function tests have been noted occasionally in animals and man, periodic
liver function tests should be performed during prolonged therapy. Blood counts should also be
monitored,during extended therapy.
Dalacin C Phosphate may be used in anuretic patients. Since the serum half-life of clindamycin in
patients with impaired hepatic function is greater than that found in normal patients, the dose of
Dalacin C Phosphate should be appropriately decreased. Hemodialysis and peritoneal dialysisare not
effective means of removing the compound from the blood. Periodic serum levels should be deter
mined in patients with severe hepatic and renal insufficiency.
Adverse Reactions: Local
(a) Intramuscular Injections: Of 404 patients treated with Dalacin C Phosphate (clindamycin
phosphate) intramuscularly (with a solution containing 150 mg/ml), six (1.5%) demonstrated local
reactions as follows: Two complained of pain at the injection site, two demonstrated induration at
the injection site and two developed sterile absesses.
(b) Intravenous Infusions: Of 192 patients treated with Dalacin C Phosphate by intravenous infusion,
14 (7.3%) demonstrated local reactions. Eleven patients developed superficial thrombophlebitis and
one patient developed both superficial and deep thrombophlebitis. The majority of these cases
developed in conjuction with the useof indwelling I.V.cathetersand it isdifficulttoknow how much the
drug contributed to the irritation. Two patients developed localized erythema, swelling and pain at
the site of the infusion.
Systemic Side Effects: Twenty-eight patients of 596 treated with Dalacin C Phosphate (clindamycin
phosphate) by either the intramuscular or intravenous routes developed systemic side effects as follows:
Number o f Patients
Rash............................................................................................................................................................. 7
Urticaria......................................................................................................................................................... 1
Pruritus......................................................................................................................................................... '
Fever, Leucocytosis..................................................................................................................................... 1
Nausea, with or withoutvom iting............................................................................................................. 1
Diarrhea (See also under ' Warnings')........................................................................................................ 4
Hypotension................................................................................................................................................. 1
Hypertension................................................................................................................................................ 1
Shortness of Breath.................................................................................................................................... 1
Superinfection' ........................................................................................................................................... 4
Cardiac a rre st**.......................................................................................................................................... 1
Bad or bitter taste in mouth................................................................................................................
5

* Superinfection is a complication of antibiotic therapy in general and is not necessarily a true side
effect of clindamycin phosphate.
* * Due to underlying myocarditis in this patient.
Clinical and Laboratory Findings: Patients treated during clinical trials of Dalacin C Phosphate*
(clindamycin phosphate) were followed with clinical laboratory tests, including complete hematology,
urinalysisandliverandkidneyfunctiontests. Someofthesetestswereabnormalinitiallyand returned ^
to normal during therapy with Dalacin C Phosphate, while others were normal initially and became ,
abnormal,during therapy. Overall evaluation of clinical laboratory values in these patients does not
indicate that Dalacin C Phosphate therapy has a toxic effect on the hematopoietic, hepatic or rena, *
systems. Transient elevations of serum transaminases have occured in some patients, but other liver
function tests (alkaline phosphatase, serum bilirubin) have not shown any tendency to increase and A
there have not been clinical signs of drug-induced hepatic toxicity.
*

Symptoms and Treatment of Overdosage: No cases of overdosage have been reported. No specific
antidote is known. Doses as high as 1200 mg every six hours (4800 mg/day) by infusion for five days^
have been given without adverse effects.
DOSAGE AND ADMINISTRATION
Adults
K
Intramuscular Injection: 600 mg/day in 2 equal doses.
Moderately severe infections: 600 to 1200 mg/day in 2 or 3 equal doses.
Severe infections: 1200 to 2400 mg/day in 2,3 or 4 equal doses. Intramuscular injections of more tharrt600 mg into a single site are not recommended.
Intravenous Administration: Dalacin C Phosphate (clindamycin phosphate) must be diluted prior to -*
I.V. administration to a dilution of 300 mg in 50 mL of diluent (6mg/mL) or more, and infused in not less
than 10 minutes. Administration of more than 1200 mg inasingle 1 hourinfusion is not recommended A
Dalacin C Phosphate should not be injected intravenously undiluted as a bolus.
Moderately severe infections: 900 to 1800 mg/day by continuous drip or in 2 or 3 equal doses, each A
infused over 20 minutes or longer.
Severe Infections: 1800 to 2700 mg/day by continuous drip or in 3 or 4 equal doses, each infused over*
20 minutes or longer. In life-threatening infections, doses of 2700 to 4800 mg/day by continuous drip or
in 3 or 4 equal doses each infused over 20 minutes or longer may be given.
Dilution and infusion rates:
y.
Time
Diluent
Dose
ir —
10 min.
50 mL
300 mg
20 min.
100 mL
600 mg
30 min.
150 mL
900 mg
45 min.
200 mL
1200 mg
Alternatively, drug may be administered in the form of asingle rapid infusion of the first dose followed
by continuous I.V. infusion as follows:
Maintenance
Rapid
To maintain serum
4
infusion rate
infusion rate
clindamycin levels
0.75 mg/min.
10m g/m in.for30m in.
Above 4 mcg/mL
't
1.00 mg/min.
15m g/m in.for30m in.
Above 5 mcg/mL
1.25 mg/min.
20m g/m in.for30m in.
Above 6 mcg/mL
Children: (Over one month of age)
Intramuscular injection: 10 to 15 mg/kg/day in 2,3 or 4 equal doses.
Moderately severe infections: 15 to 20 mg/kg/day in 3 or 4 equal doses.
Severe infections: 20 to 30 mg/kg/day in 3 or 4 equal doses.
Intravenous Administration:
4
Moderately severe infections: 15 to 25 mg/kg/day by continuous drip or in 3 or 4 equal doses, each
infused over 20 minutes or longer.
r
Severe infections: It is recommended that children be given no less than 300 mg/day regardless of body
weight. (Dilute Dalacin C Phosphate Sterile Solution in the same manner as for adults.)
* ♦
Dilution and Compatibility:
4 mL (600 mg) Dalacin C Phosphate when diluted with 1000 mL of the following commonly used in- i
fusion solutions was found to be physically compatible and demonstrated no significant change in pH
or antimicrobial potency over a period of 24 hours:
Sodium chloride injection
Dextrose 5% in water
Dextrose 5% insaline
y
Dextrose 5% in Ringer’s Solution
Dextrose 5% in half-strength saline plus 40 mEq potassium chloride
* "
Dextrose 21/2% in Lactated Ringer's Solution (Hartmann's Solution)
Dalacin C Phosphate was not stable when added to Dextrose 5% in water plus vitamins. Therefore it is **
not recommended that Dalacin C Phosphate be mixed with any infusion solution containing B vitamins.
h

Supplied:
Dalacin C Phosphate contains the following per mL of sterile solution:
^
Clindamycin phosphate equivalent to clindamycin base 150 mg
Benzyl alcohol 5 mg
* ^
Disodium edetate 0.5 mg
Water for injection q.s.
i__
When necessary the pH is adjusted with sodium hydroxide and/or hydrochloric acid to maintain a pH’~
range of 5.5 to 7.0.
Dalacin C Phosphate is available in 2 mL and 4 mL ampoules.
*- •*
NOTE: Do not store below 15°C.
Product Monograph available upon request.
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Thoracoplasty; Its Forgotten Role in the Management
of Nontuberculous Postpneumonectomy Em pyem a
The role of thoracoplasty in the manage
ment of empyema complicating pneu
monectomy is controversial because
alternative techniques, such as pedicled
muscle transplants or open-space sterili
zation, have now replaced the conven
tional collapse procedures.
Among 46 patients treated for post
pneumonectomy empyema during the
years 1975 to 1984, 17 underwent
space-reducing thoracoplasty as the final
step in pleural space management. Tech
nical considerations, critical in the suc
cess of the operation, were: (a) singlestage extramusculoperiosteal resection of
the second to the seventh rib, (b) spar
ing of the first rib to maintain integrity of
the neck and shoulder girdle, (c) inter
costal muscle closure of large fistulas
and (d) adequate drainage of pleural and
extrapleural spaces.
Immediate control of the empyema
was obtained in 15 (88% ) patients.
Fourteen patients were alive at the time
of follow-up (mean 4.5 years) and none
had major thoracic deformity or residual
infection.
Our data show that thoracoplasty is an
excellent therapeutic option for patients
with chronic postpneumonectomy
empyema. Adherence to strict surgical
principles ensures that the space is
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obliterated and the cosmetic result is
satisfactory.

Le role de la thoracoplastie dans le traitement de I'empyeme compliquant la pneumonectomie est controversy depuis que
cette operation classique a ete supplante
par les greffes musculaires pediculees et
par les techniques ouvertes de sterili
sation.
Parmi les 46 malades traites pour
empyeme post-pneumonectomie entre
1975 et 1984, 17 ont subi une
thoracoplastie dans le but d'obtenir un
controle definitif de I'espace infecte.
Plusieurs considerations techniques sont
jugees importantes pour realiser avec
succes cette intervention: a) resection
extra-musculo-periostee de la 2eme a la
7eme cote en un seul temps operatoire,
b) premiere cote laissee en place afin de
maintenir I' integrite du cou et de
I'epaule, c) fermeture par muscle inter
costal pedicule des grosses fistules
broncho-pleurales et d) drainage adequat
des espaces pleural et extra-pleural.
Le controle immediat de I'empyeme a
ete obtenu chez 15 (88% ) patients. Au
moment du suivi ulterieur (moyen de 4.5
ans), 14 malades etaient vivants sans
infection residuelle ou deformity thoracique importante.
L'analyse de ces donnees nous permet
de conclure que la thoracoplastie est une
excellente option dans la therapeutique
de I'empyeme post-pneumonectomie en
phase chronique. L'adherence a des principes stricts de chirurgie et I'attention
donnee aux details techniques previennent les echecs de traitement tout en
assurant un resultat cosmetique satisfaisant.

The management of postpneumonectomy
empyema presents a unique problem in
view of the large infected space and high
incidence of associated life-threatening
bronchopleural fistulas. Although emer
gency treatment is standardized and con
cerned mainly with dependent thoracic
drainage, definitive control of the infected
space is more controversial because in
recent years collapse procedures1’2 have
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been supplanted by filling operations
(pedicled muscle transplants)3,4 or sterili
zation techniques.5’6
The surgical principle behind thoraco
plasty is to collapse the chest wall over the
mediastinum by multiple rib resections.
Although it was originally described as a
treatment for active tuberculosis,1 this
concept was subsequently applied to
management of nontuberculous post
resection empyemas. Over the last 30
years collapse therapy has lost much of
its popularity, being referred to as
mutilating5,7,8 and poorly tolerated by
patients who have not yet recovered from
their pneumonectomy.5
We report a 10-year experience with
extramusculoperiosteal thoracoplasty for
the elective treatment of nontuberculous
empyema complicating pneumonectomy.
This study is an attempt to redefine the
role of thoracoplasty in the modern ther
apeutic approach to postpneumonectomy
empyema and to review surgical princi
ples relevant to preservation of thoracic
cage integrity.

Patients and Methods
Between January 1975 and December
1984, 46 patients with documented
nontuberculous postpneumonectomy
empyema were treated at a regional centre
for thoracic surgery. Although in 40
patients the condition was diagnosed dur
ing the early postoperative period, 6
patients presented with a late-onset
empyema (signs and symptoms more than
6 months after resection).
Seventeen patients (37%) (13 men, 4
women) underwent thoracoplasty as the
primary treatment for permanent space
control. The remaining 29 (63%) were
denied definitive surgery because of early
death (15 patients), proven or suggestive
cancer recurrence (11), or less than
optimal medical status (3). The records
of all 17 thoracoplasty patients were
reviewed to determine indications and
selection for surgery, safety of the proce
dure and its adequacy as a method for
treating postpneumonectomy empyema.
The age range of the 17 patients was
from 39 to 70 years (mean 57.4 years).
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The underlying condition was broncho
genic carcinoma in 12 patients and nontuberculous inflammatory disease in 5.
Management of the empyema during the
early purulent phase included dependent
drainage of the space, culture-specific sys
temic antibiotic therapy and intensive
cardiorespiratory supportive care. In
addition, seven patients required some
form of nutritional support during a 4to 8-week period.
The sole indication for thoracoplasty
was a persisting infected space following
pneumonectomy for nontuberculous dis
ease. Operative selection was based on
adequate control of sepsis, satisfactory
nutritional and cardiorespiratory status
and absence of detectable recurrent car
cinoma. The interval between diagnosis
of the empyema and thoracoplasty was
2 to 38 weeks (mean 10 weeks).
Seven patients had an associated bron
chopleural fistu la at the tim e of
thoracoplasty but only two of the fistulas
were considered important (more than
2 mm of bronchial stump dehiscence).
Operative Technique
T he th o raco p lasty consists o f
extramusculoperiosteal resection of a
sufficient number of ribs to collapse and
obliterate the pneumonectomy space
completely. As shown by Hopkins and
colleagues,2 adherence to strict princi
ples, knowledge of local anatomy and
attention to technical detail will ensure
that the space is obliterated and the cos
metic result is satisfactory. There are four
basic principles in posterolateral singlestage thoracoplasty:
1. The operation is done through the
original pneumonectomy incision, using
a double-lumen endotracheal tube when
a bronchopleural fistula is present or sus
pected. Although classically performed in
two or even three stages,1 thoracoplasty
can obliterate almost any pneumonec
tomy space in a one-stage procedure.
2. Technical considerations relevant
to rib resections are critical if one wants
to perform the surgery successfully. The
second to the seventh or eighth ribs
are resected extramusculoperiosteally.
Sloping resection of their anterior portion
(progressively less anterior rib being
resected) will preserve the normal config
uration of the anterolateral thoracic wall.
Removal of more of the lower ribs
does not contribute to space collapse but
accentuates the postoperative deformity.
Structural integrity of the neck, shoulder
girdle and upper thorax is maintained by
preserving the first rib (Fig. 1). To mobi
lize the cavity lining, the periosteum over
the rib is incised, using diathermy, and
stripped from its superior surface. Once
the rib is freed, the space can be collapsed
by digital pressure. To maximize paraver
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tebral collapse, the ribs should be divided
as far back as possible so that the resected
specimen includes the costovertebral
joints and sometimes part of the verte
bral transverse processes. The chances of
extrapleural or wound contamination are
minimized if the cavity is collapsed
without entering it.
3. There should be no attempt to
close a small bronchopleural fistula since
collapse of the chest wall over the medi
astinum will nearly always result in spon
taneous closure. If a large fistula is
present, a posteriorly pedicled intercostal
muscle flap is brought down through the
space to cover the bronchial stump.
4. Adequate intra- and extrapleural
drainage is mandatory. The extrapleural
drain can be removed within 5 days of
surgery, and the intrapleural catheter is
progressively withdrawn (2.5 cm per
week) over several weeks.

Fig. la

Results

There were no operative deaths and
88% of the patients had a normal
postoperative course or only minor com
plications. Respiratory failure occurred in
two; both were weaned off the respira
tor after periods of 10 and 21 days.
All patients under review were followed
up for a minimum of 1 year after
thoracoplasty or until they died. The
empyema was considered cured if the
space was collapsed completely, with
closure of any bronchopleural fistula
present. Poor results included incomplete
obliteration of the space, failure to close
the fistula or persistence of a draining
sinus for more than 2 months after
removal of the intrapleural drain.
Immediate control of the empyema was
obtained in 15 patients (88%). One of the
two remaining patients had a discharging
sinus for 3 months postoperatively while
the second had a residual space for 15
months but is alive and well 5 years after
pneumonectomy.
Fourteen patients were alive at the time
of review (mean follow-up 4.5 years) and
none had disabling thoracic deformity or
residual pleural infection.

Fig. lb
FIG. 1—(a) Chest x-ray film and (b) photo
graph of 53-year-old woman 6 months after
right-sided collapsing thoracoplasty. Empyema
space is completely obliterated without signifi
cant thoracic cage deformity. Structural
integrity of neck and shoulder girdle is main
tained by retaining first rib (arrow).
T a b l e 1— H is t o r ic a l H ig h lig h t s o f M a n a g e m e n t o f
P o s tp n e u m o n e c to m y E m p ye m a

Discussion

O p e r a t io n

The first reported surgical attempt to
treat empyema was that by Hippocrates9
who performed intercostal tube and open
drainage (Table I '.4-5.8- 10) in young
patients with infection of the pleural
space.
The concept of resecting ribs to
decrease the size of the thorax and col
lapse the infected space was described in
the late 19th century by Scheede and Eastlander.10 John Alexander1 reintroduced
these principles during the golden years
of surgery for active tuberculosis by
proposing a posterior extramusculoperi-
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osteal approach through which he could
close the cavity in the majority of
patients.2 With the advent of effective
chemotherapy for tuberculosis in the
mid-1940s, thoracoplasty is now used
almost exclusively for postresection obli
teration of the empyema space.
One of the most important contribu
tions to the management of postpneu
monectomy empyema was the description
by Clagett and Geraci5 of space steriliza
tion by irrigating with half-strength
D akin’s solution through an open
thoracic window. Surgical closure of the
drainage site was accomplished when the
pleural space was considered clean and
sterile, generally 8 to 10 weeks later.
Stafford and Clagett11 and others12,13
have reported success rates of 60% to
70%, but our own experience and that of
Shamji and associates7 has not come
close to these results. Pro van8 was able
to sterilize an infected postpneumonec
tomy space in two patients by using
thoracic catheters to drain and irrigate the
pleural space. These sterilization tech
niques have the advantage of a signifi
cantly low morbidity and mortality.
More recently, extrathoracic skeletal
muscle flaps have been used to fill the
empyema cavity and close the associated
bronchopleural fistula. An early report by
Miller and colleagues3 showed encourag
ing results, but all patients with postpneu
m onectom y empyema reported by
Pairolero and colleagues4 needed multi
ple operative procedures (mean 4.3 per
patient) and prolonged hospitalization.
Thoracoplasty is a major undertaking
that presents specific advantages when
performed in appropriately selected
patients. Treatment failures are uncom
mon and due to improper selection of
patients or to violation of basic surgical
principles noted earlier in this paper.
Selection for operation, timing of sur
gery and preoperative preparation are all
important considerations if good results
are to be achieved. Figure 2 outlines the
overall plan of management for patients
with documented postpneumonectomy
empyemas.
Emergency treatment is primarily con
cerned with drainage of the dependent
closed pleural space, aggressive cardiopul

m onary resuscitation and specific I
antimicrobial therapy. If the patient sur
vives the acute episode, we suggest a
3-month waiting period during which the
empyema cavity is irrigated daily with an
antiseptic solution and the patient’s med
ical status brought to an optimal level. To
improve response to therapy and prepare
the patient for a major surgical proce
dure, nutritional support may be
required. If there is no evidence of recur
rent carcinoma, single-stage thoracoplasty
should be considered as the next step.
In the presence of documented or sus
pected recurrent carcinoma or if the med
ical state is less than optimal, an openwindow thoracostomy should be done for
better control of local sepsis and easier
home nursing care.
We conclude th a t extrap leu ral
thoracoplasty is an excellent therapeutic
option for management of postpneu
monectomy empyema in the chronic
organization stage. Selection for opera
tion must be rigorous and should include
careful evaluation for recurrent neoplas
tic disease. Retention of the first rib will
prevent major thoracic deformity.
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Presidential Address, 1986. The Future of General Surgery
The future of general surgery is assured
provided the discipline remains flexible,
adaptable and innovative. A strong and
continuing emphasis on education and
research at all levels is essential to main
tain these qualities.
Le futur de la chirurgie generate sera
assure en autant que la discipline sait
conserver flexibility, capacite d'adaptation et innovation. Pour maintenir ces
qualites. il est essentiel que I’accent soit
mis de facon importante et continue sur
la formation et la recherche.

I have enjoyed being on the Executive of
the Canadian Association of General Sur
geons from its inception. A year ago, Mr.
Gerry Nason, executive director of the
association, fascinated and, no doubt,
bemused by our discussions in commit
tee on the definition of general surgery
and the future prospects for general sur
geons, suggested the setting up of a task
force to study the future of general sur
gery, which the association asked me to
do. First of all I needed to crystallize my
own thoughts and, to this end, I discussed
the matter with surgeons from many parts
o f the world. There were diverse views
and opinions, but the experience did pro
vide me with some insight.
Surgery may be likened to a stately
deciduous tree with its roots deeply
embedded in the basic sciences. The stout
trtink has a number of fine lateral
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branches representing the other surgical
specialties. The crown of the tree, which
largely determines its shape, is general
surgery; the crown is not static but is
characterized by a slow and continuous
change which makes it so adaptable.
There have been striking changes in
general surgery over the last 40 years. In
our larger hospitals, the plastic surgeons
do most of the hand and peripheral nerve
surgery and the management of burns;
fractures are handled by orthopedic sur
geons and, in some cities, head and neck
surgery by the otolaryngologist.
These changes have been more than
compensated for by important advances
in surgery of the esophagus, liver, biliary
tract, pancreas, peripheral vessels and
the endocrine system. Furthermore,
endoscopy, transplantation, access sur
gery for renal failure, the management of
multiple injuries and organization of
trauma care have evolved, and real
advances have been made in the under
standing and treatment of shock and
infection.
In 1982, the Canadian Association of
General Surgeons adopted a definition of
general surgery, primarily as a guide for
developing curricula, training programs
and examinations. But the definition was
sufficiently broad to allow general surgery
to adapt readily to advances in knowl
edge, to changes in disease processes and
to the needs of the community. In par
ticular, the definition emphasizes a prime
concern o f general surgeons, which is the
management of the whole patient rather
than one area or system.
If we accept that general surgery has
been successful in adapting to change over
the last 40 years, how are are we to main
tain this flexibility in the future? The
answer, of course, is through education.
Education is the major thrust of your
association and we have been fortunate
in our selection of chairmen and members
of the education committee and the three
subcommittees concerned with under
graduate, graduate and continuing med
ical education.
Let us first consider undergraduate

education, at which level general surgeons
do most of the teaching. Surgical patients
provide excellent opportunities for clini
cal teaching and, just as important, they
provide experience for students to learn
how to handle nervous, worried and even
difficult patients and their families.
To quote Albert Schweitzer, “ L’example, ce n’est pas la chose principale quand
nous voulons influence les autres: c’est la
seule chose.” [Example is not the main
thing in influencing others, it is the only
thing.]
As newer disciplines in medical schools
demand undergraduate teaching time,
there has been a tendency across the coun
try to erode the surgical quota. Surgeons
are poorly represented on most curricu
lum committees and many internists and
even a few surgeons (especially those in
the other surgical specialties) claim that
the teaching of surgical principles to med
ical students and their exposure to the
management of surgical patients is
unnecessary. It is, therefore, not difficult
to understand why many medical students
graduate with the attitude that surgeons
are mere technicians to be directed by
internists, an attitude that can lead to
inappropriate consultation and unneces
sary, expensive investigations.
We must work hard to avoid conflicts
between the demands of the operating
room, the bedside, the lecture room, the
laboratory and the committee room. The
prescription for retaining teaching hours
and maintaining a strong influence on the
undergraduate teaching program is to
teach well and enjoy doing it. The Ameri
can Society for Surgical Education was
established with this in mind. Canada has
a strong representation in this society so
that each medical school has a nucleus of
general surgical teachers who not only
teach effectively but are actively involved
in getting the best out of their colleagues.
Many general surgeons are well quali
fied to teach in the basic science depart
ments — certainly in gross anatomy and
perhaps also in physiology and microbi
ology. I know of a number of senior sur
geons energetically lecturing and demon-
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strating in the anatomy laboratories who
have considerable influence on the recep
tive minds of first-year medical students.
I commend this idea to the more senior
members of the association.
There is no doubt in my mind that
Canada has developed, over the last 40
years, the best surgical residency training
program in the world. A measure of
credit must go to those who strove to keep
this country from falling into the trap of
a two-tiered system of medical care which
can seriously undermine surgical training;
this would be especially so in a relatively
underpopulated country. We are also for
tunate that the Royal College of Physi
cians and Surgeons of Canada and the
Professional Corporation of Quebec are
responsible for both the accreditation of
training programs and the process of cer
tification, and this gives them unique
powers that have always been used for the
good of society. A number of well-known
Canadian general surgeons contributed
much to the evolution of these institutions
and we are indebted to them. Time and
again they emphasize that the surgeon is
responsible for the decision to operate,
for the preoperative care, the procedure
itself, for postoperative management and
follow-up, including an unbiased assess
ment of the result. It may seem more con
venient and possibly more economically
advantageous to abrogate our responsi
bilities in one or other of these areas —
but we do so at our peril. To see what can
occur, we need only look at the situation
in some hospitals south of the border.
Similar tendencies are evident in our
larger hospitals, and if we do not heed
these warnings, there is a real danger that
surgeons will revert to the status of the
barber-surgeons, who simply did as they
were directed by physicians.
Our graduate education committee was
instrumental in developing the Canadian
Association of General Surgeons’ “ in
training examination” which is held
annually in February. All general surgery
trainees in the country take this exami
nation each year, and it has proved to be
an excellent predictor of their perfor
mance at the Royal College examinations.
This committee also strongly endorses the
advanced trauma life support course of
the American College of Surgeons; it has
done much to improve the standard of
care of the seriously injured patient.
Are we training a sufficient number of
general surgeons? In his presidential
-address last year, Dr. Richard Railton
clearly showed that we are not. In today’s
economic climate there is little hope that
governments will fund additional train
ing positions in general surgery — even
though they recognize a need in many
parts of Canada.
How then can we make up any defi
ciency? General surgeons could work
harder and most already do so, but if they

simply spend longer hours in the operat
ing room this can be at the expense of
other duties and obligations. An answer
lies in the more efficient use of working
hours, even though this may mean higher
costs for hospital administrations. One
very unfortunate consequence of the
shortage of general surgeons is that it will
become increasingly difficult to find
young surgeons who are prepared to work
in smaller centres.
Continuing education is a vital activity
of any professional association. The
influence of scientific meetings, talks,
journals, books, films, tapes and videos
produces a slow but inexorable change in
surgical practice. It is difficult for those
engaged in active practice to appreciate
this, but it is only too obvious to a per
son who has been away from practice for
a few years.
Your association has established spe
cial committees on endoscopy, head and
neck surgery and colorectal surgery, so
that surgeons with a particular interest in
these fields can have a ready focus for
their scientific endeavours and also so
that these areas are perceived as part of
general surgery. Our trauma committee
was instrumental in establishing the
Trauma Association of Canada and is
now charged with keeping in close touch
with this body. More recently new com
mittees on surgical oncology and critical
care were struck. These special commit
tees, working with the education commit
tee and program committee have, this
year and in previous years, organized a
number of valuable postgraduate courses
and symposia.
In arranging the scientific program,
your program committee tries hard to
reach a reasonable balance between the
number of organized symposia and
individual paper sessions, and between
practical and scientific communications.
We rely on research, both in the clini
cal and basic sciences, to provide new
ideas and new concepts. Many of these
will be gleaned from other disciplines, but
new ideas developing within our own
ranks are just that much sweeter. Your
research committee has done much to
integrate and encourage research in
general surgery in Canada. Government
support for surgical research has been
declining for many years, both in Canada
and the United States. Direct support of
research within our membership by the
association calls for money and provid
ing this is a prime function of the Cana
dian Foundation for the Advancement of
General Surgery.
Therefore, it is only by concentrating
on education in its widest sense, and this
includes all forms of research, can we
ensure that general surgery remains a flex
ible discipline capable of adapting suc
cessfully to the inevitable changes that the
future holds.

As surgeons, let us continue as we have
done in the past, striving to fulfil our
tasks as scientists with professional abil
ity and integrity, as human beings with
kind hearts and high ideals, and as mem
bers of society with honesty and effi
ciency.
We can do so much to shape the future,
but more by what we do than by what we
say. ■
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o f the literature. On the positive side, certain
aspects of inflammatory bowel disease that
often receive little attention are highlighted
here. The book is heavily biased towards
Crohn’s disease as opposed to ulcerative colitis.
The audience for this work is limited. For
those familiar with the literature it adds little.
For those beginning gastroenterology, there is
insufficient broad detail. It might be useful for
the trainee in gastroenterology and the gas
troenterologist in clinical practice to keep in
touch with trends in this area. I think that there
will be relatively few buyers at the recom
mended price.
K .N . J e e je e b h o y , m d , fr csc
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College Wing,
Toronto General Hospital,
Toronto, Ont.
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METHODS A N D CONCEPTS IN H A N D
SURGERY. Edited by Neil Watson and
Richard J. Smith. 357 pp. Illust. Butterworth and Co. (Publishers) Ltd., London;
Butterworth Publishers, Stoneham, Mass.,
1986. $59.95 (US). ISBN 0-407-00428-9.

This latest volume in Butterworths’ interna
tional review series in orthopedics is coedited
by two well-respected hand surgeons and con
tains chapters written by international contri
butors, all recognized authorities in their field.
The book has been designed particularly for
those who are not full-time hand surgeons and
aims to provide a clear up-to-date review of
im portant present-day issues in hand surgery.
The 12 chapters cover a wide range of sub
jects, chosen because they contain areas of con
troversy or present difficult problems: cerebral
palsy, rheumatoid arthritis, osteoarthritis,
Dupuytren’s disease, infections, injuries to
skin, tendon, nerve and joint, replantation and
the painful hand. A brief introduction, often
reviewing historical landmarks, is followed by
assessment and classification of the subject.
Basic science information is included when it
is important and this was particularly well done
in the chapters on Dupuytren’s contracture,
tendon injuries and nerve injuries. Diagnosis
and management is then discussed with empha
sis on basic principles rather than technical
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Surgical Treatment of Anal Incontinence

A

V HThe records of 18 consecutive patients
operated upon for fecal incontinence
between January 1983 and March 1986
were reviewed. Anterior sphincteroplasty
was performed on 11 patients with
direct sphincter trauma. The results were
excellent in eight, fair in two and poor in one.
A postanal repair was performed on seven
patients, with excellent results only in
two, fair in four and poor in one. The
indications for surgery and the results
were assessed clinically and manometrically.
A careful classification of the physio
logic and anatomic derangements of the
anal sphincter aids in the appropriate
selection of candidates for surgical treat
ment. In general, anterior sphinc
teroplasty gives good results, whereas
results of postanal repairs are less satis
factory. Manometry is of some use in
providing objective measurements.
On etudie les dossiers medicaux d'une
serie de 18 patients operes pour inconti
nence fecale entre janvier 1983 et mars
1986. Une sphincteroplastie anterieure
fut pratiquee chez 11 patients souffrant
d'une lesion directe au sphincter.
D'excellents resultats ont ete obtenus
chez huit patients; ils etaient moyens chez
deux et mauvais chez un. On eut recours a
une reparation post-anale chez sept patients
avec des resultats excellents chez seulement deux sujets, moyens chez quatre et
mauvais chez un. Les indications chirurgicales et les resultats furent I'objet
d’une evaluation clinique et manometrique.
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Une classification soigneuse des per
turbations physiologiques et anatomiques
du sphincter anal aide a choisir de facon
appropriee les candidats a un traitement
chirurgical. En general, la sphincteroplas
tie anterieure donne de bons resultats
alors que ceux des reparations postanales sont moins satisfaisants. La
manometrie est d'une certaine utilite
pour objectiver les resultats.

Although the rate of occurrence of fecal
incontinence is difficult to obtain, it is
likely more common than generally
thought. Fecal soiling is a distressing
problem and may be socially disabling.
In most cases the problem can be
managed nonoperatively. However,
properly selected patients can achieve
excellent results from appropriate
surgery.
We present the rationale for surgical
intervention in fecal incontinence and the
results of our initial experience.

Slade and colleagues.1 It includes ade
quate mobilization of approximately 180°
of anterior external sphincter and scar tis
sue followed by overlapping (Fig. 1).
Posterior repair was carried out on
seven patients with the anatomic disorder
described by Parks2 as primary idi
opathic incontinence (shortened canal,
descending perineum and flattened
anorectal angle) (Fig. 2). This repair is
based on plication of the puborectalis
muscle after posterior intersphincteric dis
section (Fig. 3).
The results were classified as excellent
(complete continence to all forms of rec
tal contents, solid, liquid or gas) fair (con
tinence to solid stool) or poor (no
improvement in continence).

4

Jk

h.

A

* *■

Method

We reviewed the hospital records of 18
patients (17 women, 1 man) treated sur
gically for total primary anal incontinence
between January 1983 and March 1986.
The mean age was 47 years (range from
18 to 84 years). Patient assessment
included a complete history, physical
examination, proctosigmoidoscopy and
anal manometry. A Narco MMS 100 digi
tized recorder (Narco Scientific Ltd.,
Health Dyne Co., Downsview, Ont.) and
a probe using three radially positioned
force strain gauges were used for manometric assessment. The patients were
divided into two groups: group 1, those
who had anterior sphincteroplasty (11)
and group 2, patients treated by posterior
sphincter repair (7).
Anterior sphincteroplasty was per
formed on six patients who had suffered
obstetrical injuries, four with iatrogenic
incontinence secondary to previous fistula
surgery and one patient with congenital
absence of 180° of anterior external
sphincter musculature. The technique of
sphincteroplasty was that described by

-T

\

*

V

FIG. 1—(a) Mobilization of external sphinc
ter with preservation of scar (adapted from
Goldberg SM, Gordon PH , Nivatvongs S10).
(b) Overlapping of sphincter.
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Results

Patient follow-up ranged frpm 7 to
40 months.
Anterior Repair
The results were excellent in 8 of the
11 patients, fair in 2 and poor in 1. Seven
of the eight excellent repair results were
in patients operated on were for obstetri
cal injury and the other in a patient who
had incontinence as a result of previous
fistula surgery. One fair result was
obtained in a patient who had undergone
a previous fistula repair and one in a
patient who had congenital incontinence.
The poor result was obtained in a patient
who had undergone surgery previously
for a fistula.
Posterior Repair
The results in two of seven patients in
this group were excellent, fair in four and
poor in one.
Of the two patients with excellent

FIG. 2—Idiopathic deformity described by
Parks.2

results, the procedure followed a prolapse
repair in one and in the other the repair
was the sole procedure. Major morbidity
occurred in one patient who had an
ascending retroperitoneal abscess and
subsequently a pulmonary embolus.
The effects of the repairs on squeeze
pressures determined manometrically are
illustrated in Fig. 4.
Discussion

Anal incontinence is probably more
common than previously believed.
Although frequency rates are few in the
literature, Leigh and Turnberg3 noted
that 50% of patients who present with
diarrhea will have associated inconti
nence. The reluctance of patients to dis
cuss incontinence and physicians’ lack of
knowledge of the condition are likely rea
sons for underestimating the frequency of
this disease.
An understanding of the physiology of
normal continence and defecation and a
good classification system for inconti
nence are necessary for accurate diagno
sis and treatment of associated disorders.
Normal anorectal competence is based
upon three components — the storage
capacity of the rectum, sensory mechan
isms and sphincter function. Patients may
be classified as having total or partial,
primary or secondary incontinence.
Causative factors for primary inconti
nence include reduced rectal capacity,
sphincter trauma, anorectal anatomic
changes and neurogenic disorders. Secon
dary incontinence results from systemic
diseases or psychogenic conditions that
overcome the threshold of competence in
the face of “ norm al” continence
mechanisms.4' 7
The majority of patients do not need
surgical treatment. Partial incontinence,
primary incontinence due to reduced rec
tal capacity, neurogenic disorders and
secondary incontinence are best treated by
SQUEEZE PRESSURE
Hg
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BEFORE
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I

FIG. 4—Preoperativc and postoperative
ranges of manometric results, not statistically
significant.
Sphincter trauma
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Anorectal anatomic changes
Without prolapse
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dietary manipulation, drug therapy and
biofeedback training.8 Electrical stimula
tion is reserved for refractory cases.9
Surgery is recommended for patients who
have mechanical sphincter or anatomical
anorectal disorders. An algorithm for
treatment is presented in Fig. 5.
The excellent results of anterior sphinc
teroplasty in the present study are con
sistent with the overall 80% success rates
reported in the literature.1 The proce
dure requires meticulous mobilization of
the remaining undamaged anterior
sphincter without injuring the pudendal
nerves. Preservation of the fibrous mid
line scar is vital for a good result.10
Patients with anatomic derangements,
as described by Parks, are treated by
posterior sphincter repair. Although he
has reported excellent results, our
experience is otherwise. This repair is
designed to restore the anorectal angle
and plicate the puborectalis muscle. If
procidentia coexists, repair of the
prolapse, usually transabdominally,
should be performed first as this will
restore continence in about 50% of
patients.11
We suggest that improved patient selec
tion is necessary to elevate the results of
posterior sphincter repair to those of
anterior repair. Various methods of
assessment have been tried to assist in
selection; electromyograms in various for
mats (conventional needle electrode and
single fibre) have been used in assessing
continence.12 We have not found elec
tromyograms particularly helpful in selec
tion. Defecography has recently been
described as having some discriminating
value in defecation disorders.13 This
modality may prove of future value, par
ticularly in selecting patients for postanal
repair. Our present ability to interpret
defecograms is inadequate as a basis for
clinical decisions. Manometric studies in
our hands are of some use in document
ing changes in sphincteric pressures, but
not in affecting clinical decisions.

With prolapse

A sound understanding of anorectal
physiology allows the physician to assess
and classify properly patients with anal
incontinence. When performed for the
appropriate indications, anterior sphinc
teroplasty is an excellent procedure.
Although patients with primary idi
opathic incontinence may benefit from
posterior sphincter repair, results are less
favourable than for anterior sphinc
teroplasty.

Repair prolapse
Continence persists

References

(50%)
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REPAIR

FIG. 3—(a) Posterior intersphincteric dissec
tion. (b) Posterior plication of puborectalis and
levator muscles.

FIG. 5—Algorithm for surgical treatment of
fecal incontinence.
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Should Cholecystectomy Be Done En Passant
for Asymptomatic Cholelithiasis?
A
The management of asymptomatic gall
stones discovered during abdominal sur
gery is controversial. Should
cholecystectomy be performed en
passant? The authors report a 4-year sur
vey of 109 patients with asymptomatic
cholelithiasis who underwent surgery for
other abdominal conditions: colorectal
(31), gastric (24), vascular (20), gyneco
logic (21) and miscellaneous (13).
Cholelithiasis was established preoperatively by ultrasonography in 52 of 55
examinations (9 5 % ). In the other 54, the
gallstones were discovered at operation.
Cholecystectomy was performed in 78
patients and in 31 the gallbladder was
left in place. In the former group, 11
(1 4 % ) had complications, 2 being
attributable to the cholecystectomy.
Intraoperative cholangiograms were
obtained in 43 and led to common-bileduct explorations in 8. Common-bile-duct
stones were found in seven. In the noncholecystectomized group, three died
postoperatively and three were lost to
follow-up. Twelve of the remaining 25
are still asymptomatic and 13 have had
symptoms: 7 underwent cholecystec
tomy (4 for acute cholecystitis) between
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2 weeks and 11 months after the initial
laparotomy. Because of the low mor
bidity and the relatively high number of
cholecystectomies that were subse
quently necessary, the authors recom
mend cholecystectomy en passant
unless there is a specific contraindica
tion. They also recommend ultrasonogra
phy before major gastrointestinal or vas
cular surgery in order to plan for
cholecystectomy.
La conduite a tenir face a une cholelithiase asymptomatique rencontree en
cours de laparotomie pour une autre
pathologie pose le dilemme suivant: doiton enlever la vesicule biliaire ou est-il
preferable de la laisser en place? Les
auteurs rapportent une etude de 4 ans
portant sur 109 patients avec une cholelithiase asymptomatique chez lesquels
une chirurgie abdominale a ete pratiquee
pour pathologie colo-rectale dans 31 cas,
gastrique dans 24, vasculaire dans 20.
gynecologique dans 21 et d’autres
pathologies chez 13 autres. L'echographie preoperatoire avait demontre la pre
sence de lithiases dans 52 des 55 examens faits (9 5 % ). Chez les 54 autres les
calculs ont ete decouverts a ('interven
tion. Soixante dix-huit patients ont subi
une cholecystectomie et la vesicule
biliaire a ete laissee en place chez 31
autres. Dans le premier groupe, 11
(1 4 % ) ont eu des complications postoperatoires dont 2 directement reliees a la
cholecystectomie. Une cholangiographie
preoperatoire a ete faite chez 43 et a
conduit a une exploration des voies biliaires chez 8 dont 7 avaient des calculs
des voies biliaires. Dans le groupe de
patients non chol6cystectomises il y eut
trois deces postoperatoires et trois
autres patients ont ete perdus de vue.
Des 25 autres, 12 demeurent asympto-

matiques et 13 devinrent symptomatiques: 7 ont subi une cholecystectomie
dont 4 pour cholecystite aigue dans un
intervalle de 2 semaines a 11 mois apres
la chirurgie initiate. A moins qu'une
contre-indication soit presente les
auteurs recommandent done une cho
lecystectomie "en passant" se basant
sur la faible morbidity et sur le pourcentage relativement eleve de patients chez
qui une cholecystectomie est devenue
indiquee par la suite. Ils recommandent
egalement qu'une echographie preopera
toire a la recherche de cholelithiase soit
pratiquee avant toute chirurgie gastro
intestinal ou vasculaire afin de prevoir si
une cholecystectomie est requise.

Cholecystectomy remains one of the most
common abdominal operations in North
America1 and its value as a cure for
symptomatic gallstones has stood the
test o f time.2 The need for cholecys
tectomy in asymptomatic persons is
controversial3 as is the advisability of
removing a diseased gallbladder disco
vered incidentally during laparotomy,
because o f the increased risk to the
p atien t.4 Several investigators have
recently reviewed the question o f con
comitant cholecystectomy and have
reported no notable added morbidity.5”12
On the other hand, few authors have
addressed the issue o f leaving a diseased
gallbladder in place during laparotomy
for another condition and the subsequent
course o f these patients relative to their
biliary disease.5,10,n
Our study addressed two questions.
• Does cholecystectomy en passant
increase the risk o f the main operation?
• How many patients will eventually
require another operation for biliary
problems if the gallbladder is left in
place?
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Patients and Methods

Results

Discussion

The charts of patients with cholelithi
asis who underwent laparotomy during
the 4-year period from January 1981 to
December 1984 were reviewed retrospec
tively. We excluded patients in whom
acute or chronic cholecystitis was the indi
cation for surgery, also those operated on
for liver or pancreatic disorders, because
cholecystectomy is often part of the
procedure, and patients in whom previ
ous symptoms of pain from gallbladder
disease could be elicited. Left were 109
patients with asymptomatic cholelithiasis
who had undergone abdominal surgery
for another condition. There were 34 men
and 75 women with a mean age of 61
years (ranging from 30 to 87 years).
Colorectal disease was the most common
indication for surgery (31 cases). The
other conditions were: gastric, including
hiatus hernia (24), gynecologic (21), vas
cular (20), urologic (6), small intestinal (3)
and miscellaneous (4) (Table I).
The study was bipartite. First, we exa
mined the outcome of 78 patients (group
1) who underw ent concom itant
cholecystectomy (Table I). Then we con
ducted a follow-up study of the 31
patients (group 2) in whom the surgeon
elected not to remove the gallbladder
(Table I). In group 1, the results of
preoperative abdominal ultrasonography
were obtained for 45 patients and the
presence of gallstones was identified in
43. In the other two and also in the 33
who did not undergo ultrasonography,
cholelithiasis was diagnosed intraoperatively by palpation. In group 2 patients
ultrasonography demonstrated stones in
9 out of 10 cases; in the other 22, the
presence of stones was established at
operation (Table II).

Group 1

The decision to undertake chole
cystectomy when gallstones are dis
covered during an operation for an
unrelated condition is not always easy.
The obvious benefit to the patient is
avoidance of biliary symptoms or com
plications later, so eliminating the risk
and inconvenience of another operation.
If this sequence of events was common
there would be very little controversy. On
the other h an d , the ad d itio n of
cholecystectomy to a major surgical
procedure in an elderly patient may
present technical difficulties, prolong
operating time and be associated with an
increased mortality and morbidity. This
set of events could occur in people who
may never have symptoms from their
cholelithiasis.
In recent years several authors have
addressed the problem of concomitant
cholecystectomy in relation to its
increased risk and morbidity. The results
of nine of these studies are summarized
in Table V.5' 13 Biggers and colleagues,7
Kovalcik and colleagues9 and Shennib’s
group13 reported no complications from
cholecystectom y. Biggers studied
cholecystectomy in association with colec
tomy (242 patients at the Mayo Clinic)7
and commented that there was no differ
ence in mortality and morbidity from
patients having undergone colectomy
alone at the same institution.14,15 Specific
complications arising from the biliary
procedure are recorded in only 10 (1.5%)
o f the total o f 681 concom itant
cholecystectomies from the studies listed
in Table V, including ours.
Cholecystectomy at the time of vascu
lar reconstruction, using prosthetic
material, adds a different dimension to

The in-hospital death rate was 5% (4
of 78). The causes of death were pneu
monia, sepsis from anastomotic leakage,
myocardial infarction and metastatic car
cinoma, none of which could be directly
related to the cholecystectomy. Compli
cations occurred in 11 patients (14%)
(Table III). Two complications were
directly related to the cholecystectomy:
bleeding from the gallbladder bed in one
and stricture of the second portion of the
duodenum in another patient who also
underw ent transduodenal sphinc
teroplasty. Both patients underwent
reoperation and subsequently have done
well. Intraoperative cholangiograms were
obtained in 43 (55%) and led to commonbile-duct exploration in 8. Stones were
recovered in seven, including the one who
needed transduodenal sphincteroplasty.
Group 2
The reasons why the surgeon elected
not to do the cholecystectomy in 31
patients are listed in Table IV. Follow-up
was available in 25 of them, 3 died
postoperatively and the other 3 were lost
to follow-up. Twelve of the 25 are free
of gallbladder symptoms; 13 (52%)
became symptomatic between 2 weeks
and 2 years after their operation,
although not during their initial hospital
stay. Cholecystectomy was performed in
7 of the 13 between 2 and 11 months after
the initial operation: in 4 for acute
cholecystitis, in 1 for acute biliary pan
creatitis and in 2 for attacks of biliary
colic.

T a b le I - ■ N atu re o f S u r g e r y

M a in p ro c e d u re
C o lo re c ta l
G a s tric
G y n e c o lo g ic
V a s c u la r
U ro lo g ic
In te s tin a l
O th e r*
T o t a ls

T o t a l no.
o f p a tie n t s

T a b le I l l - M o r b i d i t y in 11 G ro u p 1 P a tie n ts

G ro u p 1

G ro u p 2

31
24
21

27
23

4
1

1

20

18

20
2

6

5

1

3
4

—

109

3

4

-

78

31

' A b d o m in a l lym p h o m a 1, v e n t r a l h e rn ia 2 , a p p e n d e c to m y 1.

No. of
p a tie n ts

C o m p lic a tio n
Ilio fe m o ra l a rt e r ia l th r o m b o s is
W o u n d d e h is c e n c e

3
2

In tr a o p e ra tiv e s p le n ic tr a u m a

2

T r a u m a t ic e n t e r o t o m y

1

In fe c tio n a ro u n d g a s t r o s t o m y tu b e
H e m o rr h a g e fr o m g a llb la d d e r bed
D u o d e n a l s t r ic t u r e

1
1
1

T a b le I V — R e a s o n s f o r N o t D o in g th e
C h o le c y s t e c t o m y in G ro u p 2
No. of
Reason

T a b le II— D ia g n o s is o f C h o le lith ia s is
P re o p e ra tiv e
u ltr a s o n o g r a p h y
Done
S to n e s
N o s to n e s
N o t d one

T o t a l no.
o f p a tie n t s

G ro u p 1
(n - 7 8 )

G ro u p 2
(n = 3 1 )

55
52
3*
54*

45

10

43
2

9
1
21

33

' D ia g n o s is e s ta b lis h e d in t r a o p e r a t iv e ly b y p a lp a tio n o f th e g a llb la d d e r.

In a p p ro p ria te in c is io n
E m e r g e n c y p ro c e d u re
L iv e r m e t a s ta s e s
T o o m a n y a d h e s io n s
S t o n e s n o t p a lp a te d
C ir rh o s is a n d a s c ite s
O ld a ge
N o t s ta t e d
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the risk factor — potential graft infection
by contamination from hollow viscus.
T hom as and colleagues8 com pared
results of nonvascular procedures, 39 of
which were cholecystectomies, at the time
of 76 aortoiliac reconstructions with those
of 43 vascular procedures alone and
found no difference in mortality (9%
versus 8.5%) and little difference in mor
bidity (17% versus 9.6%) in the two
g ro u p s.
However,
O uriel
and
colleagues10 reported one instance of late
graft infection among 18 patients who
underwent abdominal aortic resection and
concomitant cholecystectomy. In this
case, the operation was performed for a
ruptured aneurysm, the retroperitoneum
was not closed over the graft until after
the cholecystectomy, the gallbladder bed
was not closed, external drains were used
and a gastrostomy tube was put in place,
providing several other risk factors for
infection in addition to the cholecystec
tomy. String12 reviewed his experience
with 250 abdominal aortic reconstruc
tions. Concomitant cholecystectomy was
performed in 16 with no subsequent graft
infection. Ameli and associates16
reported no graft infections in 56 patients
who underwent combined cholecystec
tomy and abdominal aortic surgery. Not
withstanding the specific risk of late graft
infection, most vascular surgeons8’10,12,16
have recommended that concomitant
cholecystectomy be performed unless
acute cholecystitis is p resen t10 or
common-duct exploration is needed. In
the former situation, cholecystectomy
should be performed and the vascular
procedure deferred10 and in the latter,
the biliary procedure is best omitted at the
time of the vascular reconstruction.
Specific situations when cholecystectomy

en passant should be discouraged include
emergency laparotomy for acute condi
tions,13 inappropriate incision,11 exten
sive dissection for exposure, patient
instability5 and preterminal or terminal
conditions.11
The outcome in patients with cholelithi
asis who did not have cholecystectomy is
less well documented. Biliary problems
may occur early or late in the postopera
tive period. Some authors studied series
of acute cholecystitis occurring in the
early postoperative period.17-19 Ottinger17
in a review of 40 cases reported a high
incidence of acalculous disease (35%) and
a high death rate (42%). Bell and
Holubitsky18 mentioned one death in 26
patients, 20% of whom had acalculous
cholecystitis. Gately and Thomas19 also
mentioned one death in 17 cases of
cholecystitis, 62% of which were acal
culous. So it seems that the etiology of
early postoperative cholecystitis might be
different because of the greater number
of men than women — 1.2:1 in Ottinger’s
study17 and 2.4:1 in Gately’s19 — and of
the high percentage of acalculous
cholecystitis. Factors such as fasting,
dehydration, ischemia, narcotics, blood
transfusions, anesthesia, positive-pressure
ventilation and use of total parenteral
nutrition20 have been incriminated. In
our study, no biliary problems occurred
in the immediate postoperative period. In
the aforementioned reports, stones were
present in the majority of gallbladders,
representing the most common factor, for
which prevention could have been
achieved by concomitant cholecystec
tomy had the cholelithiasis been recog
nized at the time of the initial surgical
procedure. Few studies have examined the
long-term outcome of undisturbed

cholelithiasis after an abdominal opera
tion and the incidence and nature of late
biliary problems.5,10,11 G ra d e ’s3 and
Ransohoff’s21 studies are widely quoted
for the low incidence of biliary problems,
with the passage of time, in an asympto
matic population with demonstrated gall
stones. From these studies which con
tained a very high proportion (89%) of
men under 60 years of age (mean 54 years)
it would be difficult to conclude that con
comitant cholecystectomy should not be
performed. Our study and those of others
(Table V) have shown that cholelithiasis
is found incidentally, usually in older
women being subjected to major abdomi
nal surgery. Most of the time the gallblad
der is easily removed with little additional
operating time and trauma. In Thomson’s
study,11 cholecystectomy was not per
formed in 23 patients with cholelithiasis
found incidentally; biliary problems
including acute cholecystitis (11), jaundice
(2) and symptomatic cholelithiasis (3)
developed within 6 months. One patient
died and three suffered postoperative
complications. Schreiber and associates5
studied 44 patients in whom cholelithia
sis was found incidentally; in only 4 was
the gallbladder left in place. One of them
required emergency cholecystectomy on
postoperative day 8. O uriel and
colleagues10 studied 11 patients operated
on for abdominal aortic aneurysm in
whom cholelithiasis was found inciden
tally and the gallbladder was not
removed. Nine eventually had biliary
problems, in the early postoperative
period in two. In String’s report,12 gall
stones were retained in 17 patients; 11
(65%) later had symptoms and 9 (53%)
required cholecystectomy from 2 weeks
to 108 months after the vascular proce-

Table V—Mortality and Morbidity of Concomitant Cholecystectomy

Type of
surgery

No. of
cases
(n = 681)

Schreiber and associates, 19785
McSherry and Glenn, 1981®

Abdominal
Abdominal

39
137

Mean
age,
yr
78
62

Biggers and associates, 19827
Thomas and associates, 1983s

Colorectal
Vascular

242
39

Kovalcik and associates, 19839
Ouriel and associates, 198310
Thompson and associates, 1984"

Abdominal
Aortic
aneurysm
Abdominal

String, 198412
Shennib and associates, 198613
Present study

Vascular
Colorectal
Abdominal

Series

Mortality,
%

Complications,
%

0
7

16
15

NS
64

0.8*
9t

2*
17t

54
18

NS
67

2
6

20
6

33

>60

3

27

16
25
78

NS
69
61

6
12
5

0
0
14

Cholecystectomyrelated
complications
(no.)
Bile leak (1)
Bile leak (1)
Retained CBD
stones (2)
None
Pancreatic
pseudocyst, hernia
(drain site) (1)
None
Late graft
infection (1)
Subphrenic
abscess (1)
None
None
Bleeding (1)
Duodenal
stricture (1)

*No difference with colectomy alone.
tNo difference with vascular procedure alone.
NS - not stated, CBD = common bile duct.
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dure (7 within the first year). In our
follow-up study of 25 patients, 13 became
symptomatic even though our follow-up
was relatively short and cholecystectomy
was performed in 7 (28%) of the 25 within
11 months. These secondary operations
could have been prevented had cholecys
tectomy been done at the time o f initial
procedure, especially if we consider that
many of these were emergency procedures
for acute cholecystitis and that the death
rate from cholecystectomy for acute
cholecystitis in people over 60 years of age
is 9.8% compared with 5% for chronic
cholecystitis.21-24
Finally, asymptomatic gallstones are
discovered with increasing frequency by
abdominal ultrasonography performed
during work-up for other abdominal
problems such as aortic aneurysm, liver
screening for metastasis from gastrointes
tinal tumours and almost all gynecologic
and kidney problems. In our study there
was a recognition o f gallstones preoperatively in 48% o f patients. Ultrasonog
raphy achieved a sensitivity o f 95%.
Preoperative knowledge o f gallstones is
valuable23 to allow discussion with the
patient, to obtain consent,9,11 and to
plan an appropriate incision, adequate
operative time and proper instrumenta
tion, including possible intraoperative
cholangiography and perhaps the availa
bility of a general surgeon when the oper
ator is not familiar with biliary surgery.

In conclusion, we recommend that
cholecystectomy en passant for cholelithi
asis found incidentally be performed dur
ing laparotomy for other conditions,
unless specific contraindications are
present. Low morbidity related to the
cholecystectomy supports such an atti
tude. In a substantial number o f people
concomitant cholecystectomy will prevent
further problems that could result from
the presence o f untreated cholelithiasis.
The widespread use o f ultrasonography
as part o f the work-up for several other
conditions should be encouraged and
oriented toward the status of the gallblad
der to determine the presence or absence
o f unsuspected lithiasis.
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enjoy reading it and will find great interest in
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details of specific methods. Throughout each
chapter, authors concentrate on explaining the
issues in controversial areas and have managed
to bring together a large amount of informa
tion that previously was scattered through the
medical literature. It was pleasing to see a chap
ter devoted to the painful hand as this presents
great difficulty in daily practice. This section
could have probably been enhanced, however,
by extending the discussion on the diagnosis
of wrist pain.
The book is well illustrated with good qual
ity black-and-white photographs and clear line
drawings. The liberal use of subheadings
produces a format that is easy to follow. The
text successfully uses lists and summaries to
emphasize important issues and options and
is written in a style that is lively and interest
ing. The reference section is particularly impor
tant in this type of publication, and 1 was
impressed with the excellence of the reference
lists in this volume.
In conclusion, this volume achieves its aim
of complementing standard textbooks by
providing an up-to-date review o f key issues
in hand surgery. It can be highly recommended
to those wishing to keep abreast of current
thinking in this rapidly evolving specialty. All
surgeons with an interest in hand surgery,
whether primarily orthopedic, plastic or
general, will find this book useful. They will
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This authoritative textbook has been written
by a number o f well-known experts on the
pathophysiology and surgical treatment of
mitral valve disease. The book is divided into
four sections.
The first section is devoted to the anatomy,
physiology and pathology of the mitral valve.
Noninvasive and invasive investigations cur
rently used for the diagnosis of mitral valve dis
ease are described in a lucid manner.
The next two parts of the book deal with the
techniques of conservative mitral valve surgery
and mitral valve replacement using a variety
o f prostheses.
The chapters on the conservative surgical
management of mitral valve disease are excel
lent and give good descriptions of closed and
open mitral valvotomy. The various types of
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mitral valve annuloplasty are discussed in
detail. The text is a little deficient insofar as
it does not deal in detail with the various tech
niques of chordal shortening, resection of
redundant valvular tissue and repair of rup
tured papillary muscle.
The section devoted to prosthetic mitral
valve replacement consists of discussions of the
results achieved with a variety of mitral
prostheses. Although each chapter is excellent
and authoritative, the data presented do not
permit true comparisons between one type of
prosthesis and another.
The final part of the book describes the par
ticular problems of rheumatic mitral valve dis
ease in children, congenital mitral valve disease
and the complications of mitral valve replace
ment. The chapters are excellent and provide
up-to-date and useful knowledge.
This book provides an excellent overview of
mitral valve disease. It is principally o f interest
to cardiologists, cardiac surgeons and students
of those specialties. It is somewhat expensive
but would be a useful addition to a medical
library.
J . GUNSTENSEN, MB, CH B, FRCS(EDIN),
FRCSC

HGH - McMaster Clinic,
Hamilton General Hospital,
237 Barton St. E,
Hamilton, Ont.
L8L 2X2
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Symposium on Alternatives to Ileostomy in Ulcerative Colitis
P .H . G o r d o n , m d , f r c s c , f a c s

1. Introduction
Symposium presented at the 54th annual
meeting o f the Royal College o f Physicians
and Surgeons o f Canada by the Royal Col
lege in cooperation with the Canadian
Association o f General Surgeons, Vancou
ver, BC, Sept, f l, 1985
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Over the past decade the type o f opera
tion offered to patients suffering from the
intractable symptoms associated with
ulcerative colitis has evolved. Until
recently, when there has been a surge o f
enthusiasm for pelvic reservoirs, the gold
standard against which other procedures
were compared was total proctocolec
tomy and Brooke ileostomy. Is there still
a place for this operation and, if so, what
is its current status and its future? What
are the roles o f total abdominal colectomy
and ileorectal anastomosis and continent
ileostomy? What are the merits o f the

different types o f pelvic reservoirs and
what might be the immediate and long
term physiologic and metabolic conse
quences o f the establishment o f intra
abdominal reservoirs?
The assembled panel o f speakers for
this symposium includes leaders in the
field o f colon and rectal surgery, in par
ticular, inflammatory bowel disease. They
have acquired a great deal o f experience
in managing patients with ulcerative coli
tis. They have been asked to share their
experience with you and try to answer
these questions.

»

Br i a n M o r g a n , m d ; D a v i d G l e n n , m d ; C h r is V ic k e r s , m d
't

2. Colectom y and Ileostom y in the M anagem ent of
Ulcerative Colitis
For 3 0 years, co le c to m y w ith ile o sto m y
has been th e m ainstay o f th e surgical
tre a tm e n t fo r ulce ra tive co litis. Betw een
1 9 6 3 and 1 9 8 5 , 5 3 5 p a tien ts w ith
in fla m m a to ry b o w e l disease w ere a d m it
te d to th e Royal Prince A lfre d H ospital in

From the Department o f Surgery, Royal
Prince Alfred Hospital, Sydney, Australia
Presented as part o f a symposium on alter
natives to ileostomy in ulcerative colitis, at
the 54th annual meeting o f the Royal Col
lege o f Physicians and Surgeons o f
Canada, b y the Royal College in coopera
tion with the Canadian Association o f
General Surgeons, Vancouver, BC, Sept.
11, 1985
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Sydney, A u stra lia ; 4 71 had ulcerative
co litis and 6 4 C ro h n 's co litis. One
hundred and e ig h t-six o f these patients
u n d e rw e n t c o lo n ic resection. The p ropor
tio n o f p a tie n ts w h o u n d e rw e n t surgery
w a s the sam e fo r b o th disorders. There
have been no deaths resulting fro m the
surgical m anagem ent o f in flam m a to ry
b o w e l disease a t our hospital since
1 9 6 5 . These p a tien ts should be treated
sa fe ly by standard m eans before th e
m ore elaborate sphincter-saving proce
dures, cu rre n tly recom m ended, are tried.

co lite ulcereuse et 6 4 une maladie de
Crohn. C ent qua tre -ving t-six p a tie n t* ont
subi une resection colique. Le pourcentage des malades qui o n t passe a la chirurgie e ta it le meme pour les deux a ffe c 
tio n s. Depuis 1 9 6 5 , on n 'a enregistre a
n otre h o p ita l aucun deces attribuable au
tra ite m e n t chirurgical des pathologies
intestin a le s inflam m atoires. Ces patients
d o ive n t etre tra ite s prudem m ent par les
m oyens conve ntio n n e ls avant de te n te r
des in te rv e n tio n s plus com pliquees
visa n t a sauvegarder les sphincters.

Depuis 30 ans, la co le ctom ie avec ileosto m ie est le standard du tra ite m e n t chirurgical de la co lite ulcereuse. De 1 9 6 3 a
1 9 8 5 , 5 3 5 m alades s o u ffra n t d'une
pathologie in fla m m a to ire de I'in te s tin o n t
ete recus au Royal Prince A lfred Hospital
de Sydney en A u stra lie ; 471 avaient une

Until 1952 when Bryan Brooke described
the technique for constructing an everted
stoma, it was unusual for a surgical con
sultation to be obtained for a patient with
severe ulcerative colitis. In his report o f
10 patients, 2 died postoperatively.
Brooke’ s work was considered a major
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advance, and stimulated management
of the disease by more aggressive
surgery. Two enlightened physicians
at this hospital formulated a protocol,
especially applicable to severe colitis,
that included early surgical interven
tion. We became involved in the pro
gram in 1965 and since then 162 patients
with ulcerative colitis have been treated
surgically. The number of patients oper
ated on each year remained strikingly
constant until the sphincter-saving proce
dures became available when the numbers
increased. The proportion of patients
with Crohn’s colitis (14%) has remained
fairly constant. A similar proportion of
patients with ulcerative colitis underwent
operation as did those with Crohn’s
disease.
M ethods and Results

Of the patients treated surgically, 71
(38%) were admitted to hospital with
severe acute disease. One-third of these
had a history of inflammatory bowel dis
ease of less than 6 months. It was our
policy to treat all patients intensively, giv
ing medications, including hydrocorti
sone, intravenously. The routine use of
antibiotics ceased in 1973. The initial
remission rate was 53% in these patients
with acute disease. Forty-five colectomies
were performed for fulminant colitis and
a further 11 operations on patients who
had relapse within 6 weeks. Three patients
were operated on because of very severe
bleeding. Toxic dilatation, as measured
radiologically, was evident in 11 patients,
9 of whom had urgent colectomy, but
only one colon had perforated.
From the start our policy was to carry
out total abdominal colectomy and
ileostomy with an external mucous fistula
for acutely ill patients, the only exceptions
being patients with massive hemorrhage
or with a perforation close to the rectum.
“ Blow-hole” procedures, ileostomy alone
and other forms of partial colectomy were
not used. We believe that this relatively
conservative surgical policy in severely ill
patients is largely responsible for the
absence of any deaths in the series.
One hundred and fifteen patients had
elective surgery, 28 (24%) because of a
suspicion of cancer. However, only half
of these had invasive cancer when the
specimen was examined histologically. In
the electively managed patients, total
proctocolectomy was the operation of
choice. Early in the series, many were
treated by a two-stage procedure, but
recently a one-stage operation with inter
muscular proctectomy keeping close to
the bowel wall has usually been per
formed. One surgeon routinely preserves
the greater omentum, but the other rarely
does so.
There has been a decline in serious sep
sis since the importance of intestinal

anaerobes was recognized. Intestinal
obstruction requiring reoperation has
become more common since pelvic
pouches were introduced.
Failure of the perineum to heal in a
reasonable time, although uncommon in
ulcerative colitis, has often been a feature
of Crohn’s disease, particularly in the
early part of our experience. In two
patients it took 3 and 5 years respec
tively for their perineal wounds to heal.
An ongoing problem has been the
difficulty of differentiating between
Crohn’s disease and ulcerative colitis in
certain patients. The diagnosis was
changed from ulcerative colitis to Crohn’s
disease in six patients and from Crohn’s
disease to ulcerative colitis in four, after
the operative specimen was examined
histologically. There were five other
patients who, even now, remain in a grey
zone. We believe this is a serious problem
as many authors have drawn attention to
what may happen if pouch surgery is done
on patients with Crohn’s disease. Despite
thorough investigation and multiple biop
sies, we have already created an ileal
pouch in a patient who was found
postoperatively to have Crohn’s disease.
Discussion
Good results from the surgical treat
ment of colitis demand close cooperation
between physicians, who commonly see
the p atients first, and surgeons
experienced in the management of the dis
ease. There is often a difference of opin
ion about the timing of an operation and
a surgeon can only speak with confidence
if his experience is considerable. Despite
our interest, only 10 patients per year
have been treated surgically in this 1000bed university teaching hospital over the
20-year period of our study. Happily, res
tricting the performance of operative
treatment to two surgeons has enabled
them to gain experience and has led to the
team effort necessary in carrying out
pouch operations quickly and safely.
Surgeons attracted to the challenge of
total proctocolectomy and pouch forma
tion should be warned that this surgery
is justifiable only in a unit that can carry
it out with few or no deaths, particularly
because most of the patients are young.
Our experience with ileal pouches is
small but has encouraged us to adopt the
procedure in the majority of our patients.
In those with Crohn’s disease or diseased
anal sphincter mechanisms and in the
elderly, the anal mechanism should be
preserved if possible. Those who have had
previous anal disease and women who
have borne children should also be care
fully selected as a defective sphincter may
lead to a life of misery.
There is little doubt that our ability to
offer sphincter-saving operations will lead
to earlier surgical treatment of this

debilitating disease. In so doing, we
should be able to prevent the development
of cancer, which unfortunately still occurs
despite attempts to diagnose dysplasia by
multiple endoscopic biopsies.
We believe there is a group of patients
in whom proctocolectomy and ileostomy
remain the definitive management for
inflammatory disease. For surgeons who
rarely have the opportunity to operate on
patients with ulcerative colitis, we advise
an abdominal colectomy with preserva
tion of ileocolic vessels, the formation of
a mucous fistula and ileostomy.
Subsequent referral for consideration of
a pouch procedure is often in the patient’s
best interests. ■
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PERIOPERATIVE CARDIAC DYSFUNC
TION. Volume III. Edited by Joe R. Utley
and Rosanne Betleski. 289 pp. Illust. Wil
liams & Wilkins, Baltimore, 1985. $49.
(US). ISBN 0-683-08503-4.

This book represents a collection of topics dis
cussed at two symposia held in San Diego in
1982 and 1983, dealing with perioperative dys
function of the heart. It is a welcome addition
to the cardiac surgery literature, complement
ing the standard textbooks.
Since the book is divided into 21 chapters,
each with a different author, there is some
unevenness in format and quality and some
repetition. These disadvantages are outweighed
by the obvious advantage that, for the most
part, each topic is dealt with by an expert in
the field who presents the topic concisely and
with clear discussion, in sufficient depth to
satisfy most readers.
This monograph represents our current
understanding of the pathophysiology and
management of perioperative cardiac dysfunc
tion, which is usually ischemic in origin. Much
of the material has not yet found its way into
the standard texts. Of particular interest are
the discussions of myocardial blood flow and
performance, afterload mismatching, perioper
ative coronary spasm, infarction and reanima
tion of the heart. Lacking, however, is a dis
cussion of cardiac dysfunction during the
ever-increasing reoperations for coronary
artery disease, particularly the problem of
coronary atheroemboli.
Despite its minor flaws, this text provides an
excellent review of the topic. It is a necessary
addition to the library of all surgeons,
anesthesiologists, internists and nurses who
care for patients who undergo cardiac proce
dures.
R oy G . M a s t e r s , m d , frcsc

Cardiac surgeon,
University of Ottawa Heart Institute,
1053 Carling Ave.,
Ottawa, Ont.
K1Y 4E9
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3. Ileorectal Anastomosis for Ulcerative Colitis
Several options can be considered when
medical management of ulcerative colitis
fails or if a serious complication
develops. One alternative to proctocolec
tomy with ileostomy or ileoanal pullthrough is the ileorectal anastomosis. Its
main advantage is preservation of the
rectal reservoir without risking injury to
the pelvic nerves or anal sphincter. It is
not indicated when the rectum is
severely diseased or stenosed or in the
presence of rectal carcinoma. Patients
older than 55 to 60 years can expect a
good functional result in a relatively
short time compared with the prolonged
adaptation period associated with pullthrough procedures.
Plusieurs options s'offrent devant I'echec
du traitement medical de la colite ulcereuse ou ('apparition de complications
serieuses. A la proctocolectomie avec
ileostomie ou anastomose ileo-anale, on
peut preferer I'anastomose ileo-rectale.
Son principal avantage est de pouvoir
conserver I’ampoule rectale sans risquer
une blessure aux nerfs pelviens ou au
sphincter anal. Cette operation n'est pas
indiquee en presence d'une atteinte ou
d'une stenose grave du rectum, ou
encore d'un cancer rectal. Les patients
de plus de 55 a 60 ans peuvent s’attendre a de bons resultats fonctionnels
apres relativement peu de temps, comparativement a la periode d'adaptation prolongee que necessite l operation de
Swenson-Bill.
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tion with the Canadian Association o f
General Surgeons, Vancouver, BC, Sept.
11, 1985
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In selected cases of ulcerative colitis, total
abdominal colectomy with ileorectal
anastom osis rem ains the simplest
sphincter-saving procedure. As early as
1903, Lilienthal1 mentioned the proce
dure of ileosigmoidostomy and in 1943
Devine2 reported the use of extraperitoneal ileosigmoidostomy; Wangensteen
and Toon3 used a one-stage ileoproctostomy. Aylett, after performing the
operation in 1952, became the leading
proponent of ileorectal anastomosis and
carried out this procedure in 384
patients.4 Few reports have been so
favourable to this operation, but, with the
advent of newer ileoanal reservoir proce
dures, it is questionable whether ileorec
tal anastomosis still has a place in surgery
for ulcerative colitis.
Review of the Literature

Aylett’s group4 in 1978 reported on
their total experience with 384 patients —
178 males and 206 females whose mean
age was 36.2 years (range from 11 to 72
years). The operation was preceded by a
colectomy and ileostomy in 169 patients
who had active colitis; in the other 215
the procedure was done electively with a
protective diverting ileostomy. Five car
cinomas were found in the latter group.
There were 10 (2.6%) postoperative
deaths. Of the remaining 374 patients, 41
had the rectum removed at a later date
for the following reasons: carcinoma in
18, dysplasia without carcinoma in 3 and
a large villous adenoma in 1; severe rec
tal disease, stricture formation, anal
fistula and incontinence were the indica
tions in the 19 other patients. There were
three deaths postoperatively. Overall, 265
(71%) patients were alive and well with
the ileorectal anastomosis. The authors
calculated the risk of rectal carcinoma
from the 22 (5.7%) cases in the entire ser
ies and related them to the length of his
tory of the disease. There were no cases
with a history of less than 10 years; with
a longer history the risk was 1 in 200
patient-years and 1 in 51 with a history
over 40 years.
Hawley5 recently reported on the

experience at St. M ark’s Hospital, Lon
don, of 125 cases from 1953 to 1984. In
elective cases the anastomosis was done
as a one-stage procedure without a pro
tective ileostomy at the sacral promon
tory, leaving 12 to 15 cm of rectum; in
urgent cases a colectomy and ileostomy
were done initially. The rectum was later
excised in 33 (26%) for unsatisfactory
function in 18, technical failure in 5,
bleeding in 1, severe dysplasia in 6 and
carcinoma in 3. There was one postoper
ative death and only one patient (0.8%)
died of carcinoma of the rectum. Func
tional results were encouraging in that
83% had six or less bowel movements per
day and 4% had a regular bowel move
ment at night. Half the patients used
medications to decrease stool frequency
and 9% were treated medically for proc
titis. These results are similar to those
reported by Newton and Baker;6 of 92
patients with ileorectal anastomosis, 82%
had less than six movements per day.
Farnell and colleagues7 reviewed the
results of treatment in 63 patients from
the Mayo Clinic and used one of the fol
lowing criteria to define an unsatisfactory
outcome: more than eight bowel move
ments per day, systemic use of steroids,
severe perianal disease, incontinence,
poor general health. Of the 49 patients
who could be followed up, 55% had a
satisfactory result. However, 15 of 63
patients, whose mean age was 29 years,
underwent proctectomy while those in
whom the rectum was preserved had a
mean age of 43 years (p < 0.01), suggest
ing that younger patients were more likely
to have unsatisfactory results. The failure
rate was no higher in those with moder
ately diseased rectal mucosa than in those
with normal mucosa.
In another series of 122 patients with
ileorectal anastomosis for ulcerative coli
tis, 84 (69%) retained a functioning
anastomosis.8 The rectal stump was
excised in 30 (25%) and 5 remained with
a loop ileostomy while 3 died of pre
existing cancer. Of the patients with
ileorectal anastomosis, five (4%) suffered
from carcinoma, and all had a disease his
tory longer than 13 years.
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The main indication for performing
ileorectal anastomosis is to avoid a per
manent ileostomy and preserve the reser
voir function of the rectum. Patient selec
tion is important, and the operation
should not be offered to those with rec
tal stricture, rectal carcinoma, severe dis
ease not responding to locally applied
steroids and inadequate sphincter func
tion from complicated abscesses and
fistulas. Certain authors9 have advocated
its consideration in children and adoles
cents to allow development of physical
and sexual interests without the problems
of an ileostomy. Similarly, another
study7 has suggested that older patients
with ulcerative colitis treated with this
procedure are less likely to need proctec
tomy later.
The risk of anastomotic leakage does
not appear to be great if the procedure
is done meticulously and on rectal stumps
with only mild to moderate disease.7,9
Baker and colleagues4 reported a
postoperative death rate of 2.6%, half of
these from anastomotic leakage; they
advised using a tem p o rary loop

ileostomy, although others5,7-9 have not
employed this routinely.
The risk of cancer at follow-up was
estimated at 6% at 20 years and 15% at
30 years in one large study.4 The use of
regular sigmoidoscopy and random biop
sies every 6 months in search of dyspla
sia in chronic ulcerative colitis10 has
added greatly to the patient’s safety. With
severe dysplasia, the risk of carcinoma is
greater than expected and excision o f the
rectum should be advised before frank
invasive carcinoma develops.5 Hence,
because of the small but significant risk
of carcinoma, only patients willing to par
ticipate in a rigorous and careful
postoperative surveillance and to accept
further surgery if biopsy reveals severe
dysplasia should have this procedure sug
gested to them.
In conclusion, satisfactory results can
be expected in two-thirds of selected
patients. When the disease is moderately
severe, the rectum can be treated with
steroid enemas before reanastomosis to
lessen the degree of inflammation and
reduce the chance of exacerbation
postoperatively. Personal experience with
this procedure is limited and has been

reserved for patients over 55 years o f age
who may not be suitable candidates for
ileoanal restorative operations.
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4. Current Status of the Continent Ileostomy

r
The continent ileostomy has substantial
advantages over the standard ileostomy
in that it provides a socially acceptable,
odourless, appliance-free stoma. The
author presents the experience at the
Toronto General Hospital from 1977 to
1984 with this procedure which was
performed on 123 patients, in conjunc
tion with proctocolectomy (36) and as a
conversion from an ileostomy or colostomy
(87). There were no postoperative deaths.
Modifications to prevent nipple valve
sliding have included the addition of staples
across the valve and synthetic mesh
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slings around the outlet. Reservoir ileitis
remains a difficult problem, most likely
due to stagnant bacterial overgrowth.
The operation should not be performed
on patients with Crohn's disease, and in
the obese, technical difficulties present
considerable risk. The procedure should
be confined to large centres where the
surgeons are experienced in the
procedure.
L'ileostomie continente presente des
avantages marques par rapport a I'ileostomie traditionnelle: elle procure un
stoma inodore, socialement acceptable et
exempt d'appareil. L'auteur decrit son
experience, entre 1977 et 1984, au
Toronto General Hospital alors que cette
operation a ete pratiquee chez 123
patients, en association avec une proctocolectomie (36) ou une conversion d'une
ileostomie a une colostomie (87). II n'y a
eu aucun deces postoperatoire. Des modi
fications destinees a prevenir le glissement
de la valve d'attache comprennent la
pose de broches au dessus de la valve
et des courroies de reseau synthetique
autour de I'ouverture. L'ileite de reservoir
demeure un probleme difficile; elle est
vraisemblablement due a une stagnation
du contenu ileal et a une surcroissance

bacterienne subsequente. Cette interven
tion ne doit pas etre pratiquee chez les
patients qui souffrent de maladie de
Crohn et, chez I'obese, des difficultes
techniques posent un risque considera
ble. Cette operation doit etre reservee
aux grands centres oil les chirurgiens
possedent ('experience de la technique.

The continent ileostomy has been a great
advance, allowing hundreds of patients
around the world an appliance-free stoma
and thus improving the quality of life.1
In addition, its development has stimu
lated many surgeons to continue their
efforts not only to obviate the need for
a conventional ileostomy appliance, but
to develop a pelvic pouch procedure
without any type of permanent stoma.
Psychosocial difficulties related to a con
ventional ileostomy and external appli
ance remain the most important indica
tion for the continent ileostomy in
patients with proven ulcerative colitis. We
do not knowingly perform a continent
ileostomy in patients who have had
Crohn’s disease, and technical difficulties
in the obese can present considerable
risk.2,3 Patients who have had a large
amount of small bowel resected should be
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viewed cautiously for a continent
ileostomy. They lose a greater amount of
fluid, electrolytes and bile salts and are
therefore at an increased risk for
chololithiasis and urolithiasis.
Surgical Technique and Results
During the years 1977 to 1984 we per
formed a continent ileostomy on 123
patients (mean age 33 years), 115 of
whom had ulcerative colitis. In 36 patients
the procedure was performed in conjunc
tion with a proctocolectomy and in 87 it
followed conversion from a conventional
ileostomy or colostomy. There have been
no deaths perioperatively as a direct result
of the procedure, but one patient com
mitted suicide during the first year
postoperatively and one had a fatal pul
m onary embolus at 3 months. Three of
our continent ileostomy pouches have
been removed.
O f the first 17 patients operated upon,
10 (59%) required surgical revision,
mainly because the nipple valve was slid
ing. Since 1977, the procedure has been
modified substantially in an effort to
decrease the rate of nipple-valve sliding.
The first modification, which we under
took in 1978, was the use of the GIA sta
pler with SGIA staples across the valve.
This was done to stabilize the valve in
position and prevent complete elongation
or eversion of the valve itself. It was used
in conjunction with a modification, origi
nally described by Boley and Fazio,4 in
which a fascial sling around the base of
the outlet further secured the valve in
position. However, even with these
modifications, valve sliding continued to
be a problem and 30% of the next 45
patients in our series still required surgi
cal revision, mainly for this problem.
From 1979 to 1981, in addition to the
staples across the valve, a synthetic mesh
sling was used around the outlet, encir
cling the base in order to act as a bridge
between the pouch and the abdominal
wall. This allowed the pouch to be
anchored to the mesh and also the
abdominal wall to the mesh in an attempt
to prevent the nipple valve from sliding
on the weakened mesenteric aspect. Lift
ing the outlet into the ileostomy opening
tended to stabilize the mesenteric mass,
decrease the likelihood of eversion of the
valve and shorten the amount of outlet
required to reach the skin surface.
W ith these modifications, the compli
cation o f valve sliding has decreased sig
nificantly, but a surgical revision rate of
19% still exists, due mainly to erosion
caused by the Marlex mesh with subse
quent abscess and fistula formation.
Because of these septic complications we
are now using a softer weave Prolene
mesh or an even softer Mersilene mesh in
preference to Marlex. To date, only one
fistula has been attributable to Mersilene
358

mesh in the 30 patients who have been
operated upon by this technique.5,6
A further recent modification is
stapling the nipple valve to the side of the
continent ileostomy reservoir itself, thus
preventing eversion. We have used this
technique in one continent ileostomy and
in three continent urinary diversions with
initial success.
In our last 48 patients there was an 8%
revision rate and only one patient
presented with true nipple sliding — a
marked improvement in results. Our
study also suggests that the major com
plication seen more recently (that of
fistulas) occurs mainly in the first 3
months postoperatively, whereas sliding
has occurred up to 2 years or more after
construction of a continent ileostomy. Of
the pouches formed in our 123 patients,
three have been removed and there have
been two deaths as already noted, leaving
118 patients with a continent ileostomy
who have been followed up for a mean
of 46 months. Of these, 114 (97%) do
not wear an ileostomy appliance, 2
always wear one and 2 occasionally do
so. One constant user is awaiting
further surgical revision.
Other Complications and Concerns
The complication of reservoir ileitis is
both intriguing and often difficult to
manage. On gross inspection of the reser
voir it appears similar to Crohn’s disease,
but the two should be considered separate
entities. In our series 7% of the patients
have had pouch ileitis and in two patients
it was difficult to treat. The most likely
cause for this syndrome is bacterial over
growth due to stagnation of ileal content.
Even in the normal reservoir the bacterial
flora approaches that of normal colonic
flora with a preponderance of anaerobes.
Stool samples should be analysed in an
attempt to isolate abnormal pathogens
such as ameba, Yersinia, Campylobac
ter and Clostridium difficile and toxin.
Then appropriate treatment should be
instituted. When no specific organism is
isolated, the reservoir should be placed on
straight drainage to prevent further stag
nation. We have found that metronida
zole is the most effective agent in the
treatment of pouch ileitis. Other antibi
otic and anti-inflammatory drugs have
been tried with some degree of success.
The long-term effects of a continent
ileostomy are still not fully known. No
consistent long-term metabolic distur
bances have been reported. The stagna
tion and bacterial overgrowth in continent
ileostomies coupled with a tendency to the
formation of a colonic mucosa may place
these patients at an increased risk of
developing carcinoma within the pouch;
to date none have been reported. Our own
results have shown that fecal mutagens,
as measured in an AMES assay, as well
as fecal nitrite and nitrate levels, are lower

in continent ileostomies than in fecal sam
ples from normal controls.7 The availa
ble data suggest that the cancer risk is not
increased, but the potential remains until
further follow-up has been completed.
These potential risks are also applicable
to a pelvic pouch created for an ileoanal
pull-through anastomosis. In this regard,
the two procedures are similar with no
advantage for either.
Comment
The continent ileostomy provides sub
stantial physical and psychosocial benefits
over a conventional ileostomy. However,
it carries a substantial morbidity, so
prospective candidates should be made
aware not only of the advantages but also
the potential complications. It is a major
abdominal operation requiring meticu
lous attention to detail and should be con
fined to centres capable of acquiring a
large experience. The complication rate
in our series and in other centres that have
reported on this procedure has decreased
notably. This is due to increased
experience and to modifications in surgi
cal technique.
During the past 3 Vi years the number
of conventional ileostomies in our series
has decreased substantially. At the same
time there has been a rise in the number
of colectomies with mucosal proctectomy
and ileoanal anastomosis. Currently at
our hospital most patients choose to have
an abdominal colectomy, mucosal proc
tectomy and ileoanal anastomosis, rather
than a continent or conventional
ileostomy. This procedure, when the out
come is satisfactory, offers a quality of
life approaching normal. However, one
must still approach an ileoanal anastomo
sis with a degree of caution, mainly
because the functional results are some
times unpredictable. At present we
strongly believe that the main use of the
continent ileostomy is for patients in
whom a proctectomy and conventional
ileostomy have already been performed.
Here, the continent ileostomy continues
to offer an advantage of an appliance-free
odourless stoma that alleviates the psy
chosocial stigma of conventional
ileostomy appearance and care.
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5. Proctocolectomy and Ileoanal Anastomosis
With an S Pouch: Functional Results
Patients with total colonic ulcerative coli
tis or familial polyposis traditionally
require a proctocolectomy. In an effort
to preserve the normal pathway for defe
cation and avoid the nuisance of an
abdominal stoma, a continence
preserving procedure involving a pelvic
reservoir has been performed at the
University of Minnesota Hospitals on
120 patients. The majority were oper
ated on for colonic ulcerative colitis.
There were no deaths. The mean hospi
tal stay after restorative proctocolectomy
was 10 days and after ileostomy
takedown the mean stay was 7 days.
Functional results were assessed in 52
patients. Daytime bowel movements
averaged 6.4 and night-time movements
1.4. Major daytime incontinence
occurred in 6% of the patients, 21% had
moderate soiling at night and 7 0 % wore
a perineal pad in the evening. Ninety-two
percent of the patients expressed satis
faction with the procedure. The most
serious complication was pelvic sepsis. It
occurred in nine patients, six of whom
required subsequent surgery. The Parks
S pouch provides a means of maintaining
anal continence. This series and others
have shown that young, healthy, wellmotivated persons will benefit most from
a restorative proctocolectomy.

Traditionnellement, les patients souffrant
de colite ulcereuse ou de polypose familiale necessitent une proctocolectomie.
Dans I'espoir de conserver les voies normales de defecation et d'eviter I'embar-
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ras d'un stoma abdominal, une operation
visant a sauvegarder la continence et
necessitant un reservoir pelvien a ete
pratiquee chez 120 patients des hopitaux
de I'Universite du Minnesota. La majorite
des operes souffraient de colique ulce
reuse. On n'a enregistre aucun deces. Le
sejour hospitalier moyen a <ite de 10
jours apres proctocolectomie reconstituante et de 7 jours apres ileostomie.
Les resultats fonctionnels ont ete apprecies chez 52 patients. On a compte en
moyenne 6.4 defecations diurnes et 1 .4
nocturnes. On a observe une inconti
nence diurne majeure chez 6% des
patients, 21% se souillaient de facon
moyenne durant la nuit et 70% mettaient un tampon perineal en soiree.
Quatre-vingt-douze pourcent des patients
etaient satisfaits de I'operation. La com 
plication la plus serieuse a ete la sepsie
pelvienne. Elle est survenue chez neuf
patients dont six durent etre reoperes. La
poche en S de Park offre un moyen de
maintenir la continence anale. Les etudes
chez ce groupe de malade et chez
d'autres ont demontre que les personnes
jeunes, en sante et bien motivees vont
beneficier le plus d'une proctocolectomie
reconstituante.

Patients with total colonic ulcerative coli
tis or familial polyposis traditionally
require a proctocolectomy. This is fol
lowed by an ileostomy, which generally
is consistent with good health and a
productive life. Emotional and psycho
logic problems are often associated with
the stoma. In an effort to preserve the
normal pathway for defecation and to
avoid the nuisance of an abdominal
stoma, continence-preserving procedures
have attracted great attention. Parks and
colleagues1 first described total proc
tocolectomy with rectal mucosectomy fol
lowed by construction of a pelvic reser
voir with three limbs of ileum giving the
pouch an “ S” configuration. This proce
dure evolved naturally from pull-through
procedures, which can be traced to the
initial work of Nissen. In 1933,2 he first
reported an ileoanal anastomosis in which
a double-barrelled ileostomy was sutured
to the anal sphincters. Num erous

postoperative complications, primarily
infection and incontinence, have plagued
this procedure and have prevented its
widespread acceptance. We first per
formed ileoanal anastomosis in adults at
the University o f Minnesota Hospitals in
1980 and it has now been perform ed on
120 patients. This report centres on the
functional results obtained with the first
70 patients.
Patients
Only patients with ulcerative colitis or
familial polyposis were chosen for the
operation. C rohn’s disease is contraindi
cated because o f the fear that it will recur
in the neorectum. Fulminant colitis and
steroid usage are not contraindications,
but a staged approach is probably best if
toxic megacolon is present. The procedure
was performed in 43 males and 27
females, ranging in age from 13 to 60
years (mean 31 years), between 1980 and
1984 by surgeons in t _Division o f C^lon
and Rectal Surgery at the University of
Minnesota. The indication for operation
was ulcerative colitis in 64, familial poly
posis in 5 and recurrent colonic hem or
rhage in 1 patient. An S pouch was con
structed in 65 patients, while the J pouch
or the Balcos modification of the latter
was used in 5. The S pouch consists of
three 10-cm segments and a 2-cm spout
or efferent limb. Loop or end ileostomy
is now performed in all patients after
early experience showed a high rate of
pelvic abscess in those operated on
without a covering ileostomy.
Technique
With the patient in a m odified
lithotomy position, the operation is car
ried out by two teams, beginning with
exploratory laparotomy through a mid
line incision to exclude the presence of
C ro h n ’s disease, cancer o r o th e r
unsuspected malady. Subsequently, the
sigmoid colon is encircled and tied off
with umbilical tape to prevent distal pas
sage of colonic debris. Total abdominal
colectomy is then carried out first by tran
secting the ileum close to the cecum with
a stapling device to preserve as much ter-
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minal ileum as possible and then by main
taining the plane of dissection close to the
bowel wall down to the levator ani mus
cles, thus avoiding neurologic damage.
Simultaneously the perineal operator,
after submucosal injection of 1:200 000
epinephrine and saline solution, carries
out the rectal mucosectomy beginning at
the dentate line in a sleeve-like circum
ferential manner for 4 to 6 cm, using
either electrocautery or scissors. The rec
tal muscle is transected posteriorly by the
perineal operator and the remaining por
tion by the abdominal operator, thus
ensuring en-bloc resection of the rectal
mucosa and submucosa with the entire
colon.
The abdominal surgeon mobilizes the
small bowel, dividing the posterior
peritoneum to the duodenum, pancreas
and superior mesenteric artery. To ena
ble the ileum to swing freely and reach the
anus, the ileocolic artery is divided proximally, carefully preserving the distal
mesenteric arcade.
The distal 26 to 33 cm of terminal ileum
is aligned with stay sutures in an S shape,
with each limb measuring 8 to 10 cm,
while the efferent limb measures 2 to 3
cm. Once it has been assured that the
pouch will reach the dentate line without
tension, anastomosis between the three
ileal limbs is completed with a continu
ous 3-0 polyglycolic acid suture. The
peritoneal cavity is protected against con
tamination with laparotomy pads.
Having assured meticulous hemostasis
in the pelvis and rectal muscular sleeve,
the abdominal operator passes the pouch
through the sleeve to the perineal opera
tor who excises the staple line and per
forms the ileoanal anastomosis. Initially,
four anchoring sutures of 3-0 polyglycolic
acid are placed in four quadrants at right
angles incorporating full-thickness ileum,
internal sphincter and anoderm. The
anastomosis is completed with more
superficial sutures between each anchor
ing stitch. A sump drain is then placed in
the pelvis and a temporary loop or endileostomy is constructed. Ileostomy
closure, usually through a peristomal inci
sion, is subsequently completed within 12
weeks, after a contrast enema has con
firmed anastomotic healing and anatom
ical position of the reservoir.

to regulate bowel movements, and over
all satisfaction.
Results

Mean hospital stay of patients after
restorative proctocolectomy was 10 days
and a mean of 7 days was reported after
ileostomy takedown. The procedure was
completed in one stage in 7 patients, in
two stages in 54 and in three stages in 9
patients.
Functional results were assessed in 52
patients. The follow-up was 2 to 35
months (average 19 months) from
ileostomy closure. Daytime bowel move
ments averaged 6.4 (range from 2 to 14)
and night-time bowel movements aver
aged 1.4 (range from 0 to 5). Forty-six
(88%) patients evacuated at night an aver
age of twice (range from 1 to 5). Spon
taneous evacuation occurred in 89% of
the patients, while the remaining 11%
required catheter intubation of the pouch.
O f the latter group, the majority were in
the initial group of patients in which a
larger S pouch and a longer efferent limb
were constructed.
Although no postoperative deaths
occurred, major postoperative morbidity
was experienced. Major daytime incon
tinence occurred in 6% of the patients,
the remaining 94% were always or usually
continent. Twenty-seven percent stated
that they could not control flatus, and
42% wore some perineal protection. Con
tinence was more difficult at night, with
21% of the patients having significant
soiling and 70% wearing a perineal pad
in the evening.
Twenty-three patients (44%) used
antidiarrheal medication to decrease stool
frequency, usually a bulking agent.
Twelve (23%) of the patients modified
their diet and excluded dairy products,
fibre and spicy foods. A small number
were unable to eat an evening meal.
Bladder function was disturbed in eight
patients (15%) with urinary retention,
decreased stream and recurrent urinary
tract infections reported. None of the 31
men had problems with impotence. One
of the 21 women had temporary dyspareunia following the procedure.
All 38 patients who held full-time
employment outside the home returned to
work. F o rty-eight (92%) patients
M ethod of Assessment
expressed satisfaction with the procedure.
Since the most troublesome effects of
this operation related to continence and
To assess postoperative morbidity with
accuracy, a comprehensive chart review
stool frequency, the eight patients (15%)
of prospectively collected data was under considered to have poor results were ana
lysed further. Their average age was 34
taken. All patients who underwent a
restorative proctocolectomy were in years compared to 29 years for those
cluded. Functional results were assessed
patients considered to have good results.
by questionnaire sent to patients or by
They also had 10.5 bowel movements
telephone interview. Patients were ques daily compared with 5.6 for the younger
tioned about frequency of bowel move group. The most frequent postoperative
ment, leakage, soilage, perineal irritation,
complication was small-bowel obstruc
use o f medications, adjustments of diet
tion, which occurred in 18 patients, 13 of
360

whom required surgery. “ Pouchitis” was
a recognized problem in 14 patients. It
was so marked in one patient that an
ileostomy had to be constructed. The
most serious complication was pelvic sep
sis which occurred in nine patients; six of
them required subsequent surgery.
Comment
Much criticism has been levelled
against the S ileoanal pouch, especially
the need for intubation, which has been
necessary in as many as 50% of
patients.1 Motility studies revealed that
this reservoir configuration was more
likely to become distended and atonic
because of low peristaltic and contractile
activity. Closer scrutiny of our data rev
ealed that the small number of patients
who have to intubate their pouch were in
the early group who had a long efferent
spout. Since we have decreased the size
of the pouch and the length of the effer
ent limb, the incidence of intubation has
dropped to 4%.
The Parks S pouch provides a means
of maintaining anal continence. This ser
ies and others have shown that young,
healthy, well-motivated persons will
benefit most; in older patients the results
are not as good. Above all, only meticu
lous attention to detail by a surgeon well
trained in the procedure will provide
acceptable results.
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6. J Pouch With Ileoanal Anastomosis
15°. Through a midline incision an
abdominal colectomy and rectal mobili
zation are completed, taking care to avoid
trauma to the nervi erigentes and the
hypogastric sympathetic nerves. Dissec
tion is carried down to the level of the
prostate in men and the middle portion
of the vagina in women, and posteriorly
past the end of the coccyx. The sigmoid
is transected and the colon removed. A
The most attractive surgical procedure for pathologist verifies that the condition is
preserving fecal incontinence is an chronic ulcerative colitis and not Crohn’s
ileoanal anastomosis. It consists of a total disease. A rectal mucosal stripping from
abdominal colectomy, mucosal proctec the dentate line to above the levator mus
tomy and endorectal ileoanal anastomo cles is then performed from the perineal
sis. It removes the rectal disease, preserves end. The stripped mucosa and remaining
innervation to the anus, bladder and proximal rectum are removed, leaving a
genitalia and retains the usual pathway short cuff of denuded rectal muscle disfor defecation.
tally for a few centimetres above the den
However, since its introduction, tate line. A J-shaped ileal reservoir is
ileoanal anastomosis has enjoyed only created by a long side-to-side anastomo
periodic popularity because of the sis of the terminal 15 to 20 cm of ileum,
numerous postoperative complications and this is pulled down to the dentate line
Les inconvenients physiques et les domassociated with it, primarily infection and after the small-bowel mesentery is ade
mages psychologiques de I'ileostomie
incontinence. Recently, improved results quately mobilized. An anastomosis is car
pour le malade, ont pousse les chirurhave been reported, based upon a better ried out between the J pouch and the den
giens a rechercher des solutions plus
understanding of the physiology of con tate line and a proximal defunctioning
normales et mieux acceptables. On fait
tinence.
ileostomy created. Two suction drains are
ici le point sur I'experience acquise a la
In 1978 at the Mayo Clinic we began placed in the presacral space and brought
Clinique Mayo avec une technique de
performing the ileoanal procedure in out in the left lower quadrant. The abdo
reservoir ileo-anale ainsi qu’avec des
adults. Our initial experience, 50 adults men is then closed. Patients are usually
modifications de cette operation. Les
without a reservoir, was reported in discharged home after 10 to 14 days and
dossiers de 188 patients qui ont recu
1982.1That experience and simultaneous return 2 to 3 months later to have the tem
une poche en J sont examines. La tech
laboratory
evaluation of these patients porary ileostomy closed. We can close the
nique operatoire est decrite. II n'y a eu
convinced us, in 1981, to incorporate a ileostomy with a peristomal incision 80%
aucun deces hospitalier. On a enregistre
reservoir at the end of the ileum. It was of the time, but in the other 20% the
10 echecs. Parmi les complications
our hope that a reservoir would increase abdomen must be reopened.
observees, on compte des infections pelboth the capacity and capacitance of the
viennes (21 patients), des sinus anastoneorectum.
Findings
motiques (15), des stenoses anastomotiPatients
with
ulcerative
colitis
or
ques (22), des obstructions de I'intestin
familial polyposis are chosen for this
Among 188 patients having a J pouch
procedure; Crohn’s disease is contraindi constructed were 177 who had ulcerative
From the Department of Surgery, Mayo
cated because of fear of recurrence in the colitis (3 with coexistent carcinoma) and
Clinic, Rochester, Minn.
Presented as part of a symposium on alter neorectum. Fulminant colitis and steroid 11 with polyposis coli (2 with coexistent
natives to ileostomy in ulcerative colitis, at usage are not contraindications, but a carcinoma). A temporary diverting
the 54th annual meeting of the Royal Col staged approach is probably best in the ileostomy was constructed at the time of
lege of Physicians and Surgeons of
presence of toxic megacolon.
colectomy in 180 patients. Radiologic
Canada, by the Royal College in coopera
contrast studies of the neorectum were
tion with the Canadian Association of
Technique
obtained 2 to 3 months postoperatively,
General Surgeons, Vancouver, BC, Sept.
11, 1985
and if anastomotic healing was demon
After appropriate bowel preparation, strated the ileostomy was closed. The
Accepted for publication Jan. 27, 1987
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The physical inconvenience and adverse
psychological impact of ileostomy on
patients led surgeons to seek a more
normal and acceptable alternative. This
is a report of the Mayo Clinic experience
with, and modifications of, the ileoanal
reservoir procedure. The hospital charts
of 188 patients who had a J-pouch con
struction were reviewed. The operative
technique is described. There were no
hospital deaths. In 10 patients the opera
tion was a failure. Complications
included pelvis sepsis (21 patients),
anastomotic sinus (15), anastomotic
stricture (22), small-bowel obstruction
(43), peritonitis after ileostomy closure
(10) and pouchitis (15). Careful patient
selection for the procedure is important.
Crohn's disease is a contraindication. Of
the patients studied, 95% found life
more acceptable with an ileoanal anasto
mosis than with a loop ileostomy.

grele (43), des peritonites apres fermeture de I'ileostomie (10) et des infections
du reservoir (15). Une selection soigneuse des patients s'impose. La maladie de Crohn est une contre-indication.
Parmi les patients, 95% ont trouve la vie
plus acceptable apres une anastomose
ileo-anale qu'apres une ileostomie en
anse.

There were no hospital deaths but two
patients died of metastatic carcinoma dur
ing the follow-up period. Ten patients had
their ileostomies re-established and are
therefore considered failures (5 for pel
vic sepsis, 2 with recurrent Crohn’s dis
ease and 3 with excessive stool frequency).
Twenty-one patients had pelvic sepsis;
12 required laparotomy and 5 of these
had the pouch removed. Five patients
were treated with antibiotics alone and
five had spontaneous resolution by
decompression of the abscess into the
pouch.
Fifteen patients had anastomotic
sinuses, demonstrated by contrast studies,
at the time of planned ileostomy closure.
Seven of these had pelvic sepsis. Eleven
of the 15 subsequently underwent uncom
plicated ileostomy closure after healing of
the sinus was demonstrated radiologically. In three patients with radiologic evi
dence of a sinus, ileostomy closure was
attempted. Two had evidence of localized
sepsis requiring temporary ileostomy.
Anastomotic strictures developed in 22
patients; 8 required one dilatation, 8 more
than one and 6 required intermittent dila
tation.
Clinical evidence o f small-bowel
obstruction occurred in 43 patients after
either colectomy (27) or ileostomy closure
(16). Laparotomy was required to relieve
bowel obstruction in 13 patients after
colectomy and in 3 after stoma closure.
Peritonitis developed in 10 patients
after ileostomy closure; this occurred
after peristomal incision and was
managed by primary repair in 7 patients
and by repair and temporary ileostomy
in 3.
No men were impotent but nine
experienced at least transient retrograde
ejaculation. Six women had uncompli
cated pregnancies, and four of them deli
vered vaginally without compromise of
anal function.
Pouch inflammation (“ pouchitis” )
occurred late in 8% of patients. Clinically
this is manifest by watery diarrhea,
hematochezia, abdominal and pelvic dis
comfort, malaise and, occasionally, fever.
This syndrome, which is likely secondary
to stasis and anaerobic bacterial over
growth, is similar to that found in patients
with Kock pouches and usually responds
within 48 hours to the oral administration
of metronidazole. Three patients have
had recurrent episodes of pouchitis.
Functional results were assessed using
a mean interval from stomal closure of
375 days. Mean stool frequency was six
per day and one per night. Minor seepage
occurred more than twice a month in 25%
during waking hours and 47% nocturnally. Frank fecal soilage was experienced
by 2.5% of patients while awake and
4.5% at night. Fifty percent of patients
use stool bulking agents (psyllium seed)
and 40% use antidiarrheal agents to
362

decrease stool frequency. Forty-one per
cent require no medications. Clinical
results clearly improve with time and
patients with a longer follow-up consis
tently have better functional perfor
mance. Of the 188 patients, 179 (95%)
preferred their experience with the
ileoanal anastomosis to that with a loop
ileostomy.
Patients’ gender had little effect on
functional results, but younger patients
had a lower daily stool frequency than
those over 50 years of age (5.8 versus 8.8).
Patients with polyposis had fewer stools
daily than those with colitis (4.3 versus

The ileoanal anastomosis is now estab
lished as a viable alternative in the
management of patients with ulcerative
colitis and polyposis coli. It can be done
primarily at the time of proctocolectomy
or secondarily in a patient who has had
an abdominal colectomy with a Brooke
ileostomy or ileorectal anastomosis. Des
moids and intra-abdominal scarring may
limit small-bowel mesenteric mobility and
prevent the anastomosis. Increasing
understanding of the mechanisms of con
tinence will likely allow us to offer
patients even more cosmetic and func
tional alternatives in the future.
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Discussion
Fonkalsrud and colleagues,2 Parks
and Nicholls,3 Peck4 and Utsunomiya
and associates5 used various types of
ileal reservoirs to prevent the excessive
stool frequency associated with ileoanal
anastom osis. From our anorectal
manometry studies it appears that the
improved results are secondary to
increased ileal compliance and decreased
ileal motility after construction of the Jpouch ileal reservoir. Nicholls6 found
that almost 50% of his patients had to
catheterize the S-shaped ileal reservoir
pouch; in the other 50% defecation was
spontaneous. This complication was not
seen with the J pouch developed by
Utsunomiya and associates,5 and all of
our patients can defecate spontaneously.
Rothenberger and colleagues,7 using a
modification of Parks’ S reservoir, re
ported that 57% of patients could defecate
spontaneously. They subsequently re
ported8 that shortening the efferent con
duit seems to improve the results.
Because of unsatisfactory results in
patients with a straight end-to-end
ileoanal anastomosis and the impeded
defecation after the S-pouch procedure,
we now use the J-shaped ileal reservoir
whenever possible. The optimal reservoir
remains to be defined, but larger is not
necessarily better.
Careful patient selection for the
ileoanal anastomosis is im portant.
Crohn’s disease is a contraindication to
the procedure. Patients should be medi
cally fit as the operative procedure can be
long and the potential postoperative com
plications are serious. The patients should
be well motivated and understand that the
operation will not make them normal —
they will still have an increased frequency
of bowel movements. Sphincter function
must be normal preoperatively. If there
is any question of incontinence, we uti
lize manometry to distinguish between
sphincter dysfunction and, more com
mon, loss of reservoir capacity. Sphinc
ter function decreases with advancing age
so patients over the age of 50 years should
be carefully screened.
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NOTICES
continued from page 325

Extended Programs in
Medical Education
The University of California in San Fran
cisco is sponsoring a course entitled
“ Update on Common Cancers for the
Primary Care Physician: Colon and
Prostate” Oct. 29-30, 1987. The program
covers the etiology of breast, colon and
prostate cancer, current screening techni
ques, evolving treatment methods and
complications of therapy and meets the
criteria for 12 credit hours in Category 1.
The University’s School of Medicine is
also presenting a course entitled “ Oph
thalmic Plastic and Reconstructive Sur
gery — Past, Present and Future” Dec.
10-11. Discussion will focus on the major
topics of ptosis, entropion, ectropion,
eyelid reconstruction, cosmetic eyelid and
facial surgery, lacrimal abnormalities and
orbital disease. Further information on
these courses can be obtained by writing:
Extended Programs in Medical Educa
tion, University of California School of
Medicine, Room 569-U, San Francisco,
California 94143 or calling: (415)
476-4251.
continued on page 381
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7. Physiopathologic Aspects of Ileal Reservoirs
The author reviews some aspects of
fecal continence after ileoanal anastomo
sis with an ileal reservoir. Also, the con
sequences of fecal stasis on small-bowel
absorption and morphologic and bacteriologic features are discussed. Some
recommendations for the follow-up of
these patients are outlined.
L'auteur etudie quelques aspects de la
continence fecale apres anastomose ileoanale avec reservoir ileal. II commente
egalement les consequences d'une stase
fecale sur I'absorption de I'intestin grele
ainsi que les caracteristiques morphologiques et bacteriologiques. On propose
quelques recommandations sur la surveil
lance que necessitent ces patients.

In the assessment of continencepi eserving operations, two physiopatho
logic aspects are of clinical interest: the
mechanisms of fecal continence and the
consequences of fecal stasis on smallbowel morphology, bacteriology and
absorption. An understanding of these
aspects may help to improve surgical care
and to identify problems that occur in the
long-term follow-up of these patients.
Mechanisms of Fecal Continence

Many factors participate in the
mechanism of continence:1 the anal
sphincters, the angulation between the
rectum and anus, the rectoanal reflexes,
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the reservoir capacity of the rectum, the
sensory mechanisms, the propulsion of
the distal bowel and the volume and con
sistency of stools. In the evaluation of
continence-preserving operations, all
these factors must be considered. When
the absorptive function of the colon is
abolished, the average fecal output
increases from 150 ml/d to 600 m l/d.2
This increase in stool volume is similar
after an ileoanal anastomosis, a Brooke
ileostomy and a well-functioning Kock
pouch. In our early experience of 12
patients with a straight ileoanal anasto
mosis,2 we noted a strong correlation
between stool frequency and the volume
capacity of the distal ileum as measured
by the maximal tolerable degree of dis
tension. The greater the capacity and
compliance of the distal bowel, the fewer
the number of stools per day.
Neal and colleagues3 have shown that
when a reservoir is constructed the capac
ity of the distal bowel increases faster
than without a reservoir. The adaptation
is easier for the patient because of a
reduced stool frequency in the early
postoperative period. At 1 year after sur
gery, the capacity of an ileal reservoir is
similar to that of normal rectum. The
rationale2 5 for using an ileal reservoir is
to provide an adequate replacement for
the rectum in creating a low-pressure,
compliant and quiescent reservoir that
can still evacuate spontaneously at a
reasonable volume of distension.
The usefulness of anorectal manome
try in evaluating continence after an
ileoanal anastomosis has been well illus
trated by Taylor and colleagues.5 The
clinical result is excellent when the sub
ject has good sphincter pressure, large
reservoir compliance and ileal contrac
tions of small amplitude. Only one abnor
mal value is needed to explain a poor
result. Low resting pressure of the sphinc
ter and poor compliance, measured
before closure of the diverting ileostomy,
can be associated with a poor outcome.6
After a straight ileoanal anastomo
sis,2'5>7 large phasic contractions of more
than 100 cm H20 pressure are often
detected. These contractions can over
come anal sphincter resistance and result

in incontinence. The frequency of the
contractions increases substantially after
a meal.5’7 Construction of an ileal pouch
reduces the amplitude of these contrac
tions.5 Stryker and colleagues8 have
shown that when the reservoir is empty,
a few small-amplitude contractions are
seen. When the ileal pouch is full, the fre
quency and amplitude of ileal contrac
tions are so intense that the subject must
evacuate. The better the emptying of the
pouch, the longer it takes for the contrac
tions to appear so that continence is facili
tated. Using a semi-solid radionuclide
enema we found, however, that the ileal
pouch empties substantially less than a
normal rectum.9
The effect of rectal mucosectomy on
sphincter pressure has been evaluated
before and after the operation, in the
same patients, by Becker.10 Resting anal
sphincter pressure was shown to be
reduced after the operation. Voluntary
contractions of the anal sphincter
remained unchanged.
In healthy control patients sudden dis
tension of the rectal wall is associated
with a reflex relaxation of the internal
sphincter1which may facilitate emptying
and be associated with the sensory
mechanisms. The effect of rectal muco
sectomy on the rectoanal reflex has been
a controversial subject in the literature.
We found that the reflex is abolished
probably because our distending balloon
was positioned in the ileum above a short
rectal cuff.2 Recently, Grant and
colleagues11 compared the functional
and manometric results of a short and
long rectal cuff and found more compli
cations with a long cuff. No differences
in manometric findings were detected.
Moreover, the rectoanal reflex was absent
in both the long and short groups, but this
had no adverse effect on continence.
Effect of Fecal Stasis

Fecal stasis in an ileal reservoir may
lead to overgrowth of bacteria and
changes in mucosal morphology that are
of concern for the future.12 The patho
genesis of nonspecific inflammation of an
ileal reservoir (“ pouchitis” ) remains
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unknow n. Kelly and colleagues13,14
observed an increased number of anaero
bic bacteria in the jejunum of patients
with malfunctioning Kock pouches and
diarrhea. The malabsorption and the
number of jejunal and ileal anaerobic
bacteria decreased during treatment with
metronidazole, thus implicating an over
growth of anaerobic bacteria in the
pathogenesis of this syndrome.
It has been speculated that the motil
ity of the proximal bowel may be altered
by pouch distension. Using an assembly
of catheters to record intestinal contrac
tions, Stryker and colleagues8 studied the
motility patterns of the jejunum and
ileum of patients who had an anastomo
sis o f an ileal pouch to the anus. At the
same time, motility of the pouch was
recorded by another catheter inserted in
the pouch per anum. When compared to
control patients, the pattern of motility
in the proximal small intestine remained
unchanged after the operation. The
migrating interdigestive contractions that
clean the bowel from the jejunum to the
ileum between meals were found to be
normal. The pattern of motility after
feeding was also unchanged. Interest
ingly, the migrating contractions were not
detected in the ileal pouch. No relation
between proximal small-bowel motility
and the pattern of stooling was observed.
The latter is related to the capacity, com
pliance and emptying of the ileal
reservoir.
Another aspect of concern is the alter
ation of mucosal histologic characteris
tics after an ileoanal anastomosis. A
decrease in villous height, an increase in

the number of mucus-producing cells and
mild chronic inflammation are seen in
most patients.2,15 A colonic type of
mucosa replaced the typical ileal villous
pattern. The long-term consequences of
such metaplasia are still unknown. The
longest follow-up of the effect of fecal
stasis on mucosal morphology or on the
ileum has been reported by Nilsson and
colleagues16 in patients with the Kock
pouch. The increased number of mitoses
seen at 1 year returned to normal 6 to 10
years after surgery. Similarly, the villous
height, which was reduced at 1 year,
increased over time. Absorption of vita
min B,217 was normal in 235 patients
with the Kock pouch but subnormal in
7%. Because of the risk of permanent
neurologic damage, it is recommended
that vitamin B12 levels be checked regu
larly.
In summary, several factors are of
prognostic concern: absorption of vita
min B12, pouchitis, mucosal metaplasia
and the effect of aging on the anal sphinc
ter.18 Rectal mucosectomy and ileoanal
anastomosis with a reservoir is a good
alternative to permanent ileostomy for
well-selected patients with ulcerative coli
tis or familial polyposis. It is recom
mended, however, that these patients be
followed up indefinitely.
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8. Discussion
[Questions directed to specific panelists
were answered as follows.]
Question: Following a colectomy and
before establishment of an ileorectal
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the rectum to improve the outcome of the
operation?
Dr. Belliveau: Yes. The rectal stump can
be irrigated daily with steroid enemas
before a staged ileorectal anastomosis.
This allows mild to moderate disease to
improve and reduces the troublesome
bleeding and escape of mucus from the
rectum.
Question: If the rectum has to be excised
for persistent or worsening disease after
ileorectal anastomosis, what would the
next step be?
Dr. Belliveau: If, after ileorectal anasto
mosis, the symptoms of proctitis become
severe or if dysplasia becomes worrisome,
excision of the rectum with the creation
of an ileal reservoir with ileoanal pull-

through becomes a viable option. Under
these circumstances the results are
encouraging, since the ileum has already
adapted to a higher bacterial colonization
and has hypertrophied allowing for satis
factory bowel control. If rectal carcinoma
has developed, proctectomy and perma
nent Brooke ileostomy should be done.
Question: Is the history of a fistula-in-ano
a relative contraindication to ileorectal
anastomosis?
Dr. Belliveau: A previous fistula-in-ano
is not a contraindication to ileorectal
anastomosis as long as continence is
preserved. Anorectal manometry may be
used in certain cases.
Question: Are there any foreseeable
future modifications that might reduce
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the morbidity associated with the Koch
pouch?
Dr. Cohen: The most recent modification
has been the use of the stapling instru
ment to secure the nipple valve in the
pouch. This should significantly reduce
the complication of nipple-valve sliding.
I do not feel that major modifications will
be made in the future. The operation itself
will never be perfect and will always carry
with it a substantial morbidity. This is the
reason that patients who choose to have
this procedure must be carefully
scrutinized.
Question: How long do you treat and
what are the possible long-term compli
cations of “ pouchitis” ?
Dr. Cohen: Pouchitis is extremely
difficult to treat. Our drug of choice has
been Flagyl, but in some patients we have
not been able to discontinue its use. In
one patient in particular, when Flagyl was
discontinued, the symptoms of pouchitis
returned within 10 days. We have
removed a continent pouch as well as a
pelvic pouch because of pouchitis. We are
obviously concerned about the develop
ment of carcinoma within pouches that
have been chronically inflamed but to this
date we have not seen a report of a carci
noma in either the continent ileostomy
pouch or the pelvic pouch. I would treat
these patients with appropriate antibiotics
for as long as was necessary and some
times that might be 3 to 6 months.
Question: In the event that you find some
suggestion of Crohn’s disease in the small
intestine at the time of exploration for an
ileoanal reservoir, what is your approach?
Dr. Goldberg: I would probably do the
colectomy and either an ileorectal anasto
mosis if the rectum was uninvolved or an
ileostomy and leave the rectum in place.
I would then follow up the patient and
see how he does clinically, see what the
final pathology report is and consider an
ileoanal reservoir at a later date if the con
dition turns out not to be Crohn’s disease.
Question: Should an ileoanal reservoir be
constructed in the emergency situation?
Dr. Goldberg: Since we now have an
established pouch team and an experience
of 120 cases, we are not shy about oper
ating on a patient in an emergency situa
tion. Once the colon comes out and if,
technically, the operation goes well, we
do not hesitate to go ahead and construct
the pouch and bring up a split ileostomy.
Question: Are there any physiologic
studies that have predictive value with
respect to patient selection and patient
outcome after ileoanal reservoir anasto
mosis?
Dr. Heppell: It is not necessary in all cases
of ulcerative colitis or familial polyposis
to use anorectal manometry to select
patients for operation. When the patient
complains of incontinence before the
operation it is of value to know whether
the sphincter tone and voluntary contrac

tions of the anal sphincter are adequate,
because incontinence in ulcerative colitis
may be related to the presence of a
microrectum with a normal anal sphinc
ter mechanism. Under these circum
stances we can do the operation with the
confidence of knowing that sphincter tone
will be adequate and that the microrec
tum of ulcerative colitis can be replaced
by an adequate ileoanal reservoir. Simi
larly, in older patients or those who have
undergone previous anal surgery,
manometry can be used to assess the
sphincter tone. If the patient has good
sphincter tone on rectal examination and
had no previous problem with continence,
manometry is not justified. If a patient
has a poor functional outcome after sur
gery I usually perform endoscopy of the
reservoir, anal manometry to measure the
sphincter tone, the capacity and compli
ance of the pouch, and an emptying study
of the pouch using a radionuclide enema.
These tests can be useful to assess whether
the poor functional outcome is related to
poor sphincter tone, large volumes of
stool, inadequate emptying, or pouchitis.
Question: How would you decide which
operation you will offer your patient?
Dr. Beart: I try objectively to present the
alternatives, emphasizing the advantages
and disadvantages of each and let the
patient have a major role in deciding
which alternative will offer him the
highest quality of life.
Question: Would you tell us a little more
about the implications of incontinence
and leakage and the impact that this has
on the quality of life and management of
these symptoms?
Dr. Beart: Some stool frequency and
leakage occur initially in virtually all
patients. These can be decreased by
encouraging the patient to take enough
psyllium to thicken the stools and occa
sionally Lomotil to decrease bowel motil
ity. In spite of these recommendations,
some patients have unacceptable fre
quency and discharge. The discharge is
most common at night. The anus should
be protected from this discharge with a
zinc oxide-based cream. Fortunately, the
magnitude of symptoms related to minor
discharge is not great. If these recommen
dations are not adequate, the patient
should be evaluated for outlet obstruc
tion, bacterial overgrowth, recurrent
inflammation or pelvic inflammation,
partial small-bowel obstruction and
inadequate sphincter function. If no cor
rectable disorder is identified and symp
toms have not improved within 6 months,
conversion to an ileostomy should be
recommended.
Question: What is the influence of
pouch-anal anastomosis on sterility,
impotence and subsequent term preg
nancy?
Dr. Beart: None of the 90 men in our
reported series has been rendered impo

tent. Realistically, however, we do expect
a small incidence of impotence after an
extensive pelvic dissection. Six women
have become pregnant and none have had
subsequent complications related to the
ileoanal procedure. Four of the six deli
vered vaginally.
Question: What factors might be predic
tors of success and what factors might
predict failure or at least lessen good clin
ical results?
Dr. Beart: Crohn’s disease and gross
sphincter dysfunction are strong contrain
dications to this procedure, and age over
50 years is a relative contraindication.
Younger age and familial polyposis seem
to predict a more favourable clinical
result.
Question: What technical factors might
prevent performance of this procedure
and how might they be predicted preoperatively?
Dr. Beart: The presence of a mesenteric
desmoid is the only factor that seems
almost uniformly to be associated with
failure to achieve an anastomosis. Obesity
can foreshorten the small-bowel mesen
tery, but with careful dissection adequate
length can be achieved.
Question: What tricks can you suggest to
make the J pouch reach the anus?
Dr. Beart: Careful dissection of the
mesentery over the third portion of the
duodenum must initially be carried out.
That portion of the terminal ileum which
reaches the furthest over the pubis is then
identified and tethering vessels can be
divided and ligated. If the bowel reaches
past the pubic bone, adequate length has
usually been achieved. Several mesenteric
vessels can be ligated if necessary, as long
as the marginal vessels are preserved.
[Certain questions were directed to the
entire panel and were answered in the fol
lowing manner.]

Question: Would you do a pouch proce
dure on a person who has had a previous
fistula-in-ano?
Dr. Morgan: I would be prepared to con
struct a pouch in a patient who had had
previous fistula-in-ano, provided that the
anal sphincter was not impaired.
Dr. Cohen: A fistula-in-ano does not
necessarily preclude doing a pelvic pouch
procedure; however, I would worry that
the patient had Crohn’s disease rather
than ulcerative colitis. If the fistula was
rather superficial and did not require a
significant portion of the sphincter to be
incised and if the patient still had ade
quate sphincter tone as measured clini
cally and on anorectal manometry, and
I was completely satisfied that pathologi
cally ulcerative colitis was present, I
would do a pelvic reservoir on that
patient.
Dr. Belliveau: Yes. If the fistula surgery
was successful and if the residual sphincVOLUME 30, NO. 5, SEPTEMBER 1987 / THE CANADIAN JOURNAL OF SURGERY
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ter function, as assessed by anal manom
etry, was adequate.
Dr. Goldberg: I would assess the patient
preoperatively with anal manometric
studies. If the results were within the nor
mal range I would certainly go ahead and
do so. Obviously if a patient has had a
trans-sphincteric type of fistula, I would
probably discourage him from undergo
ing an ileoanal reservoir procedure. Also,
I would be highly suspicious that the
patient has Crohn’s disease and not a true
mucosal ulcerative colitis.
Dr. Heppell: I would do a pouch in a
patient who had an intersphincteric fistula
that had healed completely. If there was
any doubt about Crohn’s disease, I would
not do the operation.
Dr. Beart: If the patient was continent
preoperatively, I assume he will be con
tinent after surgery regardless of previous
anorectal disease.
Question: Have you seen many patients
who have required excision of the pelvic
pouch?
Dr. Heppell: Rarely.
Dr. Cohen: In our own series, four
patients have required removal of the pel
vic pouch, two because of fistulas from
the anal anastomosis, one because of
pouchitis and one because of excessive
stool frequency.
Dr. Goldberg: We have had 7 patients out
of 120 who have had their pouches
excised. Most of these were related to pel
vic sepsis, unrecognized Crohn’s disease
and our attempt to do this operation
without a covering ileostomy.
Dr. Belliveau: In my personal experience
with 45 such procedures, one patient has
had the pouch excised for a recurrent pel
vic sinus track with a chronic abscess in
the retrorectal area.
Dr. Beart: Our group has seen about 5%
of our patients fail because of technical
issues or stool frequency. Recently 12
patients have had their defective pouch
removed, repaired and replaced.
Dr. Morgan: I have not had to excise a
pelvic pouch. In fact sepsis has not
occurred in any of our patients. We
attribute this to a meticulous bowel prepa
ration which is a combination of oral
mannitol, neomycin and tinidazole.
Question: Should an ileoanal reservoir
ever be constructed without a covering
ileostomy?
Dr. Goldberg: I realize that certain sur
geons have done this operation without
a covering ileostomy. However, we have
had experience with seven of them, and
our pelvic sepsis rate and complication
rate were so high that I strongly recom
mend this operation be done with a cover
ing ileostomy. I also feel that the patient
them knows what it is like to live with an
ileostomy. In the event that stoma
problems occur, the patient is certainly
familiar with the alternative.
Dr. Belliveau: No. A temporary loop
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ileostomy is essential to allow healing of
the pelvic space without troublesome
anastomotic leakage in patients who are
often hypoproteinemic and malnour
ished.
Dr. Beart: In selected situations we have
done this but we do not yet recommend
it as a routine.
Dr. Cohen: We have always used a cover
ing ileostomy. In Dr. G oldberg’s
experience in five patients who did not
have a covering ileostomy, four suffered
septic complications. Although there are
complications related to a defunctioning
loop ileostomy, I do believe it is safer to
use this rather than to leave the ileoanal
anastomosis unprotected.
Dr. Morgan: All our reservoirs have been
protected by an ileostomy. I would be
unhappy to do the procedure without
such protection.
Dr. Heppell: No.
Question: Can rectal disease be so severe
that you would not attempt a pouch
procedure?
Dr. Heppell: No. The rectum is nearly
completely resected and a mucosectomy
performed for a very short distance (2 to
3 cm) so that only the anal sphincter is
preserved. In this manner, it is possible
to perform a mucosectomy even in the
presence of severe rectal disease.
Dr. Morgan: Most of the patients I see
with destructive disease of the rectum
have Crohn’s disease. In general, patients
with ulcerative colitis have grossly dis
eased mucosa and submucosa but rarely
is transmural disease present in the
anorectal region. We have not rejected
any patient because of this.
Dr. Cohen: The answer to that is proba
bly not. In our most recent cases, we
excised the rectum completely leaving a
rectal cuff of only 2 cm. With this tech
nique we have been able to strip away the
anorectal mucosa in all cases, even though
in some it has been quite difficult. If you
are considering leaving a rectal cuff of 8
to 10 cm, then in some cases it is practi
cally impossible to be absolutely certain
that all the diseased mucosa has been
removed.
Dr. Beart: I have not seen such a case.
Dr. Goldberg: I suspect that if the rectal
disease is so severe that the sphincters
have been destroyed, I certainly would
not attempt a pouch procedure. But if,
on anorectal manometry and on clinical
examination, the sphincters appear to be
uninvolved, I would not hesitate to do so
if I was convinced that this was mucosal
ulcerative colitis and not Crohn’s disease.
Dr. Belliveau: As long as the diagnosis is
ulcerative colitis, results are very satisfy
ing when a strictured rectum is removed
or the muscle cuff is incised posteriorly
to allow the reservoir to be pulled through
satisfactorily.
Question: Do you use systemic antibi
otics? Which ones? For how long?

Dr. Beart: Yes. A second generation
cephalosporin for three doses.
Dr. Belliveau: Systemic antibiotics are
used only in the immediate perioperative
period and consist of standard oral and
parenteral agents used in bowel prepa
ration.
Dr. Morgan: All our prophylactic antibi
otics have been given orally. We believe
that the antianaerobic agents are vital and
the metronidazole group of drugs has
been shown to be the most effective agent
in combatting these organisms. We cur
rently use tinidazole which is totally
absorbed from the gastrointestinal tract
and remains within the tissues for a con
siderable time.
Dr. Goldberg: We used Mefoxin for three
doses: one preoperatively and two
postoperatively.
Dr. Cohen: We prepare our patients with
a gastrointestinal irrigation solution of
Go-lytely. We also use Flagyl and netil
micin intravenously on call to the oper
ating room, intraoperatively and for 48
hours postoperatively.
Dr. Heppell: I use the same antibiotics I
use for prophylaxis in colon surgery.
Question: Is it necessary to preserve the
ileocolic vessels? Does it make any
difference?
Dr. Heppell: I usually preserve the ileo
colic vessels, but if I have difficulty in
mobilizing the J pouch so that it can reach
the anus, I would sacrifice vessels in the
mesentery proximal to the arcades.
Dr. Morgan: We always preserve the ileo
colic vessels. However, in one patient in
whom there was an early cancer of the
hepatic flexure, this vessel was sacrificed;
luckily, the superior mesenteric was suffi
ciently long to enable an easy pouch-anal
canal anastomosis.
Dr. Goldberg: The ileocolic vessels are
critical to the construction of an ileoanal
reservoir. We may have to sacrifice one
arcade in order to straighten out the
bowel. But we have found that since we
have gone to the short efferent limb of
2 to 3 cm, the ileum reaches the anal canal
with ease.
Dr. Beart: It is not necessary, but a
general philosophy to preserve as much
of the blood supply to the distal pouch
as possible seems reasonable. The ileo
colic vessels are usually not the limiting
vessels but we preserve them until the
limiting vessels are defined.
Dr. Belliveau: It is important to preserve
the ileocolic vessels when performing the
colectomy to obtain maximal blood sup
ply to the terminal ileum and also to use
its arcades by dividing the vessel close to
its origin to allow greater mesenteric
mobilization when constructing the
reservoir.
Dr. Cohen: I do believe it is important to
have knowledge of the various types of
pouches. When one is constructing a Jshaped reservoir, one can leave the ileo-
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colic vessels. In order to gain more length,
one can sacrifice a more proximal portion
of that vessel. However, in constructing
an S-shaped pouch, the ileocolic vessels
must be taken.
Question: How long should the rectal cuff
be?
Dr. Goldberg: We feel that the rectal cuff
only has to be about 4 to 5 cm in length,
just to the top of the anal canal.
Dr. Beart: There is no need to save rectal
muscle. We transect the rectum just above
the puborectalis.
Dr. Belliveau: The rectal cuff should be
relatively short, 4 to 6 cm from the anal
margin.
Dr. Heppell: No more than 4 cm long.
Dr. Morgan: We amputate the rectum
just above the anorectal junction.
Dr. Cohen: In our experience it is not
necessary to leave a cuff of longer than
2 cm. In fact, in our early experience,
leaving a rectal cuff of 8 to 10 cm, we had
a ninefold increase in the septic compli
cation rate. Since leaving a short rectal
cuff there has been no increase in sexual
complications produced as a result of the
operation itself. In addition, by leaving
a short cuff, one can be more certain that
all the diseased mucosa has been
removed.
Question: Describe your use of drains in
or around the pouch. How many do you
use? Where are they placed and where do
they exit?
Dr. Morgan: I insert a sump drain from
the abdomen into the pelvis and usually
remove it after 36 hours.
Dr. Cohen: We prefer to use short Silas
tic closed suction drains (Jackson-Pratt
drains). We use two drains, both placed
abdominally. From the left lower quad
rant the drain is placed into the presacral
space and from the right lower quadrant
the drain is placed to within 2 cm of the
anal anastomosis. Our usual routine is to
remove the right-sided drain close to the
anastomosis first, followed by the
presacral drain, but we may leave these
drains in place for a considerable length
of time until they have virtually stopped
draining.
Dr. Heppell: I use two Jackson-Pratt
drains that are positioned behind the
pouch and exteriorized in the left iliac
fossa. These drains are usually left in
place for 4 to 5 days.
Dr. Belliveau: Drains are used routinely.
A sump drain of Silastic material and
fairly large (7 mm) diameter is placed in
the sacral hollow beside the pouch and
brought out in the left lower abdomen.
I also place a large (24 F) Foley catheter
in the pouch, exiting from the anus to
drain residual bowel contents and blood.
Drains are generally removed in 3 or 4
days.
Dr. Beart: I place two round suction
drains behind the pouch and in front of
the sacrum bringing them out through

stab wounds in the left lower quadrant.
Dr. Goldberg: We initially started using
drains in the way Sir Alan Parks did with
perineal drains and abdominal drains.
However, in most of our patients we now
use a single no. 10 Jackson-Pratt drain
posterior to the pouch brought out
through a stab incision. It is usually left
in for 48 to 72 hours.
Chairman's Conclusions: In the selection
of the type of operation for the treatment
of intractable chronic ulcerative colitis,
the current crest of enthusiasm favours
the establishment of a pelvic reservoir and
ileoanal anastomosis with a temporary
ileostomy to be closed about 3 months
later. It is unanimously agreed that this
operation should not be performed on
patients with Crohn’s disease or those
with defective sphincter function. Most
agree that the operation should not be
performed in the emergency situation,
but, after their experience gained at the
University ot Minnesota, Dr. Goldberg
has stated that his group would not hesi
tate to construct a pouch after an emer
gency colectomy. It is not agreed above
what age the operation should not be
offered to a patient, but the upper limit
usually ranges from 50 to 60 years.
All the panelists agree that the rectal
cuff can and should be short, not more
than 2 to 4 cm above the levator muscles.
A shorter cuff will reduce operating time,
make no difference to the functional
results, and will reduce the incidence of
septic complications. Not agreed upon is
the ideal configuration of the reservoir.
The most popular configurations are the
S pouch proposed by the late Sir Alan
Parks and the J pouch proposed by
Utsunomiya. Other pouches include the
lateral ileal pouch described by Fonkalsrud and the W pouch of Nicholls.
Each kind of pouch has its proponents
and detractors, its advantages and disad
vantages. The original concern with the
S pouch was the need for catheterization,
but the modification of constructing a
short efferent limb of 2 to 3 cm has vir
tually eliminated the problem as most
patients with this limb length have spon
taneous evacuation. The pouch takes
longer to construct, but it is easier to per
form the ileoanal anastomosis without
tension. The J pouch is easier to con
struct, but difficulties have been encoun
tered mobilizing the mesentery adequately
so that the pouch-anal anastomosis can
be performed without tension. All
panelists agreed that a covering ileostomy
is indicated despite the occasional reports
of patients having a reservoir constructed
without diversion.
Although the mortality of these proce
dures has been low there has been con
siderable morbidity. The most common
complications have been pelvic sepsis,
some patients requiring reoperation, and
small-bowel obstruction, many patients

requiring laparotomy. Anastomotic
dehiscence and significant stricture occur
less frequently.
The acid test of any new procedure is
the functional result. The frequency of
defecation decreases with time and after
6 to 12 months averages five to six bowel
movements per day with about one
quarter of the patients having to rise at
night for a bowel movement. As would
be expected, the frequency of defecation
is inversely proportional to the reservoir
capacity. The fact that capacity increases
with time may explain why the stool fre
quency decreases with time. Approxi
mately half the patients require some
form of antidiarrheal medication. Leak
age is a frequent problem and many
patients require an anal pad at night when
the problem is worse. Manometric studies
of the anal sphincter after reservoir con
struction have shown a reduced resting
pressure but squeeze pressures have been
maintained. These findings suggest
impaired internal sphincter function and
may explain the night leakage, a time
when the patient cannot rely upon the
external sphincter.
Bladder and sexual problems have been
minor with the most common problem
being retrograde ejaculation.
Inflammation of the pelvic reservoir
has proven to be an annoying problem.
Various treatments have been recom
mended, a popular one being administra
tion of metronidazole.
There still remain unresolved issues, the
most prominent being the optimal con
figuration of the pouch. Although there
has been and continues to be progress in
reducing the morbidity of this operation,
future modifications will undoubtedly
improve the end results. ■
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Postmastectomy Lymphedema Treated
With the Wright Linear Pump
Fifteen patients with postmastectomy
lymphedema of the arm were treated
with the Wright linear pump, a program
mable, gradient pressure, sequential,
intermittent compression pump. The
group comprised volunteers in whom
conservative measures had failed. This is
a phase II trial to determine the efficacy
of the pump.
All patients had subjective improve
ment. Objectively, all showed a reduc
tion in edema, but this was of variable
degree and depended on the amount of
pre-existing lymphedema in the arm.
The Wright linear pump is easy to use
and treatment was well tolerated. IMo
fluid overload occurred due to treatment
and no other medical problems were
encountered.
The Wright linear pump seems more
effective than other pneumatic intermit
tent compression pumps available.
Une etude de phase II fut entreprise afin
de determiner I'efficacite d'une pompe a
compression sequentielle et intermittente
(Wright linear pump) dans le traitement
d'un lymphcedeme du bras secondaire a
une mastectomie. Quinze patientes, dont
I'etat demeurait inchange suite a des
traitements traditionnels, furent selectionees pour participer a cette etude.
Toutes les patientes ont ressenti une
amelioration subjective de leur condition.
De plus, une reduction de I'cedeme fut
observee chez toutes les participantes.
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Cependant, cette reduction fut variable,
dependant de la severite du lymphcedeme
preexistant. Le traitement fut tres bien
tolere et aucun probleme medical ne fut
rencontre, principalement en ce qui, concerne la surcharge liquidienne.
La Wright linear pump est d'usage tres
facile et semble etre plus efficace que les
autres pompes a compression intermit
tente presentement disponibles.

The incidence of lymphedema after
m astectom y varies from 6.7% to
62.5%.' Its cause is due to a combina
tion of factors, including surgical removal
of lymphatic channels in the anterior
axilla, especially along the axillary vein.
Radiotherapy increases the incidence by
scarring existing lymphatic channels and
preventing the formation of new lym
phatics. Obstruction of the axillary vein
by scar tissue leads to lymphatic stasis,
dilatation and valvular insufficiency of
the lymphatics and increased susceptibil
ity to infection. The incidence of lym
phedema rises markedly with underlying
infection, either superficial or deep.
Conservative management includes
elevation2 of the affected arm for at least
30 minutes at a time. Isometric exercises
of the limb will increase the active mus
cle pump.3 Diuretics have been used but
without much success. An elastic sleeve
interrupts the cycle of edema and prevents
stretching of tissues and loss of elasticity.
Available surgical procedures are not
very successful. They include lymphangioplasty, omental bridging,4 lymphaticovenous shunting,5 Goldsmith’s
omental transposition,6 superficial to
deep lymphatic anastomosis,7 lysis of
axillary vein adhesions8 and in very
severe cases as a last resort, amputation
of the affected limb.
Several pneumatic intermittent com
pression pumps are available. The most
common one, the Jobst unit,9 is com

posed of a single cuff that inflates and
then deflates. The unit fills all at once and
the pumping milks the limb from distal
to proximal. The pressure phase forces
edema fluid up the lymphatic channels
and the exhaust phase allows them to
refill.
The Wright linear pump (Pittsburgh,
Penn.) (Fig. I)10 was developed to over
come the inherent reverse-flow charac
teristics of single-cuff pressure devices
and thereby reduce back flow. Three cells
enclose the hand and wrist, forearm and
upper arm. Each cell is provided with a
hose to receive air from the pump at pre
set times and pressures. Pressure gra
dients between cells from distal to prox
imal are at sequentially lower pressures,
thus minimizing the tendency for back
flow. The highest pressure is midway
between the patient’s systolic and diastolic
blood pressures. There are three solidstate electronic timers. The “ on time”

FIG. 1—Wright linear pump with cuffs for
arm and leg.
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controls the full time for each cycle (90
seconds). The “ off time” controls the
time at atmospheric pressure between

cycles (30 seconds). There are two delay
timers between the three cells so that the
most distal cell is on for longer than the

middle cell which again is on longer than
the proximal cell (Fig. 2).
Patients and Methods

FIG. 2—Wright linear pump with three hoses to connect to three pressure devices and three
solid state electronic timers.
Table 1--Patient Characteristics
Patient
no.

Present
age, yr

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15

70
70
51
60
69
63
81
65
79
35
43
71
55
39
59

Surgery
L mrm
L seg +
L seg +
R seg +
R mrm
R mrm
L radical
R mrm
R mrm
L radical
R seg +
L mrm
R mrm
R mrm
L mrm

nodes
nodes
nodes

nodes

Date of
treatment

Nodal
involvement

Radiation
to axilla

August 1983
July 1981
May 1980
July 1983
January 1980
December 1982
1968
May 1985
July 1975
December 1973
November 1981
June 1984
October 1984
March 1982
September 1983

+
+

Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
Yes
Yes
Yes
No
Yes

-

+
+
+
+
+
+
-

+
+
-

+

mrm = modified radical mastectomy, seg + nodes = segmental resection and axillary node dissection, radical = radical mastectomy.

Fifteen women with chronic lym
phedema of the arm were admitted to the
A. Maxwell Evans Clinic of the Cancer
Control Agency of British Columbia in
Vancouver for treatment on the Wright
linear pump. All had had surgery for car
cinoma of the breast and 14 had received
adjuvant radiotherapy. They ranged in
age from 35 to 81 years (median 67 years).
Two patients had undergone classic rad 
ical mastectomy, nine modified radical
mastectomy and four had had segmental
resection with axillary node dissection.
Eleven patients had axillary node involve
ment. Thirteen received adjuvant fivefield radiotherapy to the internal mam 
mary, supraclavicular and axillary lymph
nodes and also the chest wall. One woman
with no cancer in the lymph nodes
received in ternal m am m ary and
supraclavicular radiation only for an
inner quadrant lesion (Table I).
The edema occurred from 1 to 168
months (mean 30 months) after initial
therapy.
The patients were self-selected in that
they requested therapy for the lym
phedema. In many, conventional conser
vative measures had failed. None adm it
ted to any psychological difficulty in
living with a lymphedematous arm.
Almost all patients complained that the
arm was cumbersome and heavy, and
50% experienced some pain in the limb,
but none had any functional disability.
Four women had had numerous episodes
of infection. In another, lymphedema was
the direct result of trauma.
Six patients had been prescribed
diuretics, usually furosemide or hydroch
lorothiazide, but only one reported any

Table II—Duration of Edema and Measurements of Arm Circumference*

Patient
no.

Time for
edema to
occur, mo

Duration,
mo

Group 1: Edema 2 - 5 cm
2
31
25
3
5
65
4
12
19
5
69
4
7
108
108
8
1
10
10
60
93
14
24
26
15
18
30
Group 2: Edema > 5 cm
1
30
6
6
22
15
12
9
120
11
18
38
12
1
19
96
13
168

Circumference
of normal
arm, cm

Difference
between normal
and affected
arms, cm

Circumference of affected arm, cm
Before treatment

After treatment

Reduction in
edema, cm

24.3
20.0
22.8
23.0
22.0
22.7
25.7
23.5
23.0

3.7
4.1
3.7
2.0
2.2
2.3
2.3
3.5
4.5

28.0
24.1
26.5
25.0
24.2
25.0
28.0
27.0
27.5

26.9
23.5
22.6
24.2
23.0
24.0
26.0
26.3
23.8

1.1
0.6
3.9
0.8
1.2
1.0
2.0
0.7
3.7

19.0
21.7
20.7
20.0
26.8
20.0

5.4
6.7
13.8
7.0
6.7
9.0

24.4
28.4
34.5
27.0
33.5
29.0

22.0
26.0
29.0
22.5
28.9
27.8

2.4
2.4
5.5
4.5
4.6
1.2

'Measured 6 cm below the olecranon.
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improvement. Twelve of the 15 patients
had previously used a Jobst pneumatic
intermittent compression pump. Seven
used it consistently for at least 3 months
but discontinued its use because of poor
results. Ten patients had been measured
for an elastic sleeve but none wore it con
sistently as they found it too hot in the
summer. Cosmetically, most patients felt
that the elastic sleeve attracted more
attention to the arm than the edema itself.
The women were treated on the Wright
linear pump according to the protocol
outlined by Alexander at the DT Watson
Rehabilitation Hospital, Sewickly, Penn
sylvania.
The patients were screened for pre
existing cardiac, respiratory, renal or
hepatic disease to reduce the risk of
volume overload. All patients had
recently undergone chest roentgenogra
phy, electrocardiography, complete blood
count, liver function testing, measure
ment of blood urea nitrogen and creati
nine levels and serum protein electropho
resis. Concurrent infection in the arm was
a contraindication to treatment.
The hospital admission period was 48
hours. Treatment with the Wright linear
pump totalled 38 hours, consisting of
seven sessions of increasing time as fol
lows: a 2-hour period, two 4-hour
periods, two 6-hour periods and two
8-hour periods with 1 hour’s rest between
each session. Vital signs, including heart
rate, blood pressure and respiration, were
checked every 2 hours.
The most distal cell of the pump was
inflated to the midpoint between the
patient’s systolic and diastolic pressures.
The middle-cell pressure was 20 mm Hg
lower and the proximal cell was in turn
20 mm Hg lower than that. The distal cell
was on for 90 seconds. The first delay
timer was set at 20 seconds so that the
middle cell was on for 70 seconds. The
second delay timer was also set for 20
seconds so that the proximal cell was on
for 50 seconds. The “ off timer” was set
at 30 seconds, thus making each cycle a
total of 120 seconds.
The women were arbitrarily divided
into two groups (mild and moderatesevere edema) to see if there was a rela
tion between volume of edema and
response to treatment. Measurements
were taken 6 cm below the olecranon,

Patient
no.
5
9
11
13

Results
All patients experienced a subjective
improvement. Even those who had little
objective improvement were pleased with
the results. All said the arm felt lighter
and pain free, and the skin felt smoother
and lax. The limb was less tense, and
some patients were pleased at being able
to see the elbow and wrist joints and ten
dons along the back of the hand for the
first time in years.
Objective improvement was less
marked (Table II). Eight patients had a
0.5- to 2-cm reduction, three had a 2- to
4-cm reduction and three others had a
4-cm reduction in arm circumference. The
patient with a 13.8 cm difference between
the two arms had the most marked reduc
tion (5.5 cm).
Discussion
The Wright linear pump is extremely
easy to use and is suitable for home ther
apy. Subjectively all patients felt
improved, but objectively the results were
mixed. In general, patients with more
edema had more fluid to lose and there
fore had a better response, although this
was not consistent (patients 3 and 13,
Table II). The disability perceived was not
in direct proportion to the amount of
edema as the tolerance of each patient
differed.
No conclusions can be drawn with such
small patient numbers, but there appears
to be no relation between prior episodes
of infection, duration of edema and
response to treatment (Table III). Under
lying infection will certainly aggravate
existing lymphedema as in patients 5, 9
and 13. In patient 11, the lymphedema
resulted from infection after a cut from
a chicken bone; three subsequent episodes
of infection aggravated the edema.
Some patients complained of stiffness
at the elbow joint and soreness through
out the arm but not pain while they were

Table III—Relation of Infection to Duration of Edema and Response
Reduction in
Difference in
Date of first
edema after
arm circumference,
infection and
treatment, cm*
cm*
no. of episodes
0.8
4.1
August 1982
5.5
1982
13.8
1984 6 X
1986
4.5
1983 4 X
7.0
1.2
1972 4 X
9.0

'Measured 6 cm below the olecranon.
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com paring the affected with the
unaffected arm. Those with a 2- to 5-cm
difference in circumference fell into group
1 (nine). A difference greater than 5 cm
put them into group 2 (six patients). (A
difference less than 2 cm would have not
been sufficient to require treatment.)

on the machine. A few patients had pre
existing arthritis which was aggravated by
the relatively long periods of immobili
zation.
One problem encountered was dif
ficulty in fastening the Wright linear
pump sleeve over the shoulder so that it
did not slide down. Many patients had
repeatedly to pull the sleeve up the arm.
This was a problem at night when they
were asleep and some had increased
edema in the axilla as a result.
It was explained to all patients that they
would require ongoing treatment and
would probably have to be on the pump
for several hours a day until a good
response was obtained. Thereafter the
time could be reduced to perhaps 1 to 2
hours a day. However, treatment would
be for an indefinite period as this treat
ment was only for symptoms.
The Wright linear pump is efficient and
has theoretical design advantages. A
phase III study would now include ran
domizing patients into two groups — one
group treated with the Wright linear
pump and the other with the Jobst inter
mittent pneumatic compression pump.
A relative disadvantage of the Wright
linear pump is its high cost, US $4000.00,
but this may be covered in part by some
insurance companies.
Patient motivation and compliance are
absolutely vital in order to obtain good
results.

■»

¥
4

k.

V

XA
i.

'w

A

V

r-

*

We thank Mrs. Evelyn White and Mrs.
Linda Moore for secretarial assistance.

References

V

r

1. BRITTON RC, N elson PA: Causes and treatment of
post-mastectomy lymphedema of the arm. Report of 114
cases. JA M A 1962; 180: 95-102

V
<

2. Stillwell GK: Treatment of postmastectomy lym
phedema. M od Treat 1969; 6: 396-412
3. E lkins EC, H errick JF, G rindlay JH, et al:
Effect of various procedure on the flow of lymph. A rch
Phys M ed 1953; 34: 31-39
4. STONE EJ, H ugo NE: Lymphedema. Surg Gynecol
Obstet 1972; 135: 625-631

■M

H

5. NlELUBOWICZ J, OLSZEWSKI W, SOKOLOWSKI J: Sur
gical lympho-venous shunts. J Cardiovasc Surg (Torino)
1968; 9: 262-267
6.

go ld sm ith HS, Santos R de los, Beattie EJ j r :
Omental transposition in the control of chronic lym
phedema. JA M A 1968; 203: 1119-1121

7. THOMPSON N: The surgical treatment of chronic lymphoedema of the extremities. Surg Clin North Am 1967;
47: 445-503

♦

8. L arson NE, C r a m p t o n AR: A surgical procedure for
postmastectomy edema. A rch Surg 1973; 106: 475-481
9. Sanderson RG, F letcher WS: Conservative manage
ment of primary lymphedema. Northwest Med 1965; 64:
584-588
10. A lexander MA, W right ES, Wright JB, et al: Lym
phedema treated with a linear pump: pediatric case report.
A rch Phys M ed Rehabil 1983; 64: 132-133

VOLUME 30, NO. 5, SEPTEMBER 1987 / THE CANADIAN JOURNAL OF SURGERY

f

S.S. S e t t , m d ;

.

BUSSE, MD, FRCSC, FACS; T. BOYD, MD, FRCSC, FACS;
J. B u r g e s s , m b , b c h , f r c sc , f a c s

Penetrating Chest Wounds: a 10-Year Review
From January 1975 to December 1984,
93 patients with penetrating chest
wounds were admitted to three hospitals
in Regina. Sixty-three percent of the
wounds were caused by knives and 34%
by firearms. Sixty-three patients were
treated conservatively, 18 patients had
thoracotomy and 12 others underwent
laparotomy. Of the 18 patients, 16 had
wounds between the nipples; 8 of the
16 had injuries to the heart or great ves
sels. Whereas the majority of penetrating
wounds to the chest may be treated by
observation or thoracostomy alone, a
surgical approach is recommended when
penetrating injuries are thought to have
traversed the mediastinum, because of
the high incidence of associated cardiac
injuries. In doubtful cases the decision
should favour early thoracotomy.
De janvier 1975 a decembre 1984, 93
patients avec blessures penetrantes a la
cage thoracique furent admis aux trois
hopitaux a Regina. Soixante-trois pourcent des blessures etaient la cause de
couteaux et 34% causes par arme a feu.
Soixante-trois patients furent soignes par
traitement conservateur, 18 patients
subirent une thoracotomie et 12 patients
ont recu une laparotomie. Seize des 18
patients avec thoracotomie avaient des
blessures entre les mamelons. Huit de
ces 16 avaient des blessures au coeur
ou grands vaisseaux. Tandis que la majo
rity des blessures penetrantes a la poitrine peuvent etre soignees par observa
tion ou thoracostomie seulement, les cas
oil on suspecte que les blessures pene
trantes pourraient avoir traverse le
mediastinum on recommande ['interven
tion chirurgicale par cause de I'association au taux eleve des blessures cardiaques. Dans les cas indecis la decision
devrait etre une thoracotomie des que
possible.
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Although the majority of patients sustain
ing penetrating chest wounds can be treat
ed conservatively by closed-tube
thoracostomy, a number require surgical
intervention. This study reports our ex
perience over 10 years and clarifies indi
cations for management.
Patients
From Jan. 1, 1975 to Dec. 31, 1984, 93
patients (83 males, 10 females) with
penetrating chest wounds were admitted
to one of three hospitals in Regina. The
patients ranged in age from 6 to 81 years
(average 26 years); 64% were under 30
years of age.
In 60 patients (63%) the wounds were
caused by knives; 37% of these wounds
were multiple. In 29 patients (34%) fire
arms (mostly of small calibre) were
responsible; 10% of the wounds were
multiple. In the remaining 3%, other
weapons were involved.
Findings
Location and Cause o f Wounds
The site of injury was divided into three
main areas based on the location of the
entrance wound — the anterior, lateral
and posterior chest wall (Table I). The
anterior chest was subdivided into the
Table 1—Location of Chest Wound
Location in
No. (%)
chest wall
of patients
Anterior
Between nipples
30 (32.2)
Nipple to anterior axillary line 33 (35.4)
Lateral
11 (11.8)
Posterior
> 5 cm from spine
4 (4.3)
< 5 cm from spine
15 (16.1)

area between the nipples and from the
nipples to the anterior axillary line. The
lateral chest extended from the anterior
to the posterior axillary line. The
posterior chest was subdivided into areas,
less and more than 5 cm from the spine
respectively.
There were three treatment regimens.
In 63 (68%) patients it consisted of obser
vation or tube thoracostomy, in 18
patients thoracotomy was performed and
another 12 underwent laparotomy (Table
II).
Thoracotomy
All patients who underwent thoracot
omy had the procedure within 24 hours
of admission to hospital, usually within
1 hour. Presenting features included signs
of cardiac tamponade, as evidenced by
increased central venous pressure and
hypotension (four patients), persistent
hypotension with a systolic blood pressure
of less than 100 mm Hg, tachycardia
(more than 100 beats/m in) (seven
patients) and continuing hemorrhage
(more than 250 m l/h) from the chest
tubes after an initial blood loss o f more
than 1000 ml of bright red blood (two
patients).
Of these 18 patients, 16 had wounds
between the nipples. Eleven of them were
operated on because o f signs o f cardiac
tamponade, persistent hypotension or
continuing hemorrhage from chest tubes.
Five were operated on principally because
the wound was between the nipples; that
is, there were no signs of cardiac tam 
ponade, and no shock or excessive chest
hemorrhage. There were, however, indi
cations of underlying injury as suggested
by indistinct heart sounds, neck-vein dis
tension and radiologic evidence of
intrathoracic bleeding. Of the 11 patients

Table II—Treatment Related to Type of Weapon Used
No. (%)
Treatment
of patients
Knife
Gun
Observation/tube thoracotomy
63 (68)
42
18
Thoracotomy
18 (19)
10
7
Laparotomy
12 (13)
8
4
Totals
93 (100)
60
29
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with obvious clinical signs, 5 had suf
fered injury to the heart or great vessels
(Tables III and IV) as had 3 of the
5 operated on principally because the
wound was between the nipples (Table
IV). Of the other two patients with
wounds outside the nipples who under
went thoracotomy, one was found to have
injury to a pulmonary artery (Table III).
Laparotomy
The most commonly injured structures
in the 12 patients who underwent
laparotomy were the diaphragm and
spleen. The diaphragm was injured in all
cases but only in seven were there major
lacerations (Table V).
Mortality and Morbidity
None of the patients died as a result of
injury. Atelectasis and consolidation
occurred in 44% but these complications
resolved with conservative management.
Pleural fibrosis developed in one woman,
who pulled her chest tube out and then
discharged herself 3 days after treatment
for a stab wound to the chest. She was
readmitted 3 weeks later complaining of
dyspnea, and a decortication for fibrothorax was required. None of the thoracot
omy wounds became infected.
T a b le Il l - T h o r a c o t o m y : O p e r a t iv e F in d in g s in
1 8 P a t ie n t s *
N o . o f in ju rie s

S tr u c t u r e in ju re d

8

V e n t r ic le s
A t r ia

1
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In t e r c o s t a l a r te r y

3
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2

D ia p h r a g m

2

P u lm o n a r y a r te r y

1

C o r o n a r y a r te r y

1

C o r o n a r y s in u s

1

O th e r

4

*T h e
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Gun

L in g u la
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Discussion
The majority of penetrating chest
wounds may be treated by observation or
tube thoracostomy, or both. In this ser
ies, 64% of patients were treated conser
vatively, a rate similar to that reported by
others.
Controversy remains concerning the
small group of patients requiring early
thoracotomy. In our series, surgery was
undertaken in 32% (thoracotomy 19%
and laparotomy 13%). In most series, the
proportion of patients requiring thoracot
omy has ranged from 15% to 21%.
The reported death rate has ranged from
10.4% to 17%.5 Our zero mortality is
attributed to the fact that the patients
underwent thoracotomy early, usually
within 1 hour of admission to the emer
gency room, and the majority of them
were young. The consequences of a delay
in the surgical management of penetrat
ing wounds of the chest have been iden
tified by McNamara and colleagues;5 the
operative death rate was reduced from
29% to 8% in the latter part of their ser
ies, when the indications for immediate
thoracotomy became more liberal.
Similarly, Robicsek and colleagues6
found a lower death rate in those patients
who underwent early as opposed to late
thoracotomy. Our experience supports
the early surgical treatment of penetrat
ing chest trauma when there is evidence
of any of the following findings: shock
unrelieved by aggressive fluid resuscita
tion, cardiac tamponade as evidenced by
hypotension and distended neck veins or
a high central venous pressure, continu
ing hemorrhage with an initial chest tube
loss of 1000 ml of bright red blood fol
lowed by a continuing loss exceeding 250
m l/h and mediastinal entrance of the
chest wound or suspicion that the trajec
tory or line of impalement may traverse
the mediastinum. Of four patients in
whom the wound was less than 5 cm from
the spine, one underwent thoracotomy
because of shock and one for cardiac tam
ponade. The first was found to be bleed
ing from a lacerated lung and the second
patient had a torn pulmonary artery.
Cardiac injury must be considered in any
patient with a mediastinal wound.8 In
this series, 50% of the patients with medi
astinal entrance wounds who underwent
thoracotomy had injuries to the heart or
great vessels.
Pericardiocentesis does not appear to
have a place in the treatment of cardiac
tamponade other than to decompress the
pericardium in the interval between the
patient’s admission and arrival in the
operating room. Pericardiocentesis was
attempted only once in this series and was
unsuccessful. The patient underwent
thoracotomy to relieve his tamponade.
Pericardiocentesis is associated with a
false-negative result in 25% of cases.3

In the majority of patients a left
anterolateral thoracotomy was performed
and in a few a median sternotomy. The
benefits of each are debatable. The choice
of incision may vary from surgeon to
surgeon.
Ideally, patients with wounds between
the nipples who may have suffered
cardiac injury, should be taken to a hospi
tal where cardiopulmonary bypass is
available. One of our patients was placed
on cardiopulmonary bypass while multi
ple penetrating wounds were repaired.
There were no complications and he was
discharged 33 days later. In none of these
patients did signs or symptoms of cardiac
decompensation develop. Because of the
transient nature of this group of patients,
follow-up was not feasible. Posttraumatic cardiac sequelae are relatively
common.2
Laparotomy, performed in 12 patients,
was accomplished through separate inci
sions in all but 1. There were two
major complications. In one patient, the
victim of a shotgun wound to the left
upper abdomen and left lower chest, a
colocutaneous fistula developed. The
other suffered a biliary-pleural fistula; he
had sustained a gunshot wound to the
right lower thorax and upper abdomen.
An anterolateral thoracotom y and
laparotomy were performed, and the
bullet was removed. Subsequently, bile
was noted draining through the chest tube
and a second laparotomy, with suturing
of the left lobe of the liver and repair of
the tear in the diaphragm, was necessary.
His postoperative course was smooth.
Since the final resting place of a bullet
penetrating the chest, especially in the
lower thorax, cannot always be ascer
tained, abdominal injury and subsequent
intra-abdominal hemorrhage should be
considered. Borja and Ransdell4 advo
cated separate thoracic and abdominal
incisions for combined injuries, to pre
vent contamination of the thoracic cavity
from the abdominal wound, osteomyeli
tis, osteochondritis and diaphragmatic
hernia.
Early complications, of which atelec
tasis was the commonest, developed in
44% of patients. None were incapacitat
ing. Delayed thoracotomy was performed
on a woman who had a retained
hemothorax, the circumstances being
previously outlined.
Conclusions
The majority of penetrating chest
wounds may be treated by observation or
tube thoracostomy, or both. Early thora
cotomy is indicated in the following cir
cumstances: in patients with wounds
between the nipples, when the injury is
thought to have traversed the mediasti
num and when there is any doubt about
the extent of injury.
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SESAP V Critique
ITEM 105
Hepatitis after transfusion in the United States is due to “ non-A, non-B hepatitis” in at least 80% of properly
studied patients. Retrospective studies indicate that this has probably always been the dominant form of posttrans
fusion hepatitis in this country. It is called non-A, non-B hepatitis because hepatitis A and B can now be ruled
out by serologic testing, and multiple different other agents, presumably viruses, are almost certainly responsible
for the problem.
Several recent prospective studies have shown that about 7.5% of all patients transfused with blood from volunteer
donors develop evidence of hepatitis within six months of transfusion. Available data suggest an incidence of 1%
to 2% after exposure to a single volunteer donor, but exposure to only a single donor is becoming increasingly
unusual in modern medical practice. These data, along with older studies using hepatitis B as the marker, indicate
that the risk of hepatitis after transfusion is cumulative and proportional to the number of donors to which the
patient is exposed. The impression that most of the risk occurs with the first exposure and decreases thereafter is
potentially dangerous as well as incorrect.
Testing for hepatitis B with currently available tests has not eliminated the transmission of this disease by trans
fusion. Blood is infective at a concentration of virus far below what can be detected by even these tests, although
most infective units are in the range of detectability.
Hepatitis A is rarely transmitted by transfusion, because the infective phase of this disease is associated with
clinical illness in the potential donor. Over 20% of multiply transfused recipients show serologic evidence of exposure
to cytomegalovirus, however, but this seems to cause clinical illness only in immunosuppressed patients or prema
ture infants. Apart from the incidence, the most disturbing observation about non-A, non-B hepatitis is its persis
tence for over a year in nearly half the patients affected, with changes on liver biopsy paralleling the degree of abnor
mality in liver function tests. Whether this disease behaves as other forms of chronic hepatitis do is now being studied.
Even when all available practical methods of screening for transmitted diseases are used, including some, such as
measuring alanine aminotransferase, not in general use, blood from commercial sources remains over twice as likely
to transmit hepatitis as blood from volunteer sources.
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Lower Extremity Amputations:
a 5-Year Review and Comparative Study
*
In order to review major lower extremity
amputations at the Toronto East General
and Orthopaedic Hospital Inc. between
1979 and 1984, 60 patients with 42
below-knee, 17 mid-thigh and 20 Cal
lander through-knee amputations were
studied retrospectively.
The three amputation groups demon
strated comparable rates of stump heal
ing. A previous history of vascular sur
gery on the extremity increased the risk
for both delayed healing and failure to
heal. The Callander through-knee ampu
tees were rehabilitated earlier and more
easily than were the mid-thigh amputees,
and once rehabilitated they were more
likely to continue using their prostheses.
The authors recommend that, when
possible, the chosen site of amputation
for the majority of patients should be
below the knee, but when this is not
practical a through-knee amputation
should be done in preference to a mid
thigh amputation.

Dans le but de comparer les principales
formes d'amputations de membres
inferieurs qui ont ete pratiquees au
Toronto East General and Orthopaedic
Hospital Inc. entre 1979 et 1984, 42
amputations sous le genou, 17 amputa
tions a mi-cuisse et 20 amputations
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selon la methode de Callander a travers
le genou ont ete etudiees retrospectivement sur 60 patients.
Les trois genres d'amputations ont
montre un taux de guerison equivalent.
On a aussi observe que dans les cas
d'antecedant de chirurgie vasculaire sur
la meme jambe, on court le risque d'une
guerison prolongee et d'un echec. ou les
deux. D'autre part, les amputes selon la
methode de Callander a travers le genou
ont ete retablis plus rapidement et avec
plus de facilite que les amputes a micuisse, et une fois retablis, ils ont eu
plus de tendance a se servir de leur prothese.
Les auteurs recommandent d'opter de
preference pour I'amputation au-dessous
du genou pour la majorite des patients,
mais si ce choix n'est pas possible on
donnera la priorite a I'amputation a
travers le genou plutot qu'a I'amputation
a mi-cuisse.

The through-knee amputation, despite a
long history of use in Europe, remains an
unpopular and infrequently performed
procedure in North America.1,2 In 1935,3
and again in 1938,1 Callander reported
on his modification of the through-knee
amputation. Apart from two notable ser
ies,2,4 the Callander amputation has
fallen out of favour in North America.
Objections raised to the performance of
this procedure include difficulty with
prosthetic fitting, poor cosmesis and
wound healing problems. A recent liter
ature review, however, confirms that
through-knee amputation remains popu
lar in Europe.5-11
The advantages of this amputation over
the above-knee one include the following:
it provides an excellent end-bearing stump
that, combined with lateral and ischial
bearing, facilitates ambulation with a
prosthesis and increases stability; because
the amputation cuts across tendons and
not muscles, it is technically a less bloody
procedure with less potential for infec
tion; the rate of prosthetic use is higher

than after other types of amputation;
and, finally, a longer lever arm provides
greater seating stability, especially for
patients with bilateral amputations.
The objectives of this study were to
compare below-knee, through-knee and
above-knee amputations with respect to
wound healing, level of amputation, dis
ease process, the presence or absence of
antecedent vascular surgery, revision
rates, mortality and the ultimate level
of rehabilitation achieved.

A

|i

y

Methods

A retrospective study was conducted
at the Toronto East General and
Orthopaedic Hospital Inc. on all ampu
tations performed by two staff surgeons
(I.J.H . and J.M.W .) between 1979 and
1984, inclusive. The in-hospital and out
patient charts of 60 patients (39 men, 21
women) were reviewed. Information on
rehabilitation and prosthetic function was
obtained by clinical review at recall
whenever possible. Patients living out
of town were followed up by telephone
interview; if the patient had died, the
relatives were questioned. The records
of the prosthetic supply company were
consulted for each patient.
All amputations were standard and
performed according to established prin
ciples. The majority of below-knee ampu
tations utilized the long posterior
myocutaneous flap. All above-knee
amputations employed the standard fishmouth incision with equal anterior and
posterior flaps. All through-knee ampu
tations were done by one surgeon
(J.M .W .), using a modification of the
Callander technique.
The Callander amputation embodies a
long, anterior, full-thickness flap, extend
ing medially from the adductor tubercle
down to and including almost the total
patellar tendon at its insertion into the
tibia and laterally to the superior margin
of the lateral condyle at its junction with
the femoral shaft. The flap should be
elongated and spatulate. Great care is
necessary in coring the patella from the
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patellar tendon as the residual raw area
is positioned over the severed end of the
femur during the final reconstruction.
A relatively short flap, no more than
7.5 cm long, with a gentle curve, should
be made posteriorly. This is a departure
from the technique of Callander, who
made a much longer flap. These soft tis
sues are severed and allowed to retract.
The femur is carefully transected
perpendicular to its long axis, just
above the adductor tubercle. Hemostasis
is assured and the flaps are approximated
and sutured with the material of the sur
geon’s choice. Hemovac drainage of the
amputation site is always used and
removed after 24 hours. The choice of
dressing is again at the discretion of the
operating surgeon.
The level of amputation was deter
mined solely by clinical judgement —
by assessing skin temperature and colour,
and the presence or absence of pulses
preoperatively, and whether the patient
would be able to walk with a prothesis.
Below-knee amputation was the preferred
choice of both surgeons, as preservation
of the knee joint provides easier rehabi
litation and virtually guarantees successful

prosthetic wear. Below-knee amputees
have a more stable gait with a prosthesis
than either Callander or above-knee
amputees.
A Callander procedure was chosen over
the mid-thigh amputation whenever the
operating surgeon (J.M.W.) thought the
patient was likely to walk postoperatively.
The final decision on the level of am pu
tation, however, was made at the time of
operation and depended on the vascular
ity of the tissues. Ancillary tests such as
fluorOcine dye studies, assessment of oxy
gen tension, Doppler studies and angiog
raphy were not used to determine the level
of amputation. Angiography was per
formed on 22 patients to determine their
suitability for vascular reconstruction.
The only real variability noted in the
study was the postoperative management
of below-knee amputations; one surgeon
(J.M .W .) favoured soft dressings and
delayed weight-bearing, the other (l.J.H .)
favoured an immediate application of a
cast with an early ambulation on a
pylon.12
Vascular surgery had been performed,
in the majority of cases, at our institution.
Included were a variety of arterial bypass

Table -Indication for Major Lower Extremity Amputations
Peripheral
Level of amputation
No.
vascular disease
Diabetes
Below-knee
42
15
26
Through-knee
20
13
7
17
Above-knee
13
4

Level of
amputation

No.

Below-knee
Through-knee
Above-knee

42
20
17

Table II- Results
Primary healing,
Delayed healing,
no. (%)
no. (%)
29 (69)
8 (19)
13 (65)
4 (20)
12 (71)
2 (12)

Failure,
no. (%)
3 (7)
2 (101
2 (12)

Other
1
—

-

Hospital
death,* no. (%)
2 (5.4)
1 15)
1 (6)

* < 3 0 d.

graft procedures with either synthetic
materials (Gore-Tex) or vein, embolectomies or sympathectomies, which could be
either surgical or chemical. An am puta
tion was said to have healed primarily if
it did so within 3 weeks from operation.
Delayed healing was present when an
amputation required 6 weeks or more to
heal, or if formal debridement or local
revision was required to achieve healing.
Failure was defined by the necessity to
revise the amputation to a higher level or
when the amputation had not healed at
the time of death (when this exceeded 6
weeks from operation).
Findings
The age of the 60 patients at the time
of amputation ranged from 37 to 84 years
(average 66.4 years). Forty-two belowknee amputations were done in 37
patients, 20 Callander amputations (20
patients) and 17 above-knee amputations
in 14 patients.
The indications for amputation are set
forth in Table I and the results in Table
II. In both the below-knee and throughknee groups, 75% of amputations with
delayed healing and 100% of stumps that
failed to heal and required revision were
associated with previous vascular surgery
on the extremity (Table III). In the above
knee group, all amputations with delayed
healing and 50% of those that failed to
heal were associated with previous vascu
lar surgery.
Twenty-eight (76%) of the 37 belowknee amputees were rehabilitated and 25
of them used their prostheses regularly.
Eleven (55%) of the 20 through-knee
amputees were rehabilitated and all used
their prostheses; 8 (57%) of the 14 above
knee amputees were successfully rehabili
tated and, of these, 7 used their prostheses
regularly.

Table Ill-Antecedent Vascular Surgery
Level of
amputation

No.

Study group
Previous vascular
surgery, no. (%)

Below-knee
Through-knee
Above-knee

42
20
17

20 (47.6)*
15 (75.0)
10 (58.8)

_______ Primary healing_______
No.
Previous vascular
surgery, no. (%)
(%)
29 (69.0)
13 (65.0)
12 (70.6)

Delayed healing

11 (37.9)
8 (61.5)
6 (50.0)

Failure

No.
(%)

Previous vascular
surgery, no. (%)

No.
(%)

Previous vascular
surgery, no. (%)

8 (19.0)
4 (20.0)
2 (11.8)

6 (75.0)
3 (75.0)
2 (100.0)

3 (7.1)
2 (10.0)
2 (11.8)

3 (100.0)
2 (100.0)
1 (50.0)

"Chemical sympathectomies.
Table IV—Rehabilitation

Amputation

No.

Above-knee
Through-knee
Below-knee
Unilateral
Bilateral
Bilateral
(excluding
below-knee)

14
20
37

Wearing
prosthesis
7
11
25
20
5
10

Time to
prosthesis wear
from operation

Never
fitted

3 mo
6 wk

2
3

4 wk

2

—

_

-

3

Wheelchair
1
—

1

Walker
No prosthesis Prosthesis
__

__

—

2

2

1
1

—

5

—

—
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Prosthesis
with cane

Community
ambulator
without assists

5
6

2
3

6
2
2

13
2
—

3 75

Discussion

The level of amputation did not signifi
cantly alter the likelihood of achieving
primary wound healing. The only iden
tifiable factor adversely influencing
wound healing was a history of vascular
surgery and was uniform in all groups
(Table III). This has been documented in
other studies.13,14 The rate of wound
infection and breakdown was approxi
mately the same at all levels, reflecting the
inaccuracy of determining level of ampu
tation by clinical judgement rather than
by the real status of the blood supply to
the tissues.
Although postoperative synovial
fistulas have been a distressing problem
in some series of through-knee amputa
tions,11’15 we did not encounter any case
in our study. Finally, contrary to the
experience in earlier series,3 and fortun
ately for our patients, we did not record
one case of gas gangrene. Routine admi
nistration of antibiotics preoperatively
and continued postoperatively may
explain this.
The near-universal unpopularity of the
Callander through-knee amputation
appears to be based on criticisms that can
no longer be substantiated. Newer light
weight materials facilitate fitting and con
tribute to a lighter end product (6 to 9 lbs)
that is minimally heavier than an above
knee (5 to 8 lbs) prosthesis. Newer inter
nal knee mechanisms, including hydraulic
and pneumatic swing phase control units,
provide a more cosmetically acceptable
prosthesis. Costs for through-knee prostheses are the same as those for above
knee units ($2753.00).
Functionally, the through-knee ampu
tation provides an excellent end-bearing
stump which, when combined with lateral
and ischial bearing in the prosthesis, con
tributes to an increased stability while
walking. It has been our impression that
through-knee amputees are rehabilitated
earlier and more easily than above-knee
amputees (Table IV), and this has been
the case in other studies.9 Furthermore,
once rehabilitated, it appears that
through-knee amputees are more likely to
continue using their prostheses than
above-knee amputees (Table IV). It
should be noted, however, that attempts
to determine frequency of prosthetic use
are notoriously inaccurate. Many patients
are seen after a long follow-up wearing
prostheses that are as new as the day they
were purchased and yet on direct ques
tioning they admit to daily use. In reality
there appears to be no easy way to recon
cile the conflicting evidence.
In our study, the below-knee amputees
ultimately achieved the best rehabilitation
with their prostheses. This was related to
their younger age (mean 64 years versus
71 and 67 for Callander and above-knee
respectively) and to the fact that their
376

knee joints were preserved, thus making
them more likely to use their prostheses.
Those below-knee amputees who were
unable to use their prostheses still found
the knee joint advantageous for seating
and transfers. For patients with above
knee and Callander amputations, their
seating stability was purely a function of
the length of their prostheses and there
fore the Callander group did better.
In general, bilateral amputees with any
combination other than bilateral belowknee amputations were not rehabilitated
well. Factors militating against rehabili
tation in such cases were loss of the knee
joint, advanced age, poor cardiovascular
status and high postoperative death rate.
Conclusions

We identified no statistically significant
difference in the rates of primary healing
amongst the three amputation groups
studied. Previous vascular surgery on the
extremity increased the risk for both
delayed healing and failure of healing.
Thirty-day in-hospital death rates were
comparable for all three amputation
groups studied.
The Callander amputation heals well
and provides an excellent end-bearing
stump for ultimate rehabilitation. Most
criticisms of the Callander through-knee
amputation seem no longer justified.
Below-knee amputation should be the
site of choice in the majority of patients.
If this is not possible, then the Callander
procedure should be performed in prefer
ence to a formal mid-thigh amputation.
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ANTIBIOTIC
ACTION
In vitro studies demonstrate that the bacteri
cidal action of cefoxitin, a cephamycin derived
from cephamycin C, results from the inhibition
of bacterial cell wall synthesis. Evidence
suggests that the m ethoxy group in the
7a position is responsible for the resistance of
cefoxitin to degradation by bacterial betalactamases.

INDICATIONS AND CLINICAL USES
TREATM ENT

The treatment of the following infections when
due to susceptible organisms:
1 - In tra -a b d o m in a l in fe c tio n s such as
peritonitis and intra-abdominal abscess
2 - G y n e c o lo g ic a l in fe c tio n s such as
endometritis and pelvic cellulitis
3 - Septicemia
4 - Urinary tract infections (including those
caused by Serratia m arcescens and
Serratia spp.)
5 - Lower respiratory tract infections
6 - Bone and jo in t infections caused by
Staphylococcus aureus
7 - Soft tissue infections such as cellulitis,
abscesses and wound infections
Appropriate culture and susceptibility studies
should be performed to determine the sus
ceptibility of the causative organism(s) to
MEFOXIN* Therapy may be started while
awaiting the results of these tests, however,
modification of the treatment may be required
once these results become available.
O rga n ism s p a rtic u la rly a p p ro p ria te fo r
therapy with MEFOXIN* are:
Gram positive

Staphylococci, penicillinase producing and
non-producing
Streptococci excluding enterococci
Gram negative (beta-lactamase producing
and non-producing strains)

E. coli
Klebsiella species (including K. pneumoniae)
Proteus, indole positive and negative
Haemophilus influenzae
Providencia species
Anaerobes

Bacteroides fragilis
MEFOXIN* may also be appropriate for the
treatment of infections involving susceptible
strains of both aerobic and anaerobic bacteria.
Clinical experience has demonstrated that
MEFOXIN* can be administered to patients
w h o are also re c e iv in g c a rb e n ic illin ,
gentam icin, tobramycin, or amikacin (see
PRECAUTIONS and ADMINISTRATION).
intravenous Administration

The intravenous route is preferable fo r
patients with bacteremia, bacterial septicemia,
or other severe or life-threatening infections,
or for patients who may be poor risks because
of lowered resistance resulting from such
d e b ilita tin g co n d itio n s as m a ln u tritio n ,
trauma, surgery, diabetes, heart failure, or
malignancy, particularly if shock is present or
impending.
PROPHYLACTIC USE

MEFOXIN* may be administered perioperatively (preoperatively, intraoperatively and
postop e ra tive ly) to patients undergoing
vaginal or abdominal hysterectomy and ab
dominal surgery when there is a significant
risk of postoperative infection or where the
occurrence of postoperative infection is
considered to be especially serious.
In patients undergoing cesarean section, intra
operative (after clamping the umbilical cord)
and postoperative use of MEFOXIN* may
reduce the incidence of surgery related post
operative infections.
Effective prophylactic use depends on the
time of administration. MEFOXIN* usually
should be given one-half to one hour before

the operation. Prophylactic administration
should usually be stopped within 12 hours. It
has been generally reported that continuing
adm in istra tio n of any a n tib io tic beyond
24 hours fo llow ing surgery increases the
possibility of adverse reactions but, in the
majority of surgical procedures, does not
reduce the incidence of subsequent infection.
If signs of postsurgical in fe ctio n should
appear, specimens for culture should be
obtained for identification of the causative
organism(s) so that appropriate therapy may
be instituted.
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MEFOXIN* is contraindicated in persons who
have shown hypersensitivity to cefoxitin or to
the cephalosporin group of antibiotics.
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Before therapy with MEFOXIN' is instituted,
careful inquiry should be made to determine
whether the patient has had previous hyper
sensitivity reactions to MEFOXIN*, cephalo
sporins, penicillins or other drugs. MEFOXIN"
should be given with caution to penicillinsensitive patients.
There is some clinical and laboratory evidence
o f p a rtia l c r o s s -a lle rg e n ic ity betw een
cephamycins and the other beta-lactam anti
b io tic s , p e n ic illin s and cephalosporins.
Severe reactions (including anaphylaxis) have
been re p o rte d w ith m ost b e ta -la cta m
antibiotics.
Pseudomembranous colitis has been reported
with virtually all antibiotics. This colitis can
range from mild to life threatening in severity.
Antibiotics should therefore be prescribed
with caution in individuals with a history of
gastrointestinal disease, particularly colitis. It
is important to consider a diagnosis of pseudo
membranous colitis in patients who develop
diarrhea in association with antibiotic use.
While studies indicate that a toxin produced
by Clostridium difficile is one primary cause of
antibiotic-associated colitis, other causes
should also be considered.
Any patient who has demonstrated some form
of allergy, particularlytodrugs,should receive
antibiotics including MEFOXIN* with caution.
If an allergic reaction to MEFOXIN* occurs,
administration of the drug should be discon
tinued. Serious hypersensitivity reactions may
require treatment with epinephrine and other
emergency measures.
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The total daily dosage should be reduced
when MEFOXIN* is administered to patients
with transient or persistent reduction of
urinary output due to renal insufficiency (see
DOSAGE AND ADMINISTRATION) because
high and prolonged serum antibiotic con
centrations can occur from usual doses.
In patients treated with MEFOXIN* a false
positive reaction to glucose in the urine may
occur with Benedict’s or Fehling's solutions
but not with the use of specific glucose
oxidase methods.
Using the Jaffe Method, falsely high creatinine
values in serum may occur if serum concen
trations of cefoxitin exceed 100#/g/mL. Serum
samples from patients treated with MEFOXIN*
should not be analyzed for creatinine if with
drawn within two hours of drug administration.
Increased nephrotoxicity has been reported
fo llo w in g co n co m ita n t adm inistration of
cephalosporins and aminoglycoside antibiotics.
The safety of MEFOXIN* in the treatment of
infections during pregnancy has not been
e s ta b lis h e d . If th e a d m in is tr a tio n o f
MEFOXIN* to pregnant patients is considered
necessary, its use requires thattheanticipated
benefits be weighed against possible hazards
to the fetus. Reproductive and teratogenic
studies have been performed in mice and rats
and have revealed no evidence of impaired
fertility or harm to the fetus due to MEFOXIN*.
Cefoxitin has been observed in the milk of
nursing mothers receiving the drug.
Prolonged use of MEFOXIN* may result in the
overgrowth of non-susceptible organisms.
Repeated evaluation of the patient's condition
is essential and if superinfection occurs
during therapy, appropriate measures should
be taken. S hould an organism become
resistant during antibiotic therapy, another
antibiotic should be substituted.

In children 3 months of age or older, higher
doses of MEFOXIN* (100 m g/kg/day and
above) have been a sso cia te d w ith an
increased incidence o f eo sin o ph ilia and
elevated SGOT.

ADVERSE REACTIONS
MEFOXIN* is generally well tolerated. Adverse
re a c tio n s ra re ly re q u ire d ce ssa tio n o f
treatment and usually have been mild and
transient.
Local Reactions
Thrombophlebitis has occurred with intra
venous administration. Some degree of pain
and tenderness is usually experienced after
in tra m u s c u la r in je c tio n s u sin g w ater.
Induration has occasionally been reported.
Allergic
M acu lo p a p u la r rash, u rtica ria , p ru ritu s,
eosinophilia, fever and other allergic reactions
have been noted.
Gastrointestinal
Symptoms of pseudomembranous colitis can
appear during or after antibiotic treatment.
Nausea and vomiting have been reported
rarely.
Blood
Transient eosinophilia, leukopenia, neutropenia,
hem olytic anemia, and throm bocytopenia
have been reported. Some individuals, particu
la rly those w ith azotem ia, may develop
positive direct Coombs tests during therapy
with MEFOXIN*.
Liver Function
Transient elevations in SGOT, SGPT, serum
LDH, and serum alkaline phosphatase have
been reported.
Kidney
Elevations in serum creatinine and/or blood
urea nitrogen levels have been observed. As
with the cephalosporins, acute renal failure
has been re p o rte d rare ly. The ro le of
MEFOXIN* in changes in renal function tests
is d iffic u lt to assess, since factors pre
disposing to prerenal azotemia or to impaired
renal function have often been present.

TREATMENT OF OVERDOSE
Other than general supportive treatment, no
specific antidote is known. MEFOXIN* can be
eliminated by dialysis in patients with renal
insufficiency.

DOSAGE AND ADMINISTRATION
MEFOXIN* may be administered intravenously
o r in tra m u s c u la rly when required. (See
complete monograph on ADMINISTRATION
and RECONSTITUTION.)
TREATMENT DOSAGE
Adults
The usual a d u lt dosage is 1 g or 2 g of
MEFOXIN* every 6 to 8 hours. Dosage and
route of administration should be determined
by severity of infection, susceptibility of the
causative organisms, and condition of the
patient. The usual adult dosages are shown in
the Table below.
Usual Adult Dosage
T yp e of
in fe c t io n

D a ily
Dosage

F re q u en c y
a n d R o u te

U n c o m p lic a te d
fo rm s * o f in 
fe c tio n s s u c h as
p n e u m o n ia ,
u rin a r y tra c t
in fe c tio n , s o ft
tis s u e in fe c tio n

3 -4 g

1 g e v e ry 6 -8 h
I.V. o r I.M .

M o d e ra te ly
se ve re o r se ve re
in fe c tio n s

6 -8 g

1 g e v e ry 4 h
or
2 g e v e ry 6 -8 h I.V.

In fe c tio n s
c o m m o n ly
n e e d in g a n t i
b io tic s in h ig h e r
d o s a g e (e .g . g a s
g a n g re n e )
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2 g e v e ry 4 h
or
3 g e v e ry 6 h I.V.

'I n c l u d in g p a t ie n t s
a b s e n t o r u n lik e ly

in

w h o r r i b a c t e r e m ia

is

Therapy may be started while awaiting the
results of susceptibility testing.
Antibiotic therapy for group A beta-hemolytic
streptococcal infectionsshould be maintained
for at least 10 days to guard against the risk of
rheum atic fever or glom erulonephritis. In
staphylococcal and other infections involving
a collection of pus, surgical drainage should
be carried out where indicated.

Adults with Impaired Renal Function
MEFOXIN* may be used in patients with
reduced renal function but a reduced dosage
should be employed and it is advisable to
m onitor serum levels in patients with severe
impairment.
In adults with renal insufficiency, an initial
loading dose of 1 g to 2 g should be given.
After a loading dose, the following recommen
dations for maintenance dosage may be used
as a guide:
RENAL
F U N C T IO N

C R E A T IN IN E
CLEARANCE
m L /m in

M ild >
im p a irm e n t
M o d e ra te
im p a irm e n t
S e ve re
im p a irm e n t
E s s e n tia lly
n o f u n c tio n

DOSE

FREQ UENCY

5 0 -3 0

1-2 g

e v e ry 8 -1 2 h

2 9 -1 0

1 -2 g

e v e ry 1 2 -2 4 h

9 -5

0.5-1 g

e v e ry 1 2 -2 4 h

<5

0.5-1 g

e v e ry 2 4 -4 8 h

In the patient undergoing hemodialysis, the
loading dose of 1 - 2g should be given after
each hemodialysis, and the maintenance dose
should be given as indicated in the Table
above.
Neonates (Including Premature Infants),
Infants and Children (See WARNINGS for
Neonates under ADMINISTRATION in the
complete monograph.)
P r e m a tu r e In fa n ts
w ith B o d y W e ig h ts
Above 1500 g

2 0 -4 0 m g /k g e v e ry 12 h I.V.

N e o n a te s

01 w e e k o f a g e2 0 -4 0 m g /k g e v e ry 12 h I.V.
2 0 -4 0 m g /k g e v e ry 8 h I.V.
1- 4 w e e k s o f a g e
In fa n ts

1 m o n th t o 2 y e a rs
o f age

2 0 -4 0 m g /k g e v e ry 6 h o r
e v e ry 8 h I.M . o r I.V.

C h ild r e n

2 0 -4 0 m g /k g e v e ry 6 h o r
e v e ry 8 h I.M . o r I.V.

In severe infections, the total daily dosage in
infants and children may be increased to
200 mg/kg, but not to exceed 12 g per day.
M EFOXIN* is not recom m ended fo r the
therapy of meningitis. If meningitis is sus
pected, an appropriate antibiotic should be
used.
At p re se n t there is in s u ffic ie n t data to
recommend a specific dosage for children
with impaired renal function. However, if the
administration of MEFOXIN* is deemed to be
essential the dosage should be m odified
co n siste nt with the recom m endations fo r
adults (see Table above).
PROPHYLACTIC USE
For prophylactic use, a three-dose regimen of
MEFOXIN* is recommended as follows:
Vaginal or abdominal hysterectomy and
abdominal surgery
2 g administered intram uscularly or in tra 
venously just prior to surgery (approximately
one-half to one hour before initial incision).
The second and third 2 g doses should be
administered at 2 -6 hour intervals after the
Initial dose.
Cesarean Section
The first dose of 2g should be administered
intravenously as soon as the umbilical cord
has been clamped. The second and third
2 g doses should be given intravenously or
intramuscularly four hours and eight hours
after the first dose.

AVAILABILITY
MEFOXIN* is supplied as sterile powder in
boxes of 10 vials:
3356 Ca - 1 g cefoxitin as sodium salt
3357 Ca - 2 g cefoxitin as sodium salt
Storage
MEFOXIN* in the dry state should be stored
below 30° C.
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Silastic Catheter Separation Due to Subcutaneous Suture
The development of large-bore, double
lumen Silastic catheters for introduction
into the superior vena cava has made it
possible for patients w ith renal failure to
receive immediate dialysis while awaiting
maturation of an arteriovenous fistula.
Although Infections and thrombotic com 
plications have been well documented,
separation of Silastic cannulas has sel
dom been described and is poorly
explained. The authors report tw o such
cases. In one the catheter was clearly
sheared off due to snaring by a sub
cutaneous suture. In the second case,
awareness of the possibility of such a
complication allowed the authors to
explore the catheter at the level of the
venotomy. By dividing the suture under
direct vision, they were able to remove
the snared catheter before it became
transected.

La mise au point de catheters de Silastic
de calibre important, a double paroi, pour
insertion dans la veine cave superieure, a
rendu possible la dialyse immediate des
patients souffrant d'insuffisance renale
en attendant la maturation d'une fistule
arterioveineuse. Alors que les infections
et les complications thrombotiques sont
bien connues, la separation de la canule
de Silastic a rarement ete decrite et elle
s'explique mal. Les auteurs en signalent
deux cas. Dans un cas, le catheter s'est
carrement detache a cause d'une defaillance d'une suture sous-cutanee. Dans le
second cas, les auteurs ayant a I'esprit
cette possibility, il leur fut possible
d explorer le catheter au niveau de la veinotomie. En divisant la suture sous ins
pection directe ils purent retirer le cathe
ter avant qu'il ne se sectionne.
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The use o f central venous access lines is
now well established in the treatment of
patients requiring vascular access for the
delivery o f drugs, blood products or
parenteral nutrition. Large-bore, double
lumen Silastic catheters have recently
been developed to allow temporary,
immediate hemodialysis for patients while
they await maturation o f an arteriovenous
fistula.1 Although infectious and throm
botic complications o f Silastic cannulas
are well documented,2’3 only a few cases
o f mechanical failure have been pub
lished.4' 10 We report two cases which
suggest that catheter separation may
result from the scissorlike action o f a sub
cutaneous suture.

Case Reports
Case 1
A 25-year-old man with renal failure due to
insulin-dependent diabetes required vascular
access for hemodialysis while awaiting matu
ration of an arteriovenous fistula. A double
lumen HemoCath dialysis catheter (Quinton
Inc., Seattle, Wash.) was inserted by cutdown
through a venotomy in the right internal jugu
lar vein because the large size of the catheter
precluded percutaneous insertion. A purses
tring suture of 5-0 Prolene controlled bleeding
at the venotomy site and, to prevent sharp
angulation, the catheter was secured in place
with a subcutaneous suture of 5-0 Prolene. A
postoperative chest x-ray film showed proper
placement above the right atrium and dialysis
proceeded without incident.
Maturation of a right Brescia-Cimino arteri
ovenous fistula allowed removal of the catheter
29 days after insertion. In the operating room,
the Dacron cuff was dissected free from the
surrounding tissue and the catheter was
removed using steady traction. However, the
catheter separated 4.2 cm distal to the cuff,
leaving a long segment in situ. An immediate
chest x-ray film demonstrated the catheter seg
ment in the internal jugular vein (Fig. 1). On
exploration of the neck, the end of the catheter
fragment was found at the entrance site to the
internal jugular vein, adjacent to the Prolene
retaining suture. This 14.8-cm segment was
withdrawn without incident (Fig. 2). It
exhibited a sharply cut edge, evidently where
it had been sheared off by the Prolene retain
ing suture.

Case 2
A 47-year-old woman with renal failure from

polycystic kidney disease underwent right
nephrectomy prior to a proposed renal trans
plant . Postoperatively her arteriovenous fistula
thrombosed and she required venous access for
hemodialysis until a permanent site could be
established. A HemoCath dialysis catheter was
inserted into the right internal jugular vein by
the cutdown technique and a pursestring of 5-0
Prolene was used to control bleeding at the
venotomy site. A subcutaneous retaining suture
was not placed in this patient. The catheter
functioned satisfactorily for 1 month, then
removal was indicated because peritoneal dial
ysis was satisfactory. The Dacron cuff was dis
sected free from the subcutaneous tissue by
sharp dissection, and the catheter was with
drawn approximately 3 to 4 cm before there
was increased resistance. After several unsuc
cessful attempts to remove the catheter, the old
incision was explored and the catheter exposed
down to its insertion into the internal jugular
vein. The pursestring suture at the site of the
venotomy had snared the catheter and only
after the suture was divided under direct vision

FIG . 1—Case 1. Chest x-ray film demon
strating fragment of distal catheter lying in
superior vena cava without evidence of migra
tion. Site of separation (arrow) corresponds to
position of subcutaneous retaining suture.

F IG . 2—Case 1. Two sections of Silastic
catheter after removal of distal fragment.
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could the catheter be removed. The catheter
had an indentation at the site of the pursestring
suture and it was clear that vigorous attempts
at withdrawal might have resulted in tran
section.
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Separation of a central venous catheter
is a serious complication, especially when
there is distal embolization which requires
complicated retrieval techniques and has
serious medicolegal implications.
Catheters inserted by the percutaneous
subclavian route such as the Hickman or
Broviac Silastic catheters are subject to
compression between clavicle and first
rib. Reports of separation after weeks or
months of catheter use have demon
strated this problem by virtue of compres
sion of the catheter at the separation
site.4,9 With other insertion techniques
separation has been reported5,8 but the
cause not clearly demonstrated. Because
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The objective of this book is to provide the
physician on the “ firing line” with a guide and
quick reference for the recognition and treat
ment of acute surgical emergencies. This text
is directed primarily to emergency physicians
and residents training in trauma surgery.
The advanced trauma life support course
(ATLS) deals with the “ first hour” of manage
ment of critically injured patients. This edition
covers full management and protocols to the
present. Management includes prehospital tri
age, organization of trauma services and emer
gency departments, planning for and handling
disaster situations, the initial and ongoing
management of the trauma patient. The major
revision and additions to this second edition
are in this field. A reference work of this nature
has been sorely needed. Although detailed
knowledge of each problem is beyond the scope
of this work, as a thumb-nail summary and ini
tial guide to management of trauma and acute
surgical emergencies, this text achieves its goal
as an emergency reference.
One criticism of the format is that the phy
sician must make an initial correct diagnosis,
and in order to derive full benefit from the
book have first studied the subject. It is not
primarily organized as a problem-solving text.
However, an initial understanding of the broad
scope of the contents provides the basis on
which to recognize the problem and use the text
as a quick reference guide. It was not intended
to, nor does it, replace detailed dissertations
in each specialty field.
The text consists of contributions from 48
recognized authorities. The first four chapters

of the findings in our two patients we
believe that a pursestring suture at the site
of the venotomy or a subcutaneous
retaining suture may snare the catheter
upon removal, leading to transection with
possible distal embolization. With the
experience gained from the first case, we
were aware of possible catheter transec
tion in the second case, and appropriate
steps were taken to divide the suture.
In case 1, the catheter was undoubtedly
sheared off at the level of the subcutane
ous retaining suture by its scissorlike
action when removal was attempted. We
now avoid using subcutaneous sutures to
stabilize the catheters, apart from those
needed to control bleeding at the venot
omy site. Because case 2 demonstrates
that even the pursestring suture may snare
the catheter, we advocate its removal in
the operating room with facilities availa
ble to perform an immediate cutdown
should there be resistance to catheter
withdrawal.

deal with the evaluation, monitoring and resus
citation of the patient. The next four give
guidance in radiologic investigations, anesthe
sia, ventilation and infection management. The
body of the text, 26 concise chapters, contains
a comprehensive review of surgical emergen
cies in each body system. A 150-page section
deals with emergencies in the pediatric patient.
The final chapter is devoted to appropriate
planning for surgical emergencies. The physi
cal characteristics of the emergency depart
ment, personnel organization, treatment pro
tocols, disaster planning and organization of
trauma services are outlined. The index is
detailed providing rapid direction to specific
problem areas.
I would recommend this text as required
reading for all emergency physicians, trauma
service personnel and those exposed to caring
for acute surgical emergencies.
C .M . Bu r n s , m d , frcsc
Director of Trauma Services,
GF419 General Centre,
Health Sciences Centre,
700 William Ave.,
Winnipeg, Man.
R3E 0Z3
VASCULAR SURGERY. A Comprehensive

Review. 2nd ed. Edited by Wesley S.
Moore. 994 pp. Illust. Grune & Stratton,
Inc., Orlando, Fla.; Academic Press
Canada, Don Mills, Ont., 1986. $166.75.
ISBN 0-12-792979-7.

This multiauthored text under the editorial
guidance of W.S. Moore was developed to
accompany the postgraduate review course in
general vascular surgery held at the University
of California at Los Angeles. It was designed
to help the vascular trainee and surgeon pre
pare for the examination to grant “ certifica
tion of special competence in general vascular
surgery” .
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Based on these goals, experts in the field of
vascular surgery have authored a textbook that
provides a strong flavour of basic science as
it pertains to vascular surgery and expert
reviews of day-to-day vascular topics.
O f particular excellence and importance are
the chapters on the pathogenesis o f atheros
clerosis, hemodynamics and the surgeon and
the noninvasive vascular laboratory. However,
certain chapters were obviously written close
to a deadline and detract from the book. An
example of this is the chapter on preoperative
evaluation of the vascular patient, which res
tricts itself to the cardiac system and ignores
renal, pulmonary, carotid and infectious
assessment. A further negative feature is the
poor quality o f the angiograms that are so
important in exemplifying certain points. One
angiogram is even printed upside down,
indicating that editorial review was often brief.
Outstanding reviews are offered by Dean
(renovascular hypertension), Moore (extra
cranial cerebrovascular disease) and Perry (vas
cular trauma). Their chapters give all levels of
vascular surgeons up-to-date and exact infor
mation in dealing with these im portant and
exciting areas o f vascular surgery.
Despite the variability in the style and depth
of the writing, this book is comprehensive yet
easily readable. The review questions at the end
of each chapter add further to the goal of the
book in aiding the trainee to prepare for board
examinations. It is a must for all vascular resi
dents and fellows in preparation for their
examination in vascular surgery. It should also
be a welcome and important addition to the
library of all vascular surgeons for ease of
review of a number of topics.
A .M . G r a h a m , m d , fr csc
Division of Cardiovascular and
Thoracic Surgery,
McGill University,
687 Pine Ave. W,
Montreal, PQ
H3A 1A1
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Aorta-Right Atrial Fistula:
an Unusual Complication of Ascending Aortic Dissection
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Ascending aortic dissection complicated
by aorta-right atrial fistula is a very rare
occurrence. The patient may present
with atypical clinical findings such as a
continuous murmur or atrioventricular
block, making the diagnosis difficult.
Surgical repair is straightforward unless
the correct diagnosis is missed, in which
case there may be difficulties during the
initial period of cardiopulmonary bypass.
This report deals with the successful
management of a 67-year-old man with
this condition.

On rencontre rarement une dissection de
I'aorte ascendante compliquee d’une fistule entre I'aorte et I'oreillette droite. Le
patient peut presenter des signes cliniques atypiques tels qu'un souffle continu
ou un bloc auriculoventriculaire, ce qui
rend le diagnostic difficile. La reparation
chirurgicale est simple a moins de rater
le diagnostic; en I'occurrence, des difficultes peuvent survenir pendant la
periode initiate de circulation extracorporelle. Cet article commente la reussite du
traitement chez un homme de 67 ans
souffrant de cette affection.

A orta-right atrial fistula has been well
described in patients with aneurysms of
the sinus of Valsalva, following trauma,
cardiac catheterization and acquired aor
tic aneurysms.1-3 A fistula arising from
rupture of the false channel of ascending
aortic dissection into the right atrium is
extremely rare. In Hirst’s exhaustive
review of dissecting aneurysms, this com
plication was not reported.4 To our
knowledge, the patient whose case we
describe here represents the third success-
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ful repair of an aorta-right atrial fistula
secondary to ascending aortic dissection.
Case Report
A 67-year-old man was admitted to hospi
tal with a diagnosis of possible ascending aor
tic dissection. Fifteen months previously he had
undergone aortic valve replacement with a no.
27 Ionescu-Shiley prosthesis for aortic insuffi
ciency. The cause of his disease was unclear,
and preoperative angiography revealed dilata
tion of the entire thoracic aorta. This was con
firmed at surgery, but it was thought that graft
replacement was not warranted. Biopsy of the
aortic wall later revealed mild intimal hyper
plasia. His postoperative course was compli
cated by sternal dehiscence. Otherwise recov
ery was smooth.
Five days before this admission (15 months
after the original operation) he was seen in the
emergency department with vague chest dis
comfort, diaphoresis and shock (blood pres
sure 80 mm Hg, pulse rate 140 beats/min).
There was no evidence of a new murmur and
the neck veins were not distended. He was
admitted to the coronary care unit where his
vital signs stabilized with volume replacement.
There were no changes in the electrocardiogram
or enzyme levels. The patient was discharged
home after 72 hours of observation. Two days
later he returned complaining of vague chest
discomfort. He was diaphorectic and hypoten
sive (blood pressure 70/50 mm Hg). A diastolic
murmur was now heard. The patient was
referred to our hospital with the provisional
diagnosis of ascending aortic dissection with
aortic insufficiency. On arrival, he was still
hypotensive. A 2-D echocardiogram revealed
an intimal flap in the ascending aorta. In view
o f his deteriorating clinical condition, aortog
raphy was not done before operation.
Cardiopulmonary bypass was instituted
through the femoral artery and a two-stage
right atrial cannula. During cardioplegic infu
sion into the coronary ostia, the venous can
nula filled with air and cardiopulmonary
bypass had to be discontinued. The aortic
lumen was inspected and a tear found in the
lateral wall communicating with the right
atrium. The defect measured approximately 2
x 2 cm. The intimal tear was 2 cm above the
left coronary ostium and 5 cm long. Cardiopul
monary bypass was restarted with two caval
cannulas and the fistula was closed with
sutures. The bioprosthetic valve appeared satis
factory and the coronary ostia retained their
usual spatial relationship with the aortic annu
lus. A woven Dacron tube graft was interposed

above the coronary ostia to the ascending aorta
below the innominate artery. An aortic wall
biopsy revealed intimal thickening with focal
atherosclerosis. The patient recovered without
complication and was well at follow-up 9
months later.
Subsequently, a large false aneurysm of the
distal anastomosis of the Dacron graft deve
loped, with a large hematoma extending into
the right chest and compressing the right
atrium, superior vena cava and lung. Under cir
culatory arrest this was repaired. A bleeding
duodenal ulcer then developed, requiring a
vagotomy apd pyloroplasty. Unfortunately, the
patient suffered severe sepsis with wound infec
tion (Escherichia colij and subsequent infec
tion of the ascending aorta Dacron graft. This
initially was drained by a small right anterior
thoracotomy, but despite this and the admi
nistration of antibiotics, the sepsis continued.
The Dacron graft was removed under deep
hypothermia and an aortic homograft was used
to reconstruct the aorta. He did well postoperatively, but bled profusely from the distal
anastomosis on postoperative day 10 and requi
red emergency re-sternotomy, repair of the
small dehiscence and placement of a right pectoralis muscle flap to cover a large space
around the homograft. At present, he appears
to be recovering satisfactorily.

F

V

f

Discussion
Kuipers and Schatz5 in 1963 were the
first to report aorta-right atrial fistula fol
lowing ascending aortic dissection.
Dulake and Ashfield6 reported a patient
with an ascending aortic dissection and
a continuous murmur who presented in
congestive failure. The patient improved
with medical therapy but died 3 months
later of congestive heart failure. The
antemortem diagnosis was aortic dissec
tion with aortic insufficiency. At autopsy,
an aorta-right atrial fistula was found.
Since then, four other patients with this
condition have been reported.7-10
Yacoub and associates" have
described the pathogenesis of this lesion.
The aortoatrial space is bounded by the
aortic media, aortic annulus and right
atrial wall. The medial layer of the aorta
is continuous with the aortic annulus
except in the region of the commissures.
In ascending aortic dissections, the false
lumen ruptures into this space then
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traverses the membranous septum into
the right atrium, creating a fistula.
These patients may present with the
usual features of aortic dissection. Addi
tionally, there may be atypical findings
suggesting the presence of an aorta-right
atrial fistula. Jugular venous distension
and other signs of acute right heart
failure, associated with a continuous mur
mur over the right sternal border, will
differentiate this complication from
ascending aortic dissection with aortic
insufficiency. The electrocardiogram may
indicate an atrioventricular block11 and
the chest x-ray film may reflect increased
pulmonary blood flow. Echocardiogra
phy and cardiac catheterization, with or
without oximetry, are also useful in estab
lishing the diagnosis.8
The size of the aorta-right atrial fistula
and the pulmonary vascular resistance
will dictate the magnitude of the left-toright shunt and hence determine the
patient’s hemodynamic status. The first
successful repair was described by Tem
ple and colleagues7 in 1966, and Page
and colleagues9 in 1973 also reported
their success. Repair of the fistula is
achieved using cardiopulmonary bypass
with cannulation and snaring of the venae
cavae and femoral artery. The left heart
is usually vented. With cardioplegic
arrest, the ascending aortic dissection is
repaired by graft interposition and closure
of the fistula. If the diagnosis is not sus
pected preoperatively, air will be siphoned
into the venous circuit via the fistula once
the aorta is opened. Either immediate
repair of the atrial defect or snared
bicaval cannulation will solve the
problem.
Our patient was unusual in that the
fistula occurred 15 months after aortic
valve replacement. The six previously
reported patients had no history of
cardiac surgery. Since our patient
presented with a dilated aorta and aortic
insufficiency, one must question the
histologic integrity of the aorta and
whether the initial procedure was the cor
rect one. The aortic biopsy specimens did
not reveal evidence of cystic medial necro
sis. The proximal aortic contour was not
consistent with that described for
annuloaortic ectasia. Most likely, the
patient’s aortic dissection was caused by
systemic hypertension superimposed on
a dilated, diseased aorta.
We acknowledge the assistance o f Dr. A.
Hess the cardiologist who initially referred this
patient to us and who subsequently managed
and diagnosed acute dissection.
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Diagnostic Ultrasound
A series of continuing education seminars
providing hands-on instruction in diag
nostic ultrasound are scheduled for the
fall, in Dallas and Nashville. Course
titles include: “ Cardiac 2-D/M-Mode
Imaging” , “ Cardiac Doppler” , “ A bdo
minal Imaging Techniques” , “ Ob/Gyn
Imaging Techniques” and “ Low er/
Upper Extremity Applications of Duplex
Technology” . For course dates, locations
and further information contact: Ms.
Barbara Bhatt, Keith Mauney and Asso
ciates, Inc., 1230 Riverbend Drive,
Suite 100, Dallas, Texas 75247; tele
phone; (214) 630-4288.

Hand Surgery
The American Association for Hand Sur
gery will be holding its 17th annual meet
ing in San Juan, Puerto Rico, Nov. 4-8,
1987. Instructional courses, panels and
scientific papers will highlight the meet
ing. Information can be obtained by writ
ing to: American Association for Hand
Surgery, 2934 Fish Hatchery Road, Suite
218, Madison, WI 53713 or calling: (608)
273-8940.
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GENERAL SURGEON: MB — Prospective partner
required to replace retiring surgeon. The group
services a productive economically stable region
of 180 000, located in a university city of 42 000.
Excellent schools, recreational and cultural facili
ties. The clinic having a modern laboratory, x-ray
and other diagnostic services is located adjacent
to a 220-bed acute care hospital. Interest in chest
or vascular surgery an asset but not essential.
Canadian fellowship is required. Contact: Mr. A.J.
Lockhart, Administrator, Box 280, Brandon, MB
R7A 5Z2.
-S 8 7 -5 3

CARDIO THORACIC SURGEON: US - Northear
stern, busy non-cardiac thoracic surgical group
w ith university affiliation has position leading to
early partnership available now or July 1988.
Please reply to: Box S 115 CJS.
-S 8 7 -5 8

GENERAL SURGEON: ON — required for a modern
medical clinic attached to a 45-bed hospital. Five
general practitioners. Located 120 miles from Ot
taw a in an unopposed catchm ent area of 8000
residents. An opportunity exists to develop an ex
cellent surgical practice. Good schools in a lovely
com m unity. All the amenities of a major center.
Situated in the picturesque Ottawa Valley. For in
formation call collect: Mr. G.C. Mahon, Adminis
trator, Deep River & District Hospital, tel:
(613) 584-33 33.
S87-57

4

GENERAL SURGEON: BC — required to move to
the beautiful Sunshine Coast and relieve the local
surgeon during his holidays. This is 10-12 weeks
a year. Ideal position for a general surgeon near
ing retirement. A pply to: Dr. E.J. Paetkau, Box
638, Schelt, BC VON 3A0.
-S 8 7 -5 4
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The Rockyview General Hospital, a 450 bed active
treatment hospital serving Calgary and Southern Alberta, is
seeking an individual to become Director of our Level 2
Trauma Unit. This hospital is a progressive, ultramodern
facility which already participates in existing air and ground
prehospital transport. Responsibilities: to coordinate clinical
activities of our Trauma Unit and assist in the development of
a regional trauma system, to organize and be responsible for
ongoing clinical teaching programs in trauma and clinical
research, to play an active role in the Department of Surgery
and head the Division of Trauma Surgery.
Requirements: Board certified General or Thoracic Surgeon
with special expertise and training in trauma surgery.
Replies should be directed to:
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The Director of Surgery
c/o Rockyview General Hospital
7007 -14 Street Southwest
Calgary, Alberta T2V 1P9
Calgary District Hospital Group owns and operates

Winthrop Laboratories
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Trauma Surgeon —
Director of Trauma Care

Johnson & Johnson Inc.
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Calgary District Hospital Group

Rockyview General Hospital, Holy Cross Hospital, Colonel Belcher Hospital

—S 8 7-59

VO LU M E 30, NO. 5, SE P TE M B E R 1987 / TH E CA N A DIA N JO U RN A L OF SURGERY

Innovative application

• simple 5-tab application method
• easy to use and manage

Sticks securely to skin yet
releases easily from itself

• BIOCLUSIVE adheres securely to dry
skin, not to moist wounds
• stays in place until removed
adhesive surfaces separate easily should
they come in contact
*

•

Promotes wound healing

• hypo-allergenic film dressing acts as a
bacterial barrier, prevents dehydration
• transparent to allow continuous
monitoring of wound site
• permeable to allow moisture vapour
and oxygen transmission
• impermeable to water and bacteria

Johnson j

19$5

HEALING
TEAM
On call to answer your needs in wound care

transparent
dressing

Now a monofilament suture
that is easy to handle and tie:

...n o w comes the
Even Greater Stapler

• Soft, supple, flexible
• Resists kinking
• Yields secure Knots

Ultra Light Compact
disposable skin stapler

•Strong

Automatically released staples
Improved staple visibility
Proven reliability
Allows for excellent accuracy
Quality stapler supplied inexpensively

the manageable monofilament.
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THE SMOOTH ONE

Y O U C A IS F E E L
N H W P R E -C Y D E *
(ChkxhexjdmeGluconate)

IVTew Pre-Cyde is the only
germicidal antiseptic hand
wash that com bines all the
effectiveness of chbrhexidine
with a gentle emollient to
sooth the skin.

IN

DEXON* PLUS

L
Pre-Cyde's broad antibacterial
spectrum makes it an excellent
bactericidal and fungiddal
antiseptic^

Excellent knot security plus superior handling
and smoother tissue passage.

quality professional products from
DAVIS+GECK
Cyanamid Canada Inc.

A T R A D IT IO N O F IN N O V A T IO N
Atria North, 2255 Sheppard Avenue East, Willowdale, (Ontario) M2J 4Y5
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